"","pathway","pval","padj","ES","NES","nMoreExtreme","size","leadingEdge"
"1","A tetrasaccharide linker sequence is required for GAG synthesis",0.801501435195407,0.977870017908165,0.313571621439179,0.426689742777246,3629,24,"AGRN, B3GALT6, B3GAT1, B3GAT2, B3GAT3, B4GALT7, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"2","ABC transporter disorders",0.840245221781464,0.977870017908165,-0.578009824879723,-0.748348594950982,4659,72,"UBB, OS9, PSMB2"
"3","ABC transporters in lipid homeostasis",0.186837702175125,0.977870017908165,-0.983470516799352,-1.34523174019988,1004,16,"ABCA2"
"4","ABC-family proteins mediated transport",0.550380572671258,0.977870017908165,-0.714205727974151,-0.965214808706629,3036,96,"ABCB10, UBB, OS9, PSMB2, ABCA2, ABCC5"
"5","ADP signalling through P2Y purinoceptor 1",0.567646521818514,0.977870017908165,-0.960251046025105,-1.24833753603402,3108,20,"GNB1, MAPK14"
"6","ADP signalling through P2Y purinoceptor 12",0.126343090033346,0.977870017908165,-0.988259901491127,-1.33369512801543,681,17,"GNB1"
"7","APC-Cdc20 mediated degradation of Nek2A",0.229412834030176,0.977870017908165,-0.979684125269978,-1.25371897984477,1261,22,"UBB, BUB3"
"8","APC/C-mediated degradation of cell cycle proteins",0.44981884057971,0.977870017908165,-0.808186239463283,-1.05342575138878,2482,77,"PTTG1, UBB, CUL1, PSMB2, BUB3"
"9","APC/C:Cdc20 mediated degradation of Cyclin B",0.0271410232899321,0.605187072507423,-0.997165800661313,-1.30911709078683,147,19,"UBB"
"10","APC/C:Cdc20 mediated degradation of Securin",0.531244404655327,0.977870017908165,-0.797573094159905,-1.01340827133035,2966,62,"PTTG1, UBB, PSMB2"
"11","APC/C:Cdc20 mediated degradation of mitotic proteins",0.50550243550424,0.977870017908165,-0.798638527888184,-1.02307694791015,2801,67,"PTTG1, UBB, PSMB2, BUB3"
"12","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1",0.507847735883096,0.977870017908165,-0.797567710580959,-1.02170520279119,2814,67,"PTTG1, UBB, PSMB2"
"13","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint",0.895694469464961,0.977870017908165,-0.546694685518648,-0.698560909270771,4971,66,"UBB, PSMB2, BUB3"
"14","ATF4 activates genes in response to endoplasmic reticulum  stress",0.784526712480603,0.977870017908165,0.4491540594873,0.614827232180216,3538,23,"ASNS, ATF3, ATF4, ATF6, CEBPB, CEBPG, DCP2, DDIT3, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"15","AUF1 (hnRNP D0) binds and destabilizes mRNA",0.866138898884491,0.977870017908165,-0.571643985904445,-0.71177637527212,4813,51,"UBB, HSPA8, PSMB2"
"16","AURKA Activation by TPX2",0.878220140515222,0.977870017908165,-0.559528114099914,-0.714959333795944,4874,66,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"17","Abortive elongation of HIV-1 transcript in the absence of Tat",0.447350919973398,0.977870017908165,0.970502868714141,1.32847868118032,2017,23,"NCBP2, CTDP1"
"18","Acetylcholine Neurotransmitter Release Cycle",0.602858380251191,0.977870017908165,0.573982958833738,0.869670113082422,2783,15,"RIMS1, CHAT"
"19","Activated NOTCH1 Transmits Signal to the Nucleus",0.38272052164463,0.977870017908165,-0.966704936854191,-1.1880285607282,2112,31,"UBB, NEURL1, MIB1, ITCH"
"20","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins",0.502072445485673,0.977870017908165,-0.798637157382645,-1.02523722054158,2785,68,"PTTG1, UBB, PSMB2, BUB3"
"21","Activation of ATR in response to replication stress",0.0401146131805158,0.745818523134684,-0.993717489698034,-1.21968839948576,223,35,"ORC3"
"22","Activation of BAD and translocation to mitochondria",0.620181896925076,0.977870017908165,0.526082315989729,0.797093468013528,2863,15,"YWHAZ, AKT1"
"23","Activation of BH3-only proteins",0.819200867835834,0.977870017908165,-0.600386032905947,-0.743137947059399,4530,28,"YWHAG, DYNLL1"
"24","Activation of G protein gated Potassium channels",0.633962956170915,0.977870017908165,-0.872079918196574,-1.14489959912983,3456,19,"GNB1, KCNJ6"
"25","Activation of GABAB receptors",0.771702744923008,0.977870017908165,0.599452567060058,0.783393868916205,3457,31,"ADCY1, KCNJ4, ADCY2"
"26","Activation of HOX genes during differentiation",0.680345572354212,0.977870017908165,-0.736970800750696,-0.911686616725056,3779,48,"CTCF, CREBBP, RBBP7"
"27","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon",0.22755158951478,0.977870017908165,-0.980585401200807,-1.3412853594889,1223,16,"UBB"
"28","Activation of Matrix Metalloproteinases",0.575573841489822,0.977870017908165,0.659328411155082,0.998981250336713,2657,15,"MMP16, COL18A1"
"29","Activation of NF-kappaB in B cells",0.822748475062792,0.977870017908165,-0.59499474923829,-0.757266448445839,4585,63,"UBB, CUL1, PSMB2, CHUK"
"30","Activation of NMDA receptors and postsynaptic events",0.733961417676088,0.977870017908165,0.615701420904807,0.824704252890808,3271,71,"NRG1, ADCY1, PPM1E, RPS6KA2, CREB1, CASK"
"31","Activation of anterior HOX genes in hindbrain development during early embryogenesis",0.680345572354212,0.977870017908165,-0.736970800750696,-0.911686616725056,3779,48,"CTCF, CREBBP, RBBP7"
"32","Activation of gene expression by SREBF (SREBP)",0.746669067338855,0.977870017908165,-0.687774321012061,-0.845667845696372,4146,41,"ACACA, CREBBP, HMGCR"
"33","Activation of kainate receptors upon glutamate binding",0.621338155515371,0.977870017908165,-0.891253262404779,-1.11441810941326,3435,26,"GNB1, NCALD"
"34","Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.963102951763859,0.982773823940463,-0.487063936892863,-0.602533604183939,5350,48,"EIF4E, EIF4A2"
"35","Activation of the pre-replicative complex",0.0484716947006692,0.79421098334342,-0.99371961102107,-1.2245813907096,267,30,"ORC3"
"36","Acyl chain remodelling of PC",0.133081537436125,0.977870017908165,0.989377274678471,1.36272444028369,598,22,"PLA2G3, PLA2G4E"
"37","Acyl chain remodelling of PE",0.133081537436125,0.977870017908165,0.989377274678471,1.36272444028369,598,22,"PLA2G3, PLA2G4E"
"38","Acyl chain remodelling of PS",0.447871416159861,0.977870017908165,0.971257000202415,1.43143456840051,2061,17,"OSBPL10, PLA2G4E"
"39","Adherens junctions interactions",0.790358744394619,0.977870017908165,0.549390548734477,0.730423658814986,3524,27,"CDH12, AFDN"
"40","Adrenaline,noradrenaline inhibits insulin secretion",0.111070515162587,0.977870017908165,-0.988254353989469,-1.2463778656152,607,24,"GNB1"
"41","Aggrephagy",0.641957275880957,0.977870017908165,-0.864787163829925,-1.12423337809212,3515,20,"UBB, DYNLL1"
"42","Amine ligand-binding receptors",0.752851711026616,0.977870017908165,0.604929101958136,0.800631116209434,3365,28,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, DRD1, DRD3, DRD4, DRD5, HRH1, HRH2, HRH3, HTR1A, HTR1B, HTR1F, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7"
"43","Amino acid transport across the plasma membrane",0.678026905829596,0.977870017908165,0.692479001760107,0.92066208143421,3023,27,"SLC6A15"
"44","Amino acids regulate mTORC1",0.513217047293652,0.977870017908165,-0.860986755536975,-1.06997697372578,2853,50,"ATP6V0C, ATP6V0B, ATP6V1C1, SESN1, ATP6V1H"
"45","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal",0.94170403587444,0.979935535138707,0.502461997959502,0.692866791015513,4199,86,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"46","Amplification of signal from the kinetochores",0.94170403587444,0.979935535138707,0.502461997959502,0.692866791015513,4199,86,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"47","Amyloid fiber formation",0.856139719121354,0.977870017908165,-0.580645762256998,-0.713945600873913,4754,41,"UBB, ITM2B, TSPAN5"
"48","Anchoring of the basal body to the plasma membrane",0.490777576853526,0.977870017908165,-0.752315891266636,-1.0105414149072,2713,92,"AHI1, YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"49","Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.400446179587284,0.977870017908165,-0.969068024485199,-1.32553141419312,2153,16,"SEC23A"
"50","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers",0.158968609865471,0.977870017908165,0.986361488083181,1.31138362081309,708,27,"TRPC1, AHCYL1"
"51","Antigen processing-Cross presentation",0.959453405017921,0.982248804367443,0.494252097065741,0.676139470720678,4282,81,"PSMA1, CTSS, PSMB3, PSMD14, PSME4, PSMD9"
"52","Antigen processing: Ubiquitination & Proteasome degradation",0.429036583030071,0.977870017908165,-0.650967029336256,-1.01914796409963,2239,281,"HECTD2, UBB, FBXO10, CUL3, FBXW7, CUL1, MGRN1, FBXW4, FBXL7, PSMB2, UBE2O, UBR2, WWP1, UBE2K, TRIM9, UBR1, RNF111, ITCH, RNF217, RNF6"
"53","Antiviral mechanism by IFN-stimulated genes",0.70508658008658,0.977870017908165,-0.66436249913592,-0.858385409103234,3908,71,"UBB, EIF4E, NUP98, EIF4A2, ARIH1, NEDD4"
"54","Apoptosis",0.849504950495049,0.977870017908165,0.526884860865662,0.780435955171046,3860,155,"BCL2L1, PSMA1, NMT1, YWHAZ, PSMB3, PSMD14, PSME4, ADD1, PSMD9"
"55","Apoptotic cleavage of cellular proteins",0.314363143631436,0.977870017908165,0.972366731977569,1.25721728818039,1391,37,"ADD1, ACIN1"
"56","Apoptotic execution phase",0.554334114254821,0.977870017908165,-0.856983737353119,-1.05551099678269,3075,44,"PAK2, DNM1L"
"57","Apoptotic factor-mediated response",0.634906886097878,0.977870017908165,0.454010659110841,0.687894118061998,2931,15,"APAF1, APIP, AVEN, BAK1, BAX, C1QBP, CASP3, CASP7, CASP9"
"58","Aquaporin-mediated transport",0.670428893905192,0.977870017908165,0.714816456478191,0.919653696636164,2969,39,"ADCY1, ADCY2"
"59","Arachidonic acid metabolism",0.00414115952466691,0.605187072507423,-0.999053862269379,-1.2284083624942,22,41,"PTGDS"
"60","Asparagine N-linked glycosylation",0.764125900644672,0.977870017908165,-0.544329348306025,-0.847175529533259,4029,264,"UBB, SEC23A, ST3GAL5, OS9, DYNLL1, ST6GALNAC3, TUSC3, SPTBN2, ARF4, MAN1A2, PREB, COPA, UGGT1"
"61","Assembly Of The HIV Virion",0.511991076408254,0.977870017908165,-0.962623127783025,-1.31671581732674,2753,16,"UBB, PPIA, FURIN"
"62","Assembly and cell surface presentation of NMDA receptors",0.795702840495266,0.977870017908165,-0.578041192712415,-0.734413622137146,4369,23,"CAMK2A, GRIN2B, CAMK2G"
"63","Assembly of collagen fibrils and other multimeric structures",0.499663752521856,0.977870017908165,0.832287955525827,1.07244865793102,2228,43,"CTSS, BMP1"
"64","Assembly of the pre-replicative complex",0.812342569269521,0.977870017908165,-0.602075043122976,-0.767121088687959,4514,64,"UBB, ORC3, PSMB2"
"65","Association of TriC/CCT with target proteins during biosynthesis",0.0680186647523331,0.894221428758959,-0.987904588147848,-1.21466975852881,378,39,"FBXW7, FBXW4, XRN2"
"66","Asymmetric localization of PCP proteins",0.590860215053763,0.977870017908165,-0.759375535850739,-0.96339341878249,3296,61,"PRICKLE1, UBB, PSMB2, DVL2"
"67","Attenuation phase",0.182265112891479,0.977870017908165,-0.982585217684779,-1.24839540481904,1000,23,"UBB, HSP90AB1, HSPA8, CREBBP"
"68","Autodegradation of Cdh1 by Cdh1:APC/C",0.915530846484935,0.977870017908165,-0.530821028359855,-0.671439415279443,5104,59,"UBB, PSMB2"
"69","Autodegradation of the E3 ubiquitin ligase COP1",0.925305975521958,0.977870017908165,-0.518826340370528,-0.641826013240189,5140,48,"UBB, PSMB2"
"70","Autophagy",0.406409322651129,0.977870017908165,-0.767712924181399,-1.05886564641606,2231,112,"PRKAG2, UBB, HSP90AB1, ATG4B, DYNLL1, HSPA8"
"71","Axon guidance",0.744359427113989,0.977870017908165,0.529261083786813,0.866367240929318,3793,471,"ROBO2, UNC5C, TYROBP, PSMA1, EPHA10, GFRA1, TREM2, PAK6, PAK3, RPS6KA2, PSMB3, TRPC1, CREB1, CLTA, LAMC1, TRPC4, ETF1, RNPS1, PSMD14, PSME4, CHL1, RHOA, PSMD9, NCBP2"
"72","B-WICH complex positively regulates rRNA expression",0.124752475247525,0.977870017908165,-0.984263136566257,-1.21276451115406,692,32,"SF3B1"
"73","BBSome-mediated cargo-targeting to cilium",0.390524684525127,0.977870017908165,0.974353782817034,1.3533946372037,1763,21,"LZTFL1, ARL6"
"74","BMAL1:CLOCK,NPAS2 activates circadian gene expression",0.76871609403255,0.977870017908165,-0.661506707225729,-0.827144297953637,4250,26,"CREBBP, CLOCK"
"75","Base Excision Repair",0.117673478553784,0.977870017908165,0.983304042179262,1.26401042207709,523,44,"PNKP, ACD"
"76","Base-Excision Repair, AP Site Formation",0.74935161170804,0.977870017908165,-0.423735002401203,-0.571846846582963,4044,17,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MUTYH, MPG, MBD4"
"77","Basigin interactions",0.507465404224326,0.977870017908165,-0.96294296321296,-1.22343950299845,2786,23,"PPIA, SLC7A6"
"78","Beta-catenin independent WNT signaling",0.27462467960454,0.977870017908165,-0.801303094904231,-1.141944331469,1499,137,"PRICKLE1, UBB, AGO2, ROR1, PRKG1, CLTC, GNB1, PSMB2, DVL2, CAMK2A"
"79","Beta-catenin phosphorylation cascade",0.680060816681147,0.977870017908165,0.361514067876662,0.532797944945464,3130,17,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, FRAT1, FRAT2, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"80","Bile acid and bile salt metabolism",0.563380281690141,0.977870017908165,0.829246005825963,1.08779809661366,2519,30,"CYP7B1, ABCB11"
"81","Binding and Uptake of Ligands by Scavenger Receptors",0.0708696624189582,0.894836219458653,0.992166396542409,1.30151572645546,316,30,"APOE, HBA1, ALB"
"82","Biological oxidations",0.683322375630068,0.977870017908165,0.600615979532267,0.870000497939925,3117,126,"CYP7B1, COMT, ABHD10"
"83","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",0.273940486925158,0.977870017908165,-0.909342222557297,-1.18199239431804,1518,75,"ST3GAL5, ST6GALNAC3, ST3GAL3"
"84","Blood group systems biosynthesis",0.582286704200953,0.977870017908165,0.637096744271881,0.965296946726709,2688,15,"ST3GAL4, B3GALT1"
"85","Branched-chain amino acid catabolism",0.63024840624313,0.977870017908165,0.672634469134003,0.961204328104395,2866,19,"ACAT1, ACAD8"
"86","Budding and maturation of HIV virion",0.176491862567812,0.977870017908165,-0.982041587901701,-1.22793932535146,975,26,"UBB, PPIA"
"87","Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",0.651957603287908,0.977870017908165,0.459823235730671,0.690524860574653,3013,16,"AKT1, DCP1A, DCP2, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"88","C-type lectin receptors (CLRs)",0.821950328707086,0.977870017908165,-0.561096896212959,-0.779994826046938,4500,117,"UBB, PDPK1, CUL1, PSMB2, CREBBP, CHUK, PAK2"
"89","CD209 (DC-SIGN) signaling",0.673979148566464,0.977870017908165,0.487131157180551,0.717931894017613,3102,17,"PAK3, RAF1"
"90","CD28 co-stimulation",0.844994617868676,0.977870017908165,-0.577856753924244,-0.710874233867006,4709,33,"PDPK1, PAK2"
"91","CD28 dependent PI3K/Akt signaling",0.0994364660970733,0.977870017908165,-0.990078293736501,-1.26702057976871,546,22,"PDPK1"
"92","CDK-mediated phosphorylation and removal of Cdc6",0.930102684201045,0.977870017908165,-0.518806896754543,-0.66292617640681,5162,66,"UBB, PSMB2"
"93","CDT1 association with the CDC6:ORC:origin complex",0.825767091333214,0.977870017908165,-0.602084727009688,-0.757124116204232,4601,55,"UBB, ORC3, PSMB2"
"94","CLEC7A (Dectin-1) signaling",0.809722474152004,0.977870017908165,-0.582838247256262,-0.784547022138369,4463,94,"UBB, PDPK1, CUL1, PSMB2, CHUK"
"95","COPI-dependent Golgi-to-ER retrograde traffic",0.756556339301863,0.977870017908165,-0.627019708568184,-0.818963936805572,4182,78,"ARF4, KIF3A, KIF3B, KIF21A, COPA, STX18, KIF5A"
"96","COPI-independent Golgi-to-ER retrograde traffic",0.598379837983798,0.977870017908165,-0.884868906275667,-1.09029543694853,3323,32,"GALNT2, DYNLL1, RAB6B"
"97","COPI-mediated anterograde transport",0.927717391304348,0.977870017908165,-0.520671759105412,-0.678666639296888,5120,77,"DYNLL1, SPTBN2, ARF4, COPA"
"98","COPII-mediated vesicle transport",0.856981473113421,0.977870017908165,0.558913494957033,0.733401043320585,3792,59,"LMAN2L, TBC1D20, TFG, SEC23IP"
"99","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling",0.799350415012631,0.977870017908165,-0.618550779631054,-0.770305082147914,4429,27,"RASGRF1, PDPK1, CAMK2A, GRIN2B, CAMK2G"
"100","CRMPs in Sema3A signaling",0.669478693489076,0.977870017908165,0.314372216974767,0.472098437892329,3094,16,"CDK5, CDK5R1, CRMP1, DPYSL2, DPYSL3, DPYSL4, DPYSL5, FES, FYN, GSK3B, NRP1, PLXNA1, PLXNA2, PLXNA3, PLXNA4"
"101","CTLA4 inhibitory signaling",0.790347575824662,0.977870017908165,0.245991573385783,0.341686646153387,3569,21,"AKT1, AKT2, AKT3, CD80, CD86, CTLA4, FYN, LCK, LYN, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E, PTPN11"
"102","Ca-dependent events",0.653342366757001,0.977870017908165,0.738745870512651,0.957781207399858,2892,33,"ADCY1, CREB1, ADCY2"
"103","Ca2+ pathway",0.258447160316319,0.977870017908165,-0.96313083479908,-1.21222849991178,1437,56,"AGO2, PRKG1, GNB1, CAMK2A, GNAO1"
"104","CaM pathway",0.650524436509708,0.977870017908165,0.738747777293553,0.965431647487234,2914,31,"ADCY1, CREB1, ADCY2"
"105","Calmodulin induced events",0.650524436509708,0.977870017908165,0.738747777293553,0.965431647487234,2914,31,"ADCY1, CREB1, ADCY2"
"106","Calnexin/calreticulin cycle",0.472415052977713,0.977870017908165,-0.964493047117591,-1.21641031037636,2585,24,"UBB, OS9, UGGT1"
"107","Cap-dependent Translation Initiation",0.749188604399567,0.977870017908165,-0.618136459980892,-0.821871508739564,4154,87,"EIF4E, EIF5, EIF4A2"
"108","Carboxyterminal post-translational modifications of tubulin",0.261435545109383,0.977870017908165,-0.975354490209318,-1.20726148475021,1445,28,"TUBB2A"
"109","Cardiac conduction",0.0696802646085998,0.894221428758959,0.92025676947842,1.32249109369003,315,119,"KCNIP4, KCND2, SLC8A3, TRPC1, KCNJ4, ATP1A1"
"110","Cargo concentration in the ER",0.775418994413408,0.977870017908165,0.579473480845325,0.763696531835456,3469,29,"LMAN2L, MIA3, CD59"
"111","Cargo recognition for clathrin-mediated endocytosis",0.38545256666062,0.977870017908165,-0.802276285688022,-1.0826148068744,2124,95,"UBB, CLTC, TFRC, SH3GL1, DVL2"
"112","Cargo trafficking to the periciliary membrane",0.65998917162967,0.977870017908165,-0.756931114096812,-0.93542149333773,3656,47,"ARF4"
"113","Caspase activation via extrinsic apoptotic signalling pathway",0.790347575824662,0.977870017908165,0.24564448172466,0.341204529697264,3569,21,"APPL1, CASP3, CASP8, CASP9, CD14, CFLAR, DAPK1, DAPK2, DAPK3, DCC"
"114","Cdc20:Phospho-APC/C mediated degradation of Cyclin A",0.891750720461095,0.977870017908165,-0.546696060235504,-0.698548323300767,4950,65,"UBB, PSMB2, BUB3"
"115","Cell Cycle Checkpoints",0.762308998302207,0.977870017908165,-0.550298619013324,-0.843654976221732,4040,234,"UBB, ORC3, YWHAG, SUMO1, DYNLL1, CENPP, PSMB2, BUB3, NUP98"
"116","Cell Cycle, Mitotic",0.201438848920863,0.977870017908165,-0.694735998623469,-1.14157487814112,1007,424,"PTTG1, UBB, HSP90AB1, ORC3, YWHAG, CUL1, DYNLL1, FBXL7, ARPP19, AKAP9, CENPP, PSMB2, PPP2R2A, CCND2, BUB3, LPIN2, NUP98, PCM1, MAX, SDCCAG8"
"117","Cell death signalling via NRAGE, NRIF and NADE",0.760619150467963,0.977870017908165,-0.632453203404028,-0.815788239537866,4225,70,"UBB, ARHGEF12, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"118","Cell junction organization",0.797351885098743,0.977870017908165,0.579497774259874,0.778410480324354,3552,72,"CDH12, SDK2, ACTN1, MPP5, FERMT2"
"119","Cell surface interactions at the vascular wall",0.300624442462087,0.977870017908165,0.814503564077212,1.13686658034798,1347,96,"ITGA4, SIRPA, SIRPG, CD47, ANGPT1"
"120","Cell-Cell communication",0.50745604273314,0.977870017908165,0.694164913259611,0.981324005213424,2279,104,"CDH12, TYROBP, KIRREL3, SIRPA, SIRPB1, SIRPG, SDK2, CASK, ACTN1, MPP5, CD47, FERMT2"
"121","Cell-cell junction organization",0.830531271015467,0.977870017908165,0.583082873156903,0.751218235491158,3704,47,"CDH12, SDK2, MPP5, AFDN"
"122","Cell-extracellular matrix interactions",0.411204845338525,0.977870017908165,0.973013088652004,1.46119133434196,1900,16,"ACTN1, FERMT2, ARHGEF6"
"123","Cellular Senescence",0.439919649379109,0.977870017908165,-0.74470981325868,-1.03523973340193,2408,117,"UBB, SCMH1, RBBP7, MAPK14"
"124","Cellular response to heat stress",0.300884955752212,0.977870017908165,-0.849273861440611,-1.14277526550187,1665,93,"CRYAB, UBB, HSP90AB1, HSPA8, HSPA4, CREBBP, HSPA9, ST13, NUP98, CAMK2A, CAMK2G"
"125","Cellular response to hypoxia",0.954406199315192,0.982248804367443,-0.504733848654111,-0.647943716772827,5295,68,"UBB, PSMB2, CREBBP, EGLN1"
"126","Cellular responses to external stimuli",0.176944780330512,0.977870017908165,-0.701471680545984,-1.15763083967072,877,442,"CRYAB, NR3C2, ATP6V0C, UBB, HSP90AB1, ATP6V0B, DYNLL1, HSPA8, DNAJA2, HSPA4, PSMB2, CREBBP, HSPA9, ST13, NUP98, CAMK2A, ATP6V1C1, SCMH1, EGLN1, CAMK2G, SESN1, TXNRD2, RBBP7"
"127","Cellular responses to stress",0.164413960056486,0.977870017908165,-0.708467039779342,-1.16750770861885,814,437,"CRYAB, NR3C2, ATP6V0C, UBB, HSP90AB1, ATP6V0B, DYNLL1, HSPA8, DNAJA2, HSPA4, PSMB2, CREBBP, HSPA9, ST13, NUP98, CAMK2A, ATP6V1C1, SCMH1, EGLN1, CAMK2G, SESN1, TXNRD2, RBBP7"
"128","Centrosome maturation",0.784375,0.977870017908165,0.585899533929982,0.792261031815652,3513,76,"CKAP5, CDK11A, CDK11B, DYNC1I2, TUBGCP4, ODF2"
"129","Chaperone Mediated Autophagy",0.666108942182562,0.977870017908165,-0.700426099443664,-0.958071853239143,3582,16,"UBB, HSP90AB1, HSPA8"
"130","Chaperonin-mediated protein folding",0.162509038322487,0.977870017908165,-0.960159902432414,-1.25627591558455,898,79,"FBXW7, FBXW4, GNB1, XRN2, TUBB2A, GNAO1, PFDN1"
"131","Chemokine receptors bind chemokines",0.343983932809932,0.977870017908165,-0.972735861789715,-1.26456794183669,1883,20,"CX3CL1"
"132","Cholesterol biosynthesis",0.767235646198182,0.977870017908165,0.513757075495829,0.703259458682538,3460,23,"GGPS1, ACAT2"
"133","Chondroitin sulfate biosynthesis",0.0257199384480106,0.605187072507423,0.997638167217761,1.42563928584636,116,19,"CSGALNACT1, BCAN"
"134","Chondroitin sulfate/dermatan sulfate metabolism",0.00939597315436242,0.605187072507423,0.997633856138453,1.28647922837113,41,46,"CSGALNACT1, AGRN"
"135","Chromatin modifying enzymes",0.149849962490623,0.977870017908165,-0.816909223736375,-1.21972718869571,798,192,"DOT1L, NCOR2, KAT6B, KDM1A, BRD1, CREBBP, CLOCK, ATF7IP, DNMT3A, SMARCA4, HDAC2, KDM2A, RBBP7, AEBP2"
"136","Chromatin organization",0.149849962490623,0.977870017908165,-0.816909223736375,-1.21972718869571,798,192,"DOT1L, NCOR2, KAT6B, KDM1A, BRD1, CREBBP, CLOCK, ATF7IP, DNMT3A, SMARCA4, HDAC2, KDM2A, RBBP7, AEBP2"
"137","Chromosome Maintenance",0.246228448275862,0.977870017908165,-0.96319350473613,-1.21517812669348,1370,58,"CENPP, RBBP7"
"138","Cilium Assembly",0.244469232199294,0.977870017908165,-0.778321018770283,-1.15157478507868,1314,178,"AHI1, YWHAG, DYNLL1, AKAP9, TTC26, ARF4, KIF3A, KIF3B, IFT20, PCM1, SDCCAG8"
"139","Circadian Clock",0.41511816705755,0.977870017908165,-0.854109335961469,-1.09413651120443,2300,67,"UBB, CRTC3, CUL1, MEF2D, CREBBP, CLOCK, CRY2"
"140","Citric acid cycle (TCA cycle)",0.704287936014219,0.977870017908165,0.607840871067969,0.83721309555734,3169,22,"FAHD1, SDHA, OGDH, ACO2"
"141","Class A/1 (Rhodopsin-like receptors)",0.916651093253598,0.977870017908165,-0.50286495394683,-0.75004695258405,4904,190,"OPRM1, CX3CL1, SST, CCK"
"142","Class B/2 (Secretin family receptors)",0.921289625360231,0.977870017908165,-0.522965996461502,-0.668226911703236,5114,65,"GNB1, RAMP1, GLP2R"
"143","Class I MHC mediated antigen processing & presentation",0.408401400233372,0.977870017908165,-0.640384091513845,-1.02212465463972,2099,325,"HECTD2, UBB, FBXO10, CUL3, FBXW7, SEC23A, CUL1, MGRN1, FBXW4, FBXL7, PSMB2, UBE2O, CHUK, UBR2, WWP1, UBE2K, TRIM9, UBR1, RNF111, ITCH, RNF217, RNF6"
"144","Class I peroxisomal membrane protein import",0.738184216311277,0.977870017908165,0.284503180483092,0.406559135739644,3357,19,"ABCD1, ABCD2, ABCD3, ACBD5, ALDH3A2, ATAD1, FIS1, GDAP1, PEX12, PEX13, PEX14, PEX16, PEX19, PEX2, PEX26, PEX3, PXMP2, PXMP4"
"145","Clathrin-mediated endocytosis",0.210718858606183,0.977870017908165,-0.838467018021662,-1.18950713340741,1151,133,"UBB, CLTC, TFRC, HSPA8, SYNJ1, SH3GL1, DVL2, BIN1"
"146","Cleavage of the damaged pyrimidine",0.70380687093779,0.977870017908165,-0.415826755717466,-0.580999098952627,3789,15,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MBD4"
"147","Cobalamin (Cbl, vitamin B12) transport and metabolism",0.122885294664436,0.977870017908165,-0.988665497233842,-1.35233764978315,660,16,"LMBRD1"
"148","Collagen biosynthesis and modifying enzymes",0.0463172164482603,0.79421098334342,0.986737938967454,1.2947882641094,204,59,"COL25A1, COLGALT1, ADAMTS14"
"149","Collagen chain trimerization",0.0735891647855531,0.918112436848329,0.990339143359006,1.28238494561152,325,36,"COL25A1, COL11A1"
"150","Collagen degradation",0.482905027932961,0.977870017908165,0.913657873241655,1.20412300500954,2160,29,"COL25A1, ADAM10"
"151","Collagen formation",0.2136292311141,0.977870017908165,0.908141263004867,1.2241030425116,952,74,"CTSS, COL25A1, COLGALT1, ADAMTS14"
"152","Complement cascade",0.479448961156278,0.977870017908165,0.893017850540782,1.15779424191844,2122,33,"C1QB, C1QA"
"153","Complex I biogenesis",0.799008562415502,0.977870017908165,0.597028185329191,0.777073430771236,3545,54,"NDUFS1, NDUFS4, ACAD9"
"154","Constitutive Signaling by AKT1 E17K in Cancer",0.757142857142857,0.977870017908165,-0.680882116603576,-0.851371201796556,4186,26,"PDPK1, CHUK"
"155","Constitutive Signaling by Aberrant PI3K in Cancer",0.541226690631319,0.977870017908165,0.732677974624567,0.972171409354064,2408,66,"NRG1, STRN"
"156","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants",0.027076809725548,0.605187072507423,-0.997165991902834,-1.32415297131429,146,18,"UBB"
"157","Constitutive Signaling by NOTCH1 HD Domain Mutants",0.245682451253482,0.977870017908165,-0.979154017405384,-1.36808801748896,1322,15,"UBB, NEURL1, MIB1"
"158","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0.860014357501795,0.977870017908165,-0.572616604027207,-0.721852514946058,4791,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"159","Constitutive Signaling by NOTCH1 PEST Domain Mutants",0.860014357501795,0.977870017908165,-0.572616604027207,-0.721852514946058,4791,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"160","Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase",0.605343179843614,0.977870017908165,0.657953539691297,0.969689218115619,2786,17,"ANAPC1, ANAPC10, ANAPC15, ANAPC16, ANAPC2, ANAPC4, ANAPC5, ANAPC7, CDC14A, CDC16, CDC20, CDC23, CDC26, CDC27"
"161","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding",0.419233524355301,0.977870017908165,-0.962980476930352,-1.18196180385245,2340,35,"GNB1, GNAO1"
"162","Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding",0.565731973780044,0.977870017908165,-0.959973000337496,-1.21966610203588,3106,23,"TUBB2A, PFDN1"
"163","Costimulation by the CD28 family",0.858504135203164,0.977870017908165,-0.577826145211748,-0.722505774012541,4774,53,"PDPK1, PAK2"
"164","Cristae formation",0.651755759337956,0.977870017908165,0.727709227528449,0.963132124452375,2913,28,"ATP5MG, APOO"
"165","Cross-presentation of soluble exogenous antigens (endosomes)",0.533109619686801,0.977870017908165,0.794242470044394,1.02419984417659,2382,46,"PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"166","Cyclin A/B1/B2 associated events during G2/M transition",0.177575205104831,0.977870017908165,-0.983329958831072,-1.2670445181545,973,21,"PPP2R2A"
"167","Cyclin A:Cdk2-associated events at S phase entry",0.819989155973251,0.977870017908165,-0.585624754473448,-0.768307589068374,4536,80,"UBB, CUL1, PSMB2, MAX"
"168","Cyclin D associated events in G1",0.102988836874325,0.977870017908165,-0.983104683381767,-1.20879770338924,571,41,"UBB, CUL1, PPP2R2A, CCND2"
"169","Cyclin E associated events during G1/S transition",0.826008319768493,0.977870017908165,-0.585628867809066,-0.764902468828455,4566,78,"UBB, CUL1, PSMB2, MAX"
"170","Cytochrome P450 - arranged by substrate type",0.0157409489543512,0.605187072507423,0.997957629973812,1.29832096107122,69,32,"CYP7B1, AHR"
"171","Cytosolic sensors of pathogen-associated DNA",0.177813736066163,0.977870017908165,-0.969834291511667,-1.21266730704226,988,53,"UBB, CREBBP, CHUK, LRRFIP1"
"172","Cytosolic sulfonation of small molecules",0.554968094804011,0.977870017908165,-0.960855773773368,-1.23808598524129,3043,21,"PODXL2"
"173","DAG and IP3 signaling",0.642050587172538,0.977870017908165,0.738742055404911,0.955153290438156,2842,37,"ADCY1, CREB1, ADCY2"
"174","DAP12 interactions",0.128159248490271,0.977870017908165,0.988183659689399,1.30787324318842,572,28,"TYROBP, TREM2, SIRPB1, B2M"
"175","DAP12 signaling",0.105602489995554,0.977870017908165,0.990616350502937,1.33246546142985,474,25,"TYROBP, TREM2, B2M"
"176","DARPP-32 events",0.0296795338674436,0.608916882116728,-0.996625042186973,-1.26623330027843,162,23,"PDE4A"
"177","DDX58/IFIH1-mediated induction of interferon-alpha/beta",0.517229002153625,0.977870017908165,-0.822928958879485,-1.03740152557796,2881,57,"UBB, CREBBP, CHUK, UBE2K, ITCH"
"178","DNA Damage Bypass",0.440216411181244,0.977870017908165,-0.940607744888092,-1.16204678082321,2440,45,"UBB, REV3L"
"179","DNA Damage Recognition in GG-NER",0.0150916277398491,0.605187072507423,-0.997162162162162,-1.22099379406952,83,38,"UBB"
"180","DNA Damage/Telomere Stress Induced Senescence",0.857558139534884,0.977870017908165,0.213672905544361,0.285537539415996,3834,26,"ACD, ASF1A, ATM, CABIN1, CCNA1, CCNA2, CCNE1, CCNE2, CDKN1A, CDKN1B"
"181","DNA Double Strand Break Response",0.672534578767738,0.977870017908165,-0.762898699468013,-0.938599379010568,3743,40,"UBB, SUMO1"
"182","DNA Double-Strand Break Repair",0.410704432591503,0.977870017908165,-0.749540211385826,-1.05207092817878,2232,125,"UBB, SUMO1, SUMO2"
"183","DNA Repair",0.160258850399695,0.977870017908165,-0.761899439586911,-1.18876876237871,841,271,"UBB, ASCC2, SUMO1, REV3L, SUMO2, RNF111"
"184","DNA Replication",0.655758683729433,0.977870017908165,-0.641999193706418,-0.892982563209019,3586,118,"UBB, ORC3, CUL1, PSMB2"
"185","DNA Replication Pre-Initiation",0.795191612436732,0.977870017908165,-0.602058877066417,-0.787735527286986,4398,79,"UBB, ORC3, PSMB2"
"186","DNA strand elongation",0.874581566614595,0.977870017908165,0.297764570811103,0.389133272542167,3918,31,"CDC45, DNA2, FEN1, GINS1, GINS2, GINS3, GINS4, LIG1, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MCM8, PCNA, POLA1, POLA2, POLD1, POLD2, POLD4, PRIM1, PRIM2, RFC1, RFC2, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3"
"187","Deactivation of the beta-catenin transactivating complex",0.731873653984207,0.977870017908165,-0.705660285850145,-0.867638655898911,4077,39,"UBB, TLE4"
"188","Deadenylation of mRNA",0.672813584078875,0.977870017908165,-0.792787192143771,-1.03063257690449,3684,20,"EIF4E, CNOT6L, CNOT4, EIF4A2"
"189","Deadenylation-dependent mRNA decay",0.96397207836073,0.982773823940463,0.477918932662444,0.618213395364663,4280,50,"LSM7, CNOT7"
"190","Death Receptor Signalling",0.573340667400073,0.977870017908165,-0.668313230084316,-0.941293176106691,3126,127,"UBB, ARHGEF12, MADD, ARHGEF11, ARHGEF7, ARHGEF18, CHUK, SPPL2A, FGD4, HDAC2"
"191","Dectin-1 mediated noncanonical NF-kB signaling",0.831537356321839,0.977870017908165,-0.595001892929517,-0.750662542961442,4629,58,"UBB, CUL1, PSMB2, CHUK"
"192","Defective B3GALT6 causes EDSP2 and SEMDJL1",0.70413295429696,0.977870017908165,0.327350427350427,0.475388937595279,3219,18,"AGRN, B3GALT6, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"193","Defective B3GALTL causes Peters-plus syndrome (PpS)",0.0266485998193315,0.605187072507423,0.996217494089835,1.29159218671515,117,33,"ADAMTS17, ADAMTS1"
"194","Defective B3GAT3 causes JDSSDHD",0.70413295429696,0.977870017908165,0.327350427350427,0.475388937595279,3219,18,"AGRN, B3GAT3, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"195","Defective B4GALT7 causes EDS, progeroid type",0.70413295429696,0.977870017908165,0.327350427350427,0.475388937595279,3219,18,"AGRN, B4GALT7, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"196","Defective CFTR causes cystic fibrosis",0.853627873563218,0.977870017908165,-0.578024899924119,-0.729244135906423,4752,58,"UBB, OS9, PSMB2"
"197","Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)",0.538272706985048,0.977870017908165,0.853823482726092,1.11581819523226,2411,31,"NUP93, RANBP2, AAAS"
"198","Defects in vitamin and cofactor metabolism",0.167969460098164,0.977870017908165,-0.983801295896328,-1.25898779539906,923,22,"ACACA, LMBRD1, MCCC1"
"199","Degradation of AXIN",0.927760763826338,0.977870017908165,-0.518822023658092,-0.64651479844181,5149,52,"UBB, PSMB2"
"200","Degradation of DVL",0.857117181883537,0.977870017908165,-0.576766136731002,-0.723225118780271,4768,54,"UBB, CUL3, PSMB2, DVL2"
"201","Degradation of GLI1 by the proteasome",0.868652431365512,0.977870017908165,-0.568262737838829,-0.714592820340879,4840,55,"UBB, CUL1, PSMB2, ITCH"
"202","Degradation of GLI2 by the proteasome",0.855319913731129,0.977870017908165,-0.576761786548622,-0.725931566151266,4758,56,"UBB, CUL1, PSMB2"
"203","Degradation of beta-catenin by the destruction complex",0.778058007566204,0.977870017908165,-0.606428727456457,-0.800245854593067,4318,82,"UBB, CUL1, PSMB2, TLE4"
"204","Degradation of the extracellular matrix",0.21343518310492,0.977870017908165,0.878832488689107,1.20992416813438,949,85,"CTSS, COL25A1, LAMC1, MMP16, A2M"
"205","Deposition of new CENPA-containing nucleosomes at the centromere",0.498173182316405,0.977870017908165,-0.963277980288916,-1.21487787857438,2726,24,"CENPP, RBBP7"
"206","Depyrimidination",0.70380687093779,0.977870017908165,-0.415826755717466,-0.580999098952627,3789,15,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MBD4"
"207","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",0.558932866827028,0.977870017908165,0.798845758978079,1.16010979346164,2555,18,"PRDX1, APP"
"208","Detoxification of Reactive Oxygen Species",0.523128491620112,0.977870017908165,0.873759765690834,1.15154070854463,2340,29,"PRDX1, ATOX1"
"209","Deubiquitination",0.759332954330112,0.977870017908165,-0.555392852821544,-0.843542037335927,4006,221,"UBB, USP47, PSMB2, SMAD7, ASXL1"
"210","Disassembly of the destruction complex and recruitment of AXIN to the membrane",0.300307358524679,0.977870017908165,-0.972788656313302,-1.20408558053279,1660,28,"DVL2"
"211","Diseases associated with N-glycosylation of proteins",0.641142115509409,0.977870017908165,0.510642963162866,0.766841763403185,2963,16,"ALG1, ALG11, ALG12, ALG14, ALG2, ALG3, ALG6, ALG8, ALG9, B4GALT1"
"212","Diseases associated with O-glycosylation of proteins",0.0923423423423423,0.977870017908165,0.982346973283734,1.277256191688,409,53,"ADAMTS17, LARGE1, ADAMTS1"
"213","Diseases associated with glycosaminoglycan metabolism",0.505420054200542,0.977870017908165,0.85483363183662,1.10525338344034,2237,37,"EXT1, ACAN"
"214","Diseases associated with glycosylation precursor biosynthesis",0.670127622755786,0.977870017908165,0.313562609634327,0.470882635922276,3097,16,"CTSA, DHDDS, DOLK, DPM2, DPM3, GALE, GALK1, GFPT1, GLB1, GNE, MPI, NEU1, NUS1, PGM1, PMM2"
"215","Diseases associated with the TLR signaling cascade",0.253085282740836,0.977870017908165,-0.978744939271255,-1.29969135531965,1373,18,"CHUK"
"216","Diseases of Immune System",0.253085282740836,0.977870017908165,-0.978744939271255,-1.29969135531965,1373,18,"CHUK"
"217","Diseases of carbohydrate metabolism",0.650787900742619,0.977870017908165,-0.833328777847247,-1.02411640906783,3592,31,"UBB"
"218","Diseases of glycosylation",0.0248406243130358,0.605187072507423,0.963931863572417,1.38965016409357,112,121,"ADAMTS17, LARGE1, EXT1, ACAN"
"219","Diseases of metabolism",0.929883512544803,0.977870017908165,0.509671810674905,0.697233720113367,4150,81,"CYP7B1, GALNS, ABCA3"
"220","Diseases of signal transduction",0.578491234981288,0.977870017908165,-0.584706576986688,-0.940911516942122,2936,350,"MAML3, SPRED2, UBB, PTPN12, NEURL1, FGFR1, FBXW7, SPRED1, ZMYM2, NCOR2, OS9, PDPK1, CUL1, AKAP9, IQGAP1, PSMB2, CREBBP, FXR1, MIB1, CHUK, HDAC9, CAMK2A, LRRFIP1, MYO18A, CAMK2G, FGFR2, ZFYVE9, NF1, HDAC2"
"221","Disorders of transmembrane transporters",0.534231448763251,0.977870017908165,0.649650000856264,0.956664265198867,2418,149,"SLC1A3, PSMA1, NUP93, PSMB3, SLC4A4, RANBP2, PSMD14, PSME4, VCP, PSMD9"
"222","Dopamine Neurotransmitter Release Cycle",0.669031256927511,0.977870017908165,0.673961393751736,0.92255610199693,3017,23,"RIMS1, CASK, APBA1"
"223","Downregulation of ERBB2 signaling",0.822645739910314,0.977870017908165,0.50089890008413,0.665953224238443,3668,27,"NRG1, AKT1"
"224","Downregulation of SMAD2/3:SMAD4 transcriptional activity",0.410652608616615,0.977870017908165,-0.968210043196544,-1.23903539551314,2258,22,"UBB, NCOR2, SKIL, RNF111"
"225","Downregulation of TGF-beta receptor signaling",0.425497287522604,0.977870017908165,-0.966041047799082,-1.20793233923099,2352,26,"UBB, PMEPA1, SMAD7, ZFYVE9"
"226","Downstream TCR signaling",0.827548806941432,0.977870017908165,-0.582859685015696,-0.762615250434244,4577,79,"UBB, PDPK1, CUL1, PSMB2, CHUK"
"227","Downstream signal transduction",0.894232507683963,0.977870017908165,-0.285989196488859,-0.353987955601211,4945,28,"STAT6, STAT5B, STAT3, STAT1, SRC, SOS1, RASA1, RAPGEF1, PTPN11, PLCG1, PIK3R2, PIK3R1, PIK3CB, PIK3CA, PDGFRB, PDGFRA, PDGFB, PDGFA, NRAS, NCK2, NCK1"
"228","Downstream signaling events of B Cell Receptor (BCR)",0.770471014492754,0.977870017908165,-0.620778626405204,-0.809150365392614,4252,77,"UBB, CUL1, PSMB2, PPIA, CHUK"
"229","Downstream signaling of activated FGFR1",0.0450271247739602,0.786473779385172,-0.994869025114772,-1.24397868131301,248,26,"FGFR1"
"230","Downstream signaling of activated FGFR2",0.412839059674503,0.977870017908165,-0.966716176073454,-1.20877651586055,2282,26,"FGFR2"
"231","Downstream signaling of activated FGFR3",0.843590677348871,0.977870017908165,-0.313668579142761,-0.398522597114382,4632,23,"SOS1, SHC1, PTPN11, PLCG1, PIK3R1, PIK3CA, NRAS, KRAS, HRAS, GRB2, GAB1, FRS3, FRS2, FGFR3, FGF9, FGF5, FGF4, FGF23, FGF20, FGF2, FGF18, FGF16, FGF1"
"232","Downstream signaling of activated FGFR4",0.843590677348871,0.977870017908165,-0.313668579142761,-0.398522597114382,4632,23,"SOS1, SHC1, PTPN11, PLCG1, PIK3R1, PIK3CA, NRAS, KRAS, KLB, HRAS, GRB2, GAB1, FRS3, FRS2, FGFR4, FGF9, FGF4, FGF23, FGF20, FGF2, FGF18, FGF16, FGF1"
"233","Dual Incision in GG-NER",0.0141907670199389,0.605187072507423,-0.997161778618732,-1.22681481412574,78,40,"UBB"
"234","Dual incision in TC-NER",0.0034184958618208,0.605187072507423,-0.997157167997834,-1.27050656067679,18,64,"UBB"
"235","E2F mediated regulation of DNA replication",0.0628081066277159,0.877638609944617,-0.993723849372385,-1.29185256996984,343,20,"ORC3"
"236","E3 ubiquitin ligases ubiquitinate target proteins",0.599204915070473,0.977870017908165,-0.824247508784108,-1.01517487005169,3315,42,"UBB, SELENOS"
"237","ECM proteoglycans",0.0994138863841298,0.977870017908165,0.983163161809453,1.27055787598836,440,49,"TNR, LAMC1, ACAN"
"238","EGFR downregulation",0.586574995476751,0.977870017908165,-0.918754891364661,-1.13710015098039,3241,29,"UBB, PTPN12, ARHGEF7, SH3GL1"
"239","EML4 and NUDC in mitotic spindle formation",0.943468468468468,0.979935535138707,0.502457309651458,0.695118732460709,4188,90,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"240","EPH-Ephrin signaling",0.973570658036677,0.983570292566566,-0.491493911627657,-0.655519589354798,5414,88,"EPHA3, CLTC, ARHGEF7, PAK2, LIMK2, GRIN2B"
"241","EPH-ephrin mediated repulsion of cells",0.921318090114324,0.977870017908165,0.507483555707069,0.653819411973119,4109,47,"EPHA10, CLTA, ADAM10"
"242","EPHB-mediated forward signaling",0.636022178501163,0.977870017908165,-0.829542684146877,-1.02030443124316,3555,34,"LIMK2, GRIN2B"
"243","ER Quality Control Compartment (ERQC)",0.486154410416285,0.977870017908165,-0.964505027329779,-1.2662387885644,2650,19,"UBB, OS9, UGGT1"
"244","ER to Golgi Anterograde Transport",0.83238137082601,0.977870017908165,0.539526141668252,0.77979009061313,3788,124,"LMAN2L, TMED9, MIA3, TBC1D20, DYNC1I2, TFG, ACTR10, SEC23IP"
"245","ER-Phagosome pathway",0.895893371757925,0.977870017908165,-0.543931563699065,-0.699797445185018,4973,69,"UBB, PSMB2, CHUK"
"246","ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression",0.500650678564789,0.977870017908165,-0.963297800566725,-1.31763866272716,2692,16,"HDAC2, RBBP7"
"247","ERK/MAPK targets",0.484835067522692,0.977870017908165,0.948612048115228,1.31763891242268,2189,21,"RPS6KA2, DUSP4"
"248","ESR-mediated signaling",0.168985719516661,0.977870017908165,-0.850392736099739,-1.22011667059023,922,144,"HSP90AB1, AGO2, KDM1A, PDPK1, GNB1, CREBBP"
"249","Effects of PIP2 hydrolysis",0.665283291230603,0.977870017908165,-0.825760893692687,-1.02835180877128,3686,27,"DGKZ, DGKB, MGLL, DGKD, DAGLB"
"250","Elastic fibre formation",0.440350563405473,0.977870017908165,-0.96251013239665,-1.18384909175676,2461,34,"FBLN2, FURIN"
"251","Elevation of cytosolic Ca2+ levels",0.703621169916435,0.977870017908165,-0.419483235512379,-0.586107984893642,3788,15,"TRPC7, TRPC6, TRPC3, STIM1, P2RX7, P2RX6, P2RX5, P2RX4, P2RX3, P2RX1, ORAI2, ORAI1, ITPR3, ITPR2, ITPR1"
"252","Endogenous sterols",0.0240542313579707,0.605187072507423,0.997958842233568,1.44926828907227,109,18,"CYP7B1, AHR"
"253","Endosomal Sorting Complex Required For Transport (ESCRT)",0.619866111814728,0.977870017908165,-0.880004854998179,-1.08914103520646,3425,29,"UBB"
"254","Energy dependent regulation of mTOR by LKB1-AMPK",0.393599710721389,0.977870017908165,-0.967079688949375,-1.19701920980774,2176,28,"PRKAG2, STRADA"
"255","Ephrin signaling",0.764965923742862,0.977870017908165,-0.496132362892077,-0.658822250080042,4152,18,"ARHGEF7, PAK2"
"256","Epigenetic regulation of gene expression",0.11503786512802,0.977870017908165,-0.961968680089485,-1.27902931092237,637,87,"SF3B1, TET3, DNMT3A, HDAC2, RBBP7, AEBP2"
"257","Estrogen-dependent gene expression",0.0372905782741848,0.71055501875174,-0.975207613576404,-1.29344967405999,206,85,"HSP90AB1, AGO2, KDM1A, CREBBP"
"258","Estrogen-dependent nuclear events downstream of ESR-membrane signaling",0.191957342812708,0.977870017908165,0.985826133909287,1.35783325626228,863,22,"CREB1, AKT1"
"259","Eukaryotic Translation Elongation",0.873948075201432,0.977870017908165,-0.560916132525281,-0.712708405519237,4880,62,"RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"260","Eukaryotic Translation Initiation",0.749188604399567,0.977870017908165,-0.618136459980892,-0.821871508739564,4154,87,"EIF4E, EIF5, EIF4A2"
"261","Eukaryotic Translation Termination",0.0788166214995483,0.928087857657603,0.980236886632826,1.29249148555501,348,63,"ETF1, APEH"
"262","Export of Viral Ribonucleoproteins from Nucleus",0.538272706985048,0.977870017908165,0.853823482726092,1.11581819523226,2411,31,"NUP93, RANBP2, AAAS"
"263","Extension of Telomeres",0.898498281165189,0.977870017908165,-0.421099936897646,-0.521175785102941,4965,29,"WRAP53, TERT, RUVBL2, RUVBL1, RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLA2, POLA1"
"264","Extra-nuclear estrogen signaling",0.822560429722471,0.977870017908165,-0.597042631007393,-0.758611273411914,4593,62,"PDPK1, GNB1"
"265","Extracellular matrix organization",0.148859031776498,0.977870017908165,0.792928556345701,1.22266523215497,697,235,"ITGA4, CTSS, COL25A1, TNR, COLGALT1, LAMC1, CASK, ACTN1, CD47, MMP16, A2M"
"266","FBXL7 down-regulates AURKA during mitotic entry and in early mitosis",0.810844892812106,0.977870017908165,-0.617357856697308,-0.769302327366423,4500,52,"UBB, CUL1, FBXL7, PSMB2"
"267","FCERI mediated Ca+2 mobilization",0.895678900741276,0.977870017908165,-0.2594337802643,-0.321118540899957,4953,28,"VAV3, VAV2, VAV1, TXK, TEC, SYK, SOS1, SHC1, PPP3R1, PPP3CB, PPP3CA, PLCG2, PLCG1, NFATC3, NFATC2, NFATC1, LYN, LCP2, LAT, ITPR3, ITPR2, ITPR1, ITK, GRB2, GRAP2"
"268","FCERI mediated MAPK activation",0.233592478756102,0.977870017908165,-0.977312626603646,-1.20968520112665,1291,28,"PAK2"
"269","FCERI mediated NF-kB activation",0.830536004331348,0.977870017908165,-0.582866821255312,-0.756845178793374,4601,74,"UBB, PDPK1, CUL1, PSMB2, CHUK"
"270","FGFR1 mutant receptor activation",0.366113316492241,0.977870017908165,-0.969077037337114,-1.20682891596851,2028,27,"FGFR1, ZMYM2, LRRFIP1, MYO18A"
"271","FGFR2 alternative splicing",0.442481784058291,0.977870017908165,0.970500877548265,1.32060027596114,2003,24,"NCBP2, GTF2F1"
"272","FGFR2 mutant receptor activation",0.583680115795187,0.977870017908165,-0.92363436026671,-1.14313924244795,3225,29,"FGFR2"
"273","FLT3 Signaling",0.659747122098509,0.977870017908165,-0.583748254985535,-0.893833849550554,3495,231,"SPRED2, UBB, CUL3, FGFR1, SPRED1, RASGRF1, PDPK1, SHC3, IQGAP1, PSMB2, SPTBN2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"274","FOXO-mediated transcription",0.882543103448276,0.977870017908165,-0.557607599554862,-0.703485389929779,4913,58,"YWHAG, CREBBP, HDAC2"
"275","FOXO-mediated transcription of cell cycle genes",0.69770463404071,0.977870017908165,0.269769952101464,0.408741864439704,3221,15,"BTG1, CCNG2, CDKN1A, CDKN1B, FOXG1, FOXO1, FOXO3, FOXO4, GADD45A"
"276","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.443218806509946,0.977870017908165,-0.965095868214961,-1.20675049194962,2450,26,"HDAC2"
"277","FRS-mediated FGFR1 signaling",0.0515312671923712,0.79421098334342,-0.99487144881571,-1.30610497864723,280,19,"FGFR1"
"278","FRS-mediated FGFR2 signaling",0.440838650865998,0.977870017908165,-0.966727407707363,-1.24565172807447,2417,21,"FGFR2"
"279","FRS-mediated FGFR3 signaling",0.698228733872731,0.977870017908165,0.391970310391363,0.569232033494086,3192,18,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, FRS3, GRB2, HRAS, KRAS"
"280","FRS-mediated FGFR4 signaling",0.698228733872731,0.977870017908165,0.391970310391363,0.569232033494086,3192,18,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF9, FGFR4, FRS2, FRS3, GRB2, HRAS, KLB, KRAS"
"281","Factors involved in megakaryocyte development and platelet production",0.653517542265043,0.977870017908165,-0.652766459937523,-0.892286166137222,3594,105,"KDM1A, KIF3A, KIF3B, KIF21A, HDAC2, KIF5A"
"282","Fanconi Anemia Pathway",0.0175501432664756,0.605187072507423,-0.997162737282983,-1.22391709482049,97,35,"UBB"
"283","Fatty acid metabolism",0.0558403515195899,0.824235047782116,-0.928553303710037,-1.33225898728205,304,144,"PTGDS, PRKAG2, ACACA, TECR"
"284","Fatty acyl-CoA biosynthesis",0.706999457406403,0.977870017908165,-0.76374529534363,-0.941179247694235,3908,30,"ACACA, TECR, HACD1"
"285","Fc epsilon receptor (FCERI) signaling",0.738899082568807,0.977870017908165,-0.598000461504116,-0.838374340431242,4026,124,"UBB, PDPK1, CUL1, PSMB2, CHUK, PAK2"
"286","Fcgamma receptor (FCGR) dependent phagocytosis",0.479053810039726,0.977870017908165,-0.782351356603538,-1.02956282005008,2652,81,"HSP90AB1"
"287","Fertilization",0.298830662624513,0.977870017908165,0.979896107400661,1.48468930203728,1379,15,"CD9, IZUMO4, ACR"
"288","Formation of ATP by chemiosmotic coupling",0.084668687743612,0.97544693006387,0.993456115496188,1.50523474435808,390,15,"ATP5MG, ATP5F1A"
"289","Formation of Fibrin Clot (Clotting Cascade)",0.898773006134969,0.977870017908165,-0.217736067037262,-0.271155100807962,4980,27,"VWF, THBD, TFPI, SERPING1, SERPINE2, SERPIND1, SERPINC1, PRTN3, PROS1, PRCP, KNG1, KLKB1, GP9, GP5, GP1BB, FGG, F8, F5, F3, F2R, F2, F13B, F13A1, F12, F11"
"290","Formation of HIV elongation complex in the absence of HIV Tat",0.294776955839498,0.977870017908165,0.970462994254816,1.25049477028987,1314,43,"NCBP2, CCNH"
"291","Formation of HIV-1 elongation complex containing HIV-1 Tat",0.313174460431655,0.977870017908165,0.970466986551328,1.24782166211765,1392,41,"NCBP2, CCNH"
"292","Formation of Incision Complex in GG-NER",0.27340079508493,0.977870017908165,-0.968167072181671,-1.19243172859596,1512,42,"UBB, SUMO1, SUMO2, RNF111"
"293","Formation of RNA Pol II elongation complex",0.196259576385759,0.977870017908165,0.970437017994859,1.2686853253736,870,56,"NCBP2, AFF4"
"294","Formation of TC-NER Pre-Incision Complex",0.00701186623516721,0.605187072507423,-0.997159283057153,-1.24683409636126,38,53,"UBB"
"295","Formation of a pool of free 40S subunits",0.015702108568865,0.605187072507423,0.989706778628022,1.32566754231283,69,71,"EIF3A, EIF1AX"
"296","Formation of the Early Elongation Complex",0.381662149954833,0.977870017908165,0.97048294495103,1.2582274417739,1689,33,"NCBP2, CCNH"
"297","Formation of the HIV-1 Early Elongation Complex",0.381662149954833,0.977870017908165,0.97048294495103,1.2582274417739,1689,33,"NCBP2, CCNH"
"298","Formation of the beta-catenin:TCF transactivating complex",0.372396305017207,0.977870017908165,-0.967245221854528,-1.18869254203921,2055,31,"TLE4, CREBBP, SMARCA4"
"299","Formation of the cornified envelope",0.487253661182426,0.977870017908165,-0.962525320729237,-1.19138196366315,2694,28,"CAPNS1, FURIN"
"300","Formation of the ternary complex, and subsequently, the 43S complex",0.0606535362578335,0.85898521619202,0.989726953230603,1.27311421728806,270,42,"EIF3A, EIF1AX"
"301","Formation of tubulin folding intermediates by CCT/TriC",0.30066691367173,0.977870017908165,-0.975372781863572,-1.31630345945183,1622,17,"TUBB2A"
"302","G alpha (12/13) signalling events",0.915226781857451,0.977870017908165,-0.530174504840851,-0.683861072446302,5084,70,"ARHGEF12, GNB1, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"303","G alpha (i) signalling events",0.612916842549599,0.977870017908165,0.584066072636033,0.910853551665772,2903,263,"APOE, ADCY1, NMT1, CREB1, CCL23, PSAP, NPY2R, GRM8"
"304","G alpha (q) signalling events",0.300311869381765,0.977870017908165,-0.768837194568824,-1.11989636638212,1636,159,"DGKZ, DGKB, ARHGEF25, GNB1, MGLL, DGKD, DAGLB, CCK"
"305","G alpha (s) signalling events",0.720424209179009,0.977870017908165,-0.595527646988035,-0.850689469384037,3939,139,"PDE4A, PDE10A, GNB1, PDE7A, RAMP1, ADCY8, GLP2R"
"306","G alpha (z) signalling events",0.668165467625899,0.977870017908165,0.714816063749701,0.919106967199623,2971,41,"ADCY1, ADCY2"
"307","G beta:gamma signalling through CDC42",0.126417549730433,0.977870017908165,-0.988260693563622,-1.3517839425429,679,16,"GNB1"
"308","G beta:gamma signalling through PI3Kgamma",0.601971882417382,0.977870017908165,-0.943345180936025,-1.22635971465367,3296,20,"PDPK1, GNB1"
"309","G beta:gamma signalling through PLC beta",0.126417549730433,0.977870017908165,-0.988260693563622,-1.3517839425429,679,16,"GNB1"
"310","G protein gated Potassium channels",0.633962956170915,0.977870017908165,-0.872079918196574,-1.14489959912983,3456,19,"GNB1, KCNJ6"
"311","G-protein activation",0.511212397447584,0.977870017908165,-0.963082945265573,-1.24095574976422,2803,21,"GNB1, OPRM1, GNAO1"
"312","G-protein beta:gamma signalling",0.580837242872609,0.977870017908165,-0.94333966308246,-1.1747771736664,3218,27,"PDPK1, GNB1"
"313","G-protein mediated events",0.637076888590002,0.977870017908165,0.722995102666458,0.931474976024024,2841,47,"ADCY1, CREB1, ADCY2"
"314","G0 and Early G1",0.512927895120175,0.977870017908165,-0.962740465744178,-1.22318222566009,2816,23,"MAX, DYRK1A"
"315","G1 Phase",0.102988836874325,0.977870017908165,-0.983104683381767,-1.20879770338924,571,41,"UBB, CUL1, PPP2R2A, CCND2"
"316","G1/S DNA Damage Checkpoints",0.927842435094002,0.977870017908165,-0.51881122165198,-0.659209277658644,5181,62,"UBB, PSMB2"
"317","G1/S Transition",0.6398312855309,0.977870017908165,-0.646563628644355,-0.902752200441897,3488,121,"UBB, ORC3, CUL1, PSMB2, MAX"
"318","G1/S-Specific Transcription",0.875722543352601,0.977870017908165,0.186209410652805,0.250467911378709,3938,25,"CCNA1, CCNE1, CDC25A, CDC45, CDC6, DHFR, E2F1, E2F4, E2F5, E2F6, FBXO5, HDAC1, LIN37, LIN52, LIN54, LIN9"
"319","G2/M Checkpoints",0.721621125985696,0.977870017908165,-0.60664185298884,-0.849387612574933,3934,123,"UBB, ORC3, YWHAG, SUMO1, PSMB2"
"320","G2/M DNA damage checkpoint",0.796518930558048,0.977870017908165,-0.623817793311012,-0.784453539917605,4438,55,"YWHAG, SUMO1"
"321","G2/M Transition",0.774449990756147,0.977870017908165,-0.558053390631445,-0.818533835311628,4188,168,"UBB, HSP90AB1, YWHAG, CUL1, DYNLL1, FBXL7, AKAP9, PSMB2, PPP2R2A, PCM1, SDCCAG8"
"322","GAB1 signalosome",0.82178432221741,0.977870017908165,0.203575524522701,0.308447396752338,3794,15,"BTC, CSK, EGF, EGFR, EPGN, GAB1, GRB2, HBEGF, PAG1, PIK3CA, PIK3R1, PTPN11, PXN"
"323","GABA B receptor activation",0.771702744923008,0.977870017908165,0.599452567060058,0.783393868916205,3457,31,"ADCY1, KCNJ4, ADCY2"
"324","GABA receptor activation",0.621161174624524,0.977870017908165,0.734722454177445,0.946583978045247,2770,47,"ADCY1, ARHGEF9, KCNJ4"
"325","GABA synthesis, release, reuptake and degradation",0.71578559587401,0.977870017908165,-0.631478662200508,-0.838550806650306,3885,18,"HSPA8, STXBP1"
"326","GLI3 is processed to GLI3R by the proteasome",0.855319913731129,0.977870017908165,-0.576761786548622,-0.725931566151266,4758,56,"UBB, CUL1, PSMB2"
"327","GPCR ligand binding",0.868131868131868,0.977870017908165,-0.510053223859238,-0.794177858504504,4581,265,"GNB1, OPRM1, CX3CL1, RAMP1, SST, CCK, GLP2R"
"328","GPVI-mediated activation cascade",0.593993124660756,0.977870017908165,-0.908392583711877,-1.12427520527698,3282,29,"PDPK1"
"329","GRB2 events in ERBB2 signaling",0.0201385881333911,0.605187072507423,0.998583282736288,1.51300317031022,92,15,"NRG1, BTC"
"330","GTP hydrolysis and joining of the 60S ribosomal subunit",0.760382809678584,0.977870017908165,-0.618151151236641,-0.813477777104325,4210,81,"EIF4E, EIF5, EIF4A2"
"331","Gamma carboxylation, hypusine formation and arylsulfatase activation",0.491880187657885,0.977870017908165,-0.962595368307339,-1.19875704416938,2725,27,"DPH7, DHPS, FURIN"
"332","Gap junction trafficking",0.62948503439301,0.977870017908165,-0.817155879013914,-1.11773968447772,3385,16,"MYO6, CLTC"
"333","Gap junction trafficking and regulation",0.651317001289372,0.977870017908165,-0.817154586118701,-1.08511289195431,3535,18,"MYO6, CLTC"
"334","Gap-filling DNA repair synthesis and ligation in GG-NER",0.0255754475703325,0.605187072507423,-0.997164844066424,-1.25761569882976,139,24,"UBB"
"335","Gap-filling DNA repair synthesis and ligation in TC-NER",0.00376749192680301,0.605187072507423,-0.997157360406091,-1.26911004479122,20,63,"UBB"
"336","Gastrin-CREB signalling pathway via PKC and MAPK",0.200735453168938,0.977870017908165,0.985899338820672,1.48054284903197,927,16,"RPS6KA2, CREB1, CCKBR"
"337","Gene Silencing by RNA",0.724417975094748,0.977870017908165,-0.649250546934737,-0.843043605086724,4013,74,"AGO2, TSNAX, NUP98, DROSHA"
"338","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation",0.478174243796414,0.977870017908165,-0.962044978726278,-1.18230172192072,2639,31,"PPIA, HSPA9, PAK2, HNRNPA2B1"
"339","Generation of second messenger molecules",0.611852175814564,0.977870017908165,0.676720318484702,0.98275525667543,2797,18,"PAK3, CD101"
"340","Global Genome Nucleotide Excision Repair (GG-NER)",0.0776436678076022,0.927755898997253,-0.968080780699377,-1.27748339844524,430,82,"UBB, SUMO1, SUMO2, RNF111"
"341","Glucagon signaling in metabolic regulation",0.6554114490161,0.977870017908165,0.714819006628237,0.955234168601869,2930,26,"ADCY1, ADCY2"
"342","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion",0.616475233309404,0.977870017908165,-0.842868396729466,-1.03422645128799,3434,36,"GNB1, IQGAP1, ADCY8"
"343","Glucagon-type ligand receptors",0.444282592862345,0.977870017908165,-0.965980425244684,-1.22729866307379,2439,23,"GNB1, GLP2R"
"344","Gluconeogenesis",0.345576261986611,0.977870017908165,-0.969207914106287,-1.19954350808916,1909,29,"GOT2, MDH1"
"345","Glucose metabolism",0.727027634239497,0.977870017908165,0.605390300226251,0.833465267642136,3235,85,"NUP93, RANBP2, AAAS"
"346","Glutamate Neurotransmitter Release Cycle",0.507175977036873,0.977870017908165,0.903363038443009,1.22924306969686,2296,24,"SLC1A3, RIMS1, ARL6IP5"
"347","Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.381985892566468,0.977870017908165,-0.967044840626688,-1.19170951511801,2111,30,"MYO6, CAMK2A, EPB41L1, CAMK2G"
"348","Glutathione conjugation",0.298087333092746,0.977870017908165,-0.973330632637904,-1.21212608183669,1651,27,"GSTZ1, CHAC2"
"349","Glycerophospholipid biosynthesis",0.74063464081093,0.977870017908165,0.582954841323448,0.83428933867877,3360,115,"PLA2G3, PTDSS2, GPCPD1, OSBPL10, PLD3, PLA2G4E"
"350","Glycogen metabolism",0.0245931283905967,0.605187072507423,-0.997164461247637,-1.2468488818535,135,26,"UBB"
"351","Glycogen synthesis",0.0258124419684308,0.605187072507423,-0.997166565472576,-1.39325540764119,138,15,"UBB"
"352","Glycolysis",0.331460674157303,0.977870017908165,0.853781431293504,1.13901970706736,1474,69,"NUP93, RANBP2, AAAS"
"353","Glycosaminoglycan metabolism",0.355388360256694,0.977870017908165,0.76504204984451,1.08635282893738,1605,107,"CSGALNACT1, HS6ST3, HS3ST4, EXT1, ST3GAL4"
"354","Glycosphingolipid metabolism",0.153516681695221,0.977870017908165,0.982702702702703,1.27130564681734,680,38,"PSAP, ARSA"
"355","Glyoxylate metabolism and glycine degradation",0.742542035798228,0.977870017908165,-0.714720799794084,-0.88465773480582,4106,28,"GOT2"
"356","Golgi Associated Vesicle Biogenesis",0.489935298346513,0.977870017908165,-0.844944095987273,-1.06347473985882,2725,56,"CLTC, TFRC, HSPA8, PUM1, AP1M1"
"357","Golgi-to-ER retrograde transport",0.371563808483524,0.977870017908165,-0.788624352654262,-1.08435420534446,2040,110,"GALNT2, DYNLL1, RAB6B, ARF4, KIF3A, KIF3B, KIF21A, COPA, STX18"
"358","Growth hormone receptor signaling",0.781543562350341,0.977870017908165,-0.304610886189834,-0.404497759969987,4242,18,"STAT5B, STAT3, STAT1, SOCS3, SOCS2, SOCS1, SH2B1, PTPN6, PTPN1, PRLR, MAPK3, MAPK1, LYN, JAK2, IRS2, IRS1"
"359","HATs acetylate histones",0.568800721370604,0.977870017908165,-0.74549774770431,-0.969022053424121,3153,75,"KAT6B, BRD1, CREBBP, CLOCK, RBBP7"
"360","HCMV Early Events",0.920387911592242,0.977870017908165,0.5176469248313,0.676796972425975,4080,58,"NUP93, CREB1, RANBP2, DYNC1I2, AAAS"
"361","HCMV Infection",0.67867531886328,0.977870017908165,0.634420677758917,0.866690375450042,3032,80,"CEBPD, NUP93, CREB1, RANBP2, DYNC1I2, AAAS"
"362","HCMV Late Events",0.308333333333333,0.977870017908165,0.914341272317981,1.18883457998573,1368,53,"CEBPD, NUP93, RANBP2, AAAS"
"363","HDACs deacetylate histones",0.456863809007054,0.977870017908165,-0.963398163155051,-1.18721563845485,2525,30,"NCOR2, KDM1A, HDAC2, RBBP7"
"364","HDMs demethylate histones",0.495182694055626,0.977870017908165,-0.963755399568035,-1.23333470983144,2723,22,"KDM1A, KDM2A"
"365","HDR through Homologous Recombination (HRR)",0.00342219020172911,0.605187072507423,-0.997156975563528,-1.27413088187887,18,65,"UBB"
"366","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)",0.0521754829391587,0.79421098334342,-0.968535973418322,-1.29838810933517,288,91,"UBB, SUMO1, SUMO2"
"367","HDR through Single Strand Annealing (SSA)",0.946716899892357,0.980957939302813,-0.239211375418388,-0.293308981142351,5276,37,"WRN, TOPBP1, TOP3A, RPA3, RPA2, RPA1, RMI2, RMI1, RHNO1, RFC5, RFC4, RFC3, RFC2, RBBP8, RAD9B, RAD9A, RAD52, RAD51, RAD50, RAD17, RAD1"
"368","HIV Infection",0.984900042535091,0.987637857989731,0.476448133842514,0.731038071991614,4630,214,"PSMA1, NMT1, NUP93, PSMB3, RANBP2, PSMD14, PSME4, PSMD9, NCBP2"
"369","HIV Life Cycle",0.891570671055038,0.977870017908165,-0.517752743142186,-0.740610556646947,4875,140,"UBB, PPIA, NUP98, FURIN"
"370","HIV Transcription Elongation",0.313174460431655,0.977870017908165,0.970466986551328,1.24782166211765,1392,41,"NCBP2, CCNH"
"371","HIV Transcription Initiation",0.970582927269446,0.982773823940463,-0.265870418612814,-0.328564778724787,5377,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1, TAF1L, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"372","HIV elongation arrest and recovery",0.922296685383083,0.977870017908165,-0.220878529553372,-0.271447875724083,5091,31,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"373","HS-GAG biosynthesis",0.667710196779964,0.977870017908165,0.700831417171053,0.936542131509987,2985,26,"HS6ST3, HS3ST4, EXT1, AGRN"
"374","HS-GAG degradation",0.722356561881732,0.977870017908165,0.337827326938035,0.4827601077638,3285,19,"AGRN, GLB1, GLB1L, GPC1, GPC3, GPC4, GPC5, GPC6, GUSB, HPSE, HPSE2, HSPG2, IDS, IDUA"
"375","HSF1 activation",0.198219476744186,0.977870017908165,-0.98077390026612,-1.23041943635869,1090,25,"UBB, HSP90AB1"
"376","HSF1-dependent transactivation",0.361296129612961,0.977870017908165,-0.967243009590706,-1.19179308064484,2006,32,"CRYAB, UBB, HSP90AB1, HSPA8, CREBBP, CAMK2A, CAMK2G"
"377","HSP90 chaperone cycle for steroid hormone receptors (SHR)",0.551064210338043,0.977870017908165,-0.920705505433881,-1.13243106716114,3080,34,"NR3C2, HSP90AB1, DYNLL1, HSPA8, DNAJA2"
"378","Hedgehog 'off' state",0.958788148808198,0.982248804367443,0.493505014851332,0.687854360595793,4303,94,"ADCY1, PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"379","Hedgehog 'on' state",0.735144927536232,0.977870017908165,-0.64205636144305,-0.836884707955758,4057,77,"UBB, CUL3, PSMB2, SPOP, KIF3A, ITCH"
"380","Hedgehog ligand biogenesis",0.848387096774194,0.977870017908165,-0.578022748095091,-0.732405162227121,4733,60,"UBB, OS9, PSMB2"
"381","Hemostasis",0.343934760448522,0.977870017908165,-0.632637931321473,-1.05044331413713,1686,469,"DGKZ, DGKB, PDE10A, APLP2, PRKG1, TMSB4X, KDM1A, PDPK1, GNB1, PPIA, MGLL, DGKD, KIF3A, KIF3B, KIF21A, DAGLB, VTI1B, HDAC2, ACTN4, CLU, SLC7A6, MANF"
"382","Heparan sulfate/heparin (HS-GAG) metabolism",0.662759242560866,0.977870017908165,0.700802858090084,0.905659025326745,2939,49,"HS6ST3, HS3ST4, EXT1, AGRN"
"383","Hh mutants abrogate ligand secretion",0.85567936736161,0.977870017908165,-0.578029201835559,-0.724808915664477,4760,54,"UBB, OS9, PSMB2"
"384","Hh mutants that don't undergo autocatalytic processing are degraded by ERAD",0.85814455231931,0.977870017908165,-0.578030276949713,-0.722761017498079,4772,53,"UBB, OS9, PSMB2"
"385","Homologous DNA Pairing and Strand Exchange",0.958980845681243,0.982248804367443,-0.290918394932994,-0.358306261922962,5306,42,"XRCC3, XRCC2, WRN, TOPBP1, TOP3A, RPA3, RPA2, RPA1, RMI2, RMI1, RHNO1, RFC5, RFC4, RFC3, RFC2, RBBP8, RAD9B, RAD9A, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50, RAD17, RAD1"
"386","Homology Directed Repair",0.0406312352621077,0.745818523134684,-0.968523166677973,-1.30962869760525,223,97,"UBB, SUMO1, SUMO2"
"387","Host Interactions of HIV factors",0.911882998171846,0.977870017908165,-0.516939789092237,-0.719032395077134,4987,118,"UBB, PACS1, PSMB2, PPIA, PAK2, NUP98, AP1M1"
"388","Host Interactions with Influenza Factors",0.492446448703495,0.977870017908165,0.85381354269424,1.09632688055383,2183,40,"NUP93, RANBP2, AAAS"
"389","IGF1R signaling cascade",0.281852586051541,0.977870017908165,-0.966810869271326,-1.19078047790821,1563,44,"FGFR1, PDPK1, FGFR2"
"390","IKK complex recruitment mediated by RIP1",0.665327734161037,0.977870017908165,-0.808624642177997,-1.05122144627841,3643,20,"UBB, CHUK"
"391","IRE1alpha activates chaperones",0.764103485447359,0.977870017908165,-0.658732188703561,-0.816396502461912,4252,49,"PREB"
"392","IRS-mediated signalling",0.300144040331293,0.977870017908165,-0.96681759816179,-1.1887715642185,1666,41,"FGFR1, PDPK1, FGFR2"
"393","IRS-related events triggered by IGF1R",0.288034650785057,0.977870017908165,-0.96681311253802,-1.18895729426498,1595,43,"FGFR1, PDPK1, FGFR2"
"394","ISG15 antiviral mechanism",0.721302626844189,0.977870017908165,-0.664381878727005,-0.84650801579482,4008,64,"UBB, EIF4E, NUP98, EIF4A2, ARIH1, NEDD4"
"395","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell",0.0290671473636773,0.608916882116728,0.990664321472061,1.29512916728972,128,56,"TYROBP, ITGA4, TREM2, B2M"
"396","Inactivation of APC/C via direct inhibition of the APC/C complex",0.240829937013709,0.977870017908165,-0.97962350718575,-1.32203997840213,1299,17,"BUB3"
"397","Inactivation, recovery and regulation of the phototransduction cascade",0.732170457054537,0.977870017908165,0.586076060916958,0.797497689787158,3315,24,"NMT1, CALM1"
"398","Infection with Mycobacterium tuberculosis",0.556686046511628,0.977870017908165,-0.959967596030514,-1.2043171092848,3063,25,"UBB, RAB7A, ATP6V1H"
"399","Infectious disease",0.812758417011223,0.977870017908165,-0.516698866623415,-0.838790075859456,4127,377,"UBB, HSP90AB1, NCOR2, CLTC, DYNLL1, PACS1, PSMB2, PPIA, PAK2, SH3GL1, SV2A, NUP98, AP1M1, RAB7A, RBBP7, FURIN"
"400","Inflammasomes",0.745256953398416,0.977870017908165,-0.55152327896542,-0.732376750231392,4045,18,"HSP90AB1"
"401","Influenza Infection",0.633039647577093,0.977870017908165,0.623457971167898,0.89708598419661,2873,120,"NUP93, CLTA, RANBP2, AAAS"
"402","Influenza Life Cycle",0.645842596709649,0.977870017908165,0.623467977996624,0.887385420518508,2904,111,"NUP93, CLTA, RANBP2, AAAS"
"403","Influenza Viral RNA Transcription and Replication",0.208147818343722,0.977870017908165,0.85374362247969,1.20521767713173,934,103,"NUP93, RANBP2, AAAS"
"404","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits",0.633962956170915,0.977870017908165,-0.872079918196574,-1.14489959912983,3456,19,"GNB1, KCNJ6"
"405","Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components",0.240829937013709,0.977870017908165,-0.97962350718575,-1.32203997840213,1299,17,"BUB3"
"406","InlB-mediated entry of Listeria monocytogenes into host cell",0.595728876508821,0.977870017908165,-0.873586542223785,-1.22058762912798,3207,15,"UBB, SH3GL1"
"407","Inositol phosphate metabolism",0.329369531074714,0.977870017908165,0.936602054002601,1.20415513450282,1467,45,"INPP4B, CALM1"
"408","Insertion of tail-anchored proteins into the endoplasmic reticulum membrane",0.592660215446412,0.977870017908165,-0.958631394250236,-1.24623196987583,3245,20,"SGTA, VAPA"
"409","Insulin processing",0.567768895348837,0.977870017908165,-0.959292513332883,-1.20347019148643,3124,25,"KIF5A"
"410","Insulin receptor recycling",0.633466860888565,0.977870017908165,-0.885625088744074,-1.12520550002335,3478,23,"ATP6V0C, ATP6V0B, ATP6V1C1"
"411","Insulin receptor signalling cascade",0.257715213860314,0.977870017908165,-0.966804137651274,-1.19478424570506,1427,47,"FGFR1, PDPK1, FGFR2"
"412","Integration of energy metabolism",0.622528568837294,0.977870017908165,-0.673818155382701,-0.911131115514172,3431,97,"PRKAG2, ACACA, GNB1, IQGAP1, STXBP1, ADIPOR2, ADCY8"
"413","Integrin cell surface interactions",0.134234234234234,0.977870017908165,0.977409536692594,1.27083649312058,595,53,"ITGA4, CD47, AGRN"
"414","Integrin signaling",0.661337209302326,0.977870017908165,-0.839564554696863,-1.05326675791082,3639,25,"PDPK1"
"415","Interaction between L1 and Ankyrins",0.546654611211573,0.977870017908165,-0.960167431812044,-1.20058800255386,3022,26,"SPTBN2, SCN1B, SCN1A"
"416","Interactions of Rev with host cellular proteins",0.527998186352301,0.977870017908165,0.853820170725026,1.10253382930073,2328,34,"NUP93, RANBP2, AAAS"
"417","Interactions of Vpr with host cellular proteins",0.527998186352301,0.977870017908165,0.853820170725026,1.10253382930073,2328,34,"NUP93, RANBP2, AAAS"
"418","Interconversion of nucleotide di- and triphosphates",0.390261627906977,0.977870017908165,-0.968338621481131,-1.21481888998461,2147,25,"CTPS2"
"419","Interferon Signaling",0.47723532638508,0.977870017908165,-0.703810651485458,-1.00536778214602,2609,139,"UBB, SUMO1, EIF4E, TRIM2, NUP98, CAMK2A, CAMK2G, EIF4A2, ARIH1, NEDD4"
"420","Interferon alpha/beta signaling",0.951005025125628,0.980957939302813,-0.272362477714191,-0.334880988514948,5298,39,"XAF1, TYK2, STAT2, STAT1, SOCS3, SOCS1, SAMHD1, RNASEL, PTPN6, PTPN11, PTPN1, PSMB8, OAS3, OAS2, OAS1, JAK1, ISG20, ISG15, IRF9, IRF7, IRF6, IRF5, IRF3, IRF2, IRF1, IP6K2, IFNAR2, IFNAR1, IFITM1, IFITM3, IFITM2, IFIT3, IFIT2, IFI35"
"421","Interferon gamma signaling",0.519921033740129,0.977870017908165,-0.821483585625642,-1.03557945770396,2896,57,"SUMO1, TRIM2, CAMK2A, CAMK2G"
"422","Interleukin receptor SHC signaling",0.802127269392995,0.977870017908165,-0.276270506213574,-0.362698400932583,4373,19,"SOS1, SHC1, PTPN6, PIK3R3, PIK3R2, PIK3R1, PIK3CD, PIK3CB, PIK3CA, JAK3, JAK2, JAK1, INPPL1, INPP5D, IL5, IL2, GRB2, GAB2"
"423","Interleukin-1 family signaling",0.969790518191841,0.982773823940463,0.483972895573119,0.691807955583053,4397,114,"IL1RAPL1, PSMA1, PSMB3, IL1R1, PSMD14, PSME4, TAB2, PSMD9"
"424","Interleukin-1 signaling",0.888529306005034,0.977870017908165,-0.53863544846234,-0.7207514616542,4941,90,"UBB, CUL1, PSMB2, CHUK"
"425","Interleukin-10 signaling",0.146860986547085,0.977870017908165,0.98703666194045,1.31228127542382,654,27,"IL12B, IL1R1"
"426","Interleukin-12 family signaling",0.303418803418803,0.977870017908165,0.938201997185428,1.21081516293102,1348,48,"IL12B, AIP"
"427","Interleukin-12 signaling",0.381038374717833,0.977870017908165,0.938202079423319,1.20705252755987,1687,39,"IL12B, AIP"
"428","Interleukin-17 signaling",0.675098672407607,0.977870017908165,-0.699209430362817,-0.889903386086242,3762,63,"UBB, CUL1, CHUK"
"429","Interleukin-2 family signaling",0.914870494475639,0.977870017908165,-0.302404921822068,-0.371639442742997,5050,31,"SYK, STAT5B, STAT4, STAT3, STAT1, SOS2, SOS1, SHC1, PTPN6, PTK2B, PIK3R3, PIK3R2, PIK3R1, PIK3CD, PIK3CB, PIK3CA, LCK, JAK3, JAK2, JAK1, INPPL1, INPP5D, IL5, IL21R, IL2, IL15RA, IL15, HAVCR2, GRB2"
"430","Interleukin-3, Interleukin-5 and GM-CSF signaling",0.0593028519692168,0.851361491284099,0.992231304465311,1.28412762540415,261,35,"YWHAZ, BLNK"
"431","Interleukin-37 signaling",0.0339014449796221,0.657939154419332,-0.996289049321908,-1.34453077492154,182,17,"PTPN12"
"432","Interleukin-4 and Interleukin-13 signaling",0.140116019634092,0.977870017908165,0.941225950974087,1.27664770502065,627,77,"IL12B, BCL2L1, CEBPD"
"433","Interleukin-6 family signaling",0.832536924413553,0.977870017908165,0.194660199954754,0.286889401310797,3832,17,"CBL, CNTFR, CRLF1, CTF1, IL11RA, IL31RA, IL6R, IL6ST, JAK1, JAK2, LIFR"
"434","Interleukin-7 signaling",0.438202247191011,0.977870017908165,-0.967139001349528,-1.28427964121313,2378,18,"SMARCA4"
"435","Intra-Golgi and retrograde Golgi-to-ER traffic",0.307950102401787,0.977870017908165,-0.752934372083166,-1.10792243531849,1653,173,"GALNT2, GOLGA1, VPS54, DYNLL1, RAB6B, ARF4, KIF3A, KIF3B, MAN1A2, KIF21A, COPA, STX18"
"436","Intra-Golgi traffic",0.657788719785139,0.977870017908165,0.720599036838567,0.926927245710275,2938,42,"STX16, MAN2A2, ARF1"
"437","Intracellular signaling by second messengers",0.983270598076119,0.987037918375261,0.475430981542272,0.745915047246224,4701,284,"NRG1, ADCY1, PSMA1, PSMB3, CREB1, STRN, PSMD14, PSME4, PSMD9"
"438","Intraflagellar transport",0.178790061217141,0.977870017908165,-0.975332837737379,-1.19924166187623,992,41,"DYNLL1, TTC26, KIF3A, KIF3B, IFT20"
"439","Intrinsic Pathway for Apoptosis",0.679892400806994,0.977870017908165,0.692112028972125,0.89168658710841,3032,47,"BCL2L1, NMT1, YWHAZ, AKT1"
"440","Intrinsic Pathway of Fibrin Clot Formation",0.804735013032146,0.977870017908165,0.207960088427787,0.306490722189003,3704,17,"A2M, C1QBP, F11, F12, F2, F8, GP1BB, GP5, GP9, KLKB1, KNG1, PRCP, SERPINC1, SERPIND1, SERPINE2, SERPING1"
"441","Inwardly rectifying K+ channels",0.6439532334673,0.977870017908165,-0.872074611372544,-1.09985297650538,3524,24,"GNB1, KCNJ6"
"442","Ion channel transport",0.449065591791865,0.977870017908165,-0.70482312452286,-1.02143982139378,2450,154,"ATP6V0C, UBB, ATP6V0B, WNK2, TTYH1, WWP1, CAMK2A, ATP6V1C1, TRPM7, CAMK2G, UNC80"
"443","Ion homeostasis",0.527665317139001,0.977870017908165,0.793855528431391,1.02452596976445,2345,48,"SLC8A3, TRPC1, ATP1A1, ABCC9"
"444","Ion transport by P-type ATPases",0.752023017442906,0.977870017908165,-0.666341337876065,-0.828084617543694,4181,50,"CAMK2A, CAMK2G"
"445","Iron uptake and transport",0.384435657800144,0.977870017908165,-0.927752847694532,-1.16333834589451,2138,54,"ATP6V0C, UBB, ATP6V0B, CUL1, TFRC, ATP6V1C1"
"446","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1",0.391511476829796,0.977870017908165,0.974161775618971,1.4760009309066,1807,15,"TAB2, IKBKG"
"447","KSRP (KHSRP) binds and destabilizes mRNA",0.462253947653039,0.977870017908165,0.962671173816099,1.44566069398885,2136,16,"YWHAZ, AKT1"
"448","Keratan sulfate biosynthesis",0.692529372644646,0.977870017908165,0.637082463940367,0.872074157410757,3123,23,"ST3GAL4, ACAN"
"449","Keratan sulfate/keratin metabolism",0.72377544173563,0.977870017908165,0.637073530898755,0.84317466377449,3235,28,"ST3GAL4, ACAN"
"450","Keratinization",0.565011286681716,0.977870017908165,0.798326806931789,1.02709470727045,2502,39,"KRT12, CAPN1"
"451","Kinesins",0.457824838478105,0.977870017908165,-0.959456720048652,-1.179691922117,2550,39,"KIF3A, KIF3B, KIF21A, KIF5A"
"452","L13a-mediated translational silencing of Ceruloplasmin expression",0.980657989877079,0.985446100108677,-0.486988100469198,-0.637176599695367,5424,79,"EIF4E, EIF4A2"
"453","L1CAM interactions",0.648830038091783,0.977870017908165,-0.666024744533318,-0.896522718702668,3576,94,"FGFR1, CLTC, HSPA8, SPTBN2, SCN1B"
"454","LDL clearance",0.681893534720943,0.977870017908165,-0.733564543070654,-0.974112311536257,3701,18,"CLTC, NCEH1"
"455","Lagging Strand Synthesis",0.788740143040528,0.977870017908165,-0.434520405880076,-0.570454872455499,4300,19,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POLD4, POLD2, POLD1, POLA2, POLA1, PCNA"
"456","Laminin interactions",0.229882509421414,0.977870017908165,0.983125210934863,1.34575685014546,1036,23,"LAMC1, COL18A1"
"457","Late Phase of HIV Life Cycle",0.902349486049927,0.977870017908165,-0.517778323891815,-0.731295818004067,4915,130,"UBB, PPIA, NUP98, FURIN"
"458","Late endosomal microautophagy",0.100054278994029,0.977870017908165,-0.987710176244176,-1.22244289645511,552,29,"UBB, HSPA8"
"459","Listeria monocytogenes entry into host cells",0.637210151542815,0.977870017908165,-0.87357887083124,-1.13566269951904,3489,20,"UBB, SH3GL1"
"460","Long-term potentiation",0.527438347033992,0.977870017908165,0.884324269818002,1.21802908401009,2373,22,"NRG1, ACTN2"
"461","Loss of Nlp from mitotic centrosomes",0.877473911478949,0.977870017908165,-0.559532430418667,-0.71291632510221,4876,64,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"462","Loss of proteins required for interphase microtubule organization from the centrosome",0.877473911478949,0.977870017908165,-0.559532430418667,-0.71291632510221,4876,64,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"463","Lysosome Vesicle Biogenesis",0.891833810888252,0.977870017908165,-0.527992421822714,-0.648057660844079,4979,35,"CLTC, HSPA8, AP1M1"
"464","M Phase",0.278609831029186,0.977870017908165,-0.698811050319934,-1.10195674659127,1450,295,"PTTG1, UBB, YWHAG, DYNLL1, ARPP19, AKAP9, CENPP, PSMB2, PPP2R2A, BUB3, LPIN2, NUP98, PCM1, SDCCAG8"
"465","MAP kinase activation",0.682926829268293,0.977870017908165,-0.699215164020889,-0.884442393579093,3807,59,"UBB, CUL1, CHUK"
"466","MAP2K and MAPK activation",0.74870327311751,0.977870017908165,-0.697561231554043,-0.85797250608024,4185,34,"IQGAP1"
"467","MAP3K8 (TPL2)-dependent MAPK1/3 activation",0.252091466815393,0.977870017908165,-0.978882741870193,-1.33895639147699,1355,16,"UBB, CUL1, CHUK"
"468","MAPK family signaling cascades",0.641949554333397,0.977870017908165,-0.583394739749385,-0.905132810324558,3384,255,"SPRED2, UBB, AGO2, CUL3, FGFR1, SPRED1, RASGRF1, SHC3, IQGAP1, PSMB2, SPTBN2, PAK2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"469","MAPK targets/ Nuclear events mediated by MAP kinases",0.422535211267606,0.977870017908165,0.961246244018682,1.26095492444254,1889,30,"RPS6KA2, CREB1, ATF1"
"470","MAPK1/MAPK3 signaling",0.717871296471032,0.977870017908165,-0.569848592877989,-0.865006226812624,3803,219,"SPRED2, UBB, CUL3, FGFR1, SPRED1, RASGRF1, SHC3, IQGAP1, PSMB2, SPTBN2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"471","MAPK6/MAPK4 signaling",0.828139074040713,0.977870017908165,-0.577025115769464,-0.761444727111403,4596,82,"UBB, AGO2, PSMB2, PAK2"
"472","MECP2 regulates neuronal receptors and channels",0.690277003160439,0.977870017908165,-0.605343562202484,-0.828014017390803,3712,16,"OPRM1, GRIN2B, HDAC2"
"473","MET activates PTK2 signaling",0.239886289088126,0.977870017908165,0.983130904183536,1.42773467516076,1096,18,"LAMC1, HGF"
"474","MET promotes cell motility",0.324983225229255,0.977870017908165,0.975894665766374,1.291608608391,1452,28,"LAMC1, RAP1A, CRK"
"475","MHC class II antigen presentation",0.717547644732111,0.977870017908165,-0.634499002028261,-0.846249598246682,3990,88,"SEC23A, CLTC, DYNLL1, SPTBN2, KIF3A, KIF3B, AP1M1, RAB7A"
"476","Macroautophagy",0.157597816196542,0.977870017908165,-0.916704506673151,-1.24473210226241,865,100,"PRKAG2, UBB, ATG4B, DYNLL1, HSPA8"
"477","Major pathway of rRNA processing in the nucleolus and cytosol",0.75758129338692,0.977870017908165,-0.57343062513462,-0.827787277382043,4146,149,"RBM28, XRN2, EBNA1BP2, EXOSC10, TBL3, UTP4"
"478","Meiosis",0.417444364680546,0.977870017908165,-0.886417401684956,-1.11743638972061,2325,57,"SYCP3, SYNE1"
"479","Meiotic recombination",0.883357558139535,0.977870017908165,-0.220641328562749,-0.276803225548668,4861,25,"PRDM9, TOP3A, TEX15, RPA3, RPA2, RPA1, RBBP8, RAD51C, RAD51, RAD50, PSMC3IP, NBN, MSH5, MSH4, MRE11, MND1, MLH3, MLH1"
"480","Meiotic synapsis",0.589881593110872,0.977870017908165,-0.886464999689102,-1.09052135018659,3287,33,"SYCP3, SYNE1"
"481","Metabolic disorders of biological oxidation enzymes",0.0144092219020173,0.605187072507423,0.99871751603105,1.3671004706318,64,23,"CYP7B1, ACY1"
"482","Metabolism of amino acids and derivatives",0.438881935753025,0.977870017908165,0.642600422366985,1.01087447016515,2103,295,"PSMA1, IYD, ACAT1, PSMB3, SEPSECS, OGDH, PSMD14, PSME4, PSMD9"
"483","Metabolism of carbohydrates",0.669987282746927,0.977870017908165,0.567012088750334,0.88282260525342,3160,259,"CSGALNACT1, HS6ST3, HS3ST4, NUP93, RANBP2, EXT1, ST3GAL4"
"484","Metabolism of cofactors",0.70264986967854,0.977870017908165,0.288537329782463,0.425245128774897,3234,17,"AKT1, CALM1, COQ2, COQ3, COQ5, COQ6, COQ7, COQ9, DHFR"
"485","Metabolism of fat-soluble vitamins",0.017607223476298,0.605187072507423,0.997365220916092,1.29148297646926,77,36,"APOE, AGRN"
"486","Metabolism of folate and pterines",0.750868809730669,0.977870017908165,0.238850280008097,0.352016559370463,3456,17,"ALDH1L1, ALDH1L2, DHFR2, DHFR, FOLR2, FPGS, MTHFD1, MTHFD1L, MTHFD2, MTHFD2L, MTHFR, MTHFS, SHMT1, SHMT2, SLC19A1, SLC25A32, SLC46A1"
"487","Metabolism of non-coding RNA",0.439810640216411,0.977870017908165,0.850435114250793,1.099031243644,1950,49,"NUP93, RANBP2, NCBP2"
"488","Metabolism of nucleotides",0.959697732997481,0.982248804367443,-0.500065215986034,-0.668388245289527,5333,89,"UPP2, APRT, CTPS2"
"489","Metabolism of polyamines",0.49401670806051,0.977870017908165,0.794225142575406,1.03490954928307,2187,55,"PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"490","Metabolism of porphyrins",0.756696922736329,0.977870017908165,0.422333420106249,0.586628590111427,3417,21,"ABCC1, ABCC2, ABCG2, ALAD, ALAS1, ALAS2, ALB, BLVRA, BLVRB, COX10, CPOX, FECH, FLVCR1, GUSB, HMBS, HMOX1, HMOX2"
"491","Metabolism of steroid hormones",0.865533230293663,0.977870017908165,0.190259214256784,0.258893501968176,3919,24,"AKR1B1, CGA, CYP11A1, CYP19A1, FDX1, HSD11B1, HSD11B2, HSD17B1, HSD17B11, HSD17B12, HSD17B2, HSD17B3, HSD3B2, HSD3B1"
"492","Metabolism of steroids",0.844121532364597,0.977870017908165,0.534029781795114,0.77049128045293,3833,122,"CYP7B1, NCOA6, GGPS1, ABCB11"
"493","Metabolism of vitamins and cofactors",0.88808585194919,0.977870017908165,0.510599410078557,0.758539681140906,4054,158,"APOE, NADK"
"494","Metabolism of water-soluble vitamins and cofactors",0.0779031670913724,0.927755898997253,-0.959615852594591,-1.31288298628198,427,106,"ACACA, LMBRD1, MCCC1"
"495","Metal ion SLC transporters",0.757763975155279,0.977870017908165,-0.663932766302147,-0.837346277135128,4147,24,"SLC41A2, SLC41A1, SLC40A1, SLC39A8, SLC39A7, SLC39A6, SLC39A3, SLC39A2, SLC39A14, SLC39A10, SLC39A1, SLC31A1, SLC30A8, SLC30A7, SLC30A6, SLC30A5, SLC30A3, SLC30A2, SLC30A10, SLC30A1, SLC11A2, SLC11A1"
"496","Metalloprotease DUBs",0.625766871165644,0.977870017908165,-0.830317480582999,-1.13574266868534,3365,16,"UBB"
"497","MicroRNA (miRNA) biogenesis",0.402221412964312,0.977870017908165,-0.968511319131993,-1.23051421755409,2208,23,"AGO2"
"498","Miscellaneous transport and binding events",0.722333637192343,0.977870017908165,-0.698346266484624,-0.899836113785089,3961,21,"NIPA1, TUSC3"
"499","Misspliced GSK3beta mutants stabilize beta-catenin",0.644001732351667,0.977870017908165,0.361465290427039,0.547674029625871,2973,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"500","Mitochondrial Fatty Acid Beta-Oxidation",0.900249376558603,0.977870017908165,0.478141837659138,0.617422226949231,3970,34,"ACAA2, ACAD10, ACAD11, ACADL, ACADM, ACADS, ACADVL, ACBD6, ACBD7, ACOT11, ACOT12, ACOT13, ACOT1, ACOT2, ACOT7, ACOT9, ACSF2, ACSM3"
"501","Mitochondrial biogenesis",0.57910823444804,0.977870017908165,-0.710898847204742,-0.948146272756859,3220,88,"PRKAG2, CRTC3, MEF2D, CREBBP, HSPA9"
"502","Mitochondrial calcium ion transport",0.408014168696037,0.977870017908165,0.973476412229196,1.35217595393961,1842,21,"SLC8A3, VDAC1, MICU1, AFG3L2"
"503","Mitochondrial protein import",0.92850699142986,0.977870017908165,0.51305443797698,0.670792529919294,4116,58,"COX19, VDAC1, ACO2"
"504","Mitochondrial tRNA aminoacylation",0.977260223730057,0.984777610066442,-0.123632179172542,-0.162309014828483,5328,19,"YARS2, WARS2, VARS2, TARS2, SARS2, RARS2, PPA2, PARS2, NARS2, MARS2, LARS2, KARS1, IARS2, HARS2, FARS2, EARS2, DARS2"
"505","Mitochondrial translation",0.66871276403683,0.977870017908165,-0.659184982182118,-0.883682141094735,3703,91,"MRPS21, MRPL4, MRPL21, MRPS33"
"506","Mitochondrial translation elongation",0.679877499549631,0.977870017908165,-0.659196151386832,-0.874313361875838,3773,85,"MRPS21, MRPL4, MRPL21, MRPS33"
"507","Mitochondrial translation initiation",0.679877499549631,0.977870017908165,-0.659196151386832,-0.874313361875838,3773,85,"MRPS21, MRPL4, MRPL21, MRPS33"
"508","Mitochondrial translation termination",0.679877499549631,0.977870017908165,-0.659196151386832,-0.874313361875838,3773,85,"MRPS21, MRPL4, MRPL21, MRPS33"
"509","Mitophagy",0.582820976491863,0.977870017908165,-0.94921927126693,-1.1868984836585,3222,26,"UBB"
"510","Mitotic Anaphase",0.413525498891353,0.977870017908165,-0.712552802552972,-1.0425938586046,2237,166,"PTTG1, UBB, DYNLL1, CENPP, PSMB2, PPP2R2A, BUB3, NUP98"
"511","Mitotic G1 phase and G1/S transition",0.529250457038391,0.977870017908165,-0.680369977840922,-0.968845710281693,2894,136,"UBB, ORC3, CUL1, PSMB2, PPP2R2A, CCND2, MAX, DYRK1A"
"512","Mitotic G2-G2/M phases",0.77732417888291,0.977870017908165,-0.5580490686596,-0.819377057165486,4188,170,"UBB, HSP90AB1, YWHAG, CUL1, DYNLL1, FBXL7, AKAP9, PSMB2, PPP2R2A, PCM1, SDCCAG8"
"513","Mitotic Metaphase and Anaphase",0.412036182388776,0.977870017908165,-0.712550832777064,-1.04407121264443,2231,167,"PTTG1, UBB, DYNLL1, CENPP, PSMB2, PPP2R2A, BUB3, NUP98"
"514","Mitotic Prometaphase",0.725399183067211,0.977870017908165,-0.577380262525952,-0.849581367565844,3906,172,"YWHAG, DYNLL1, AKAP9, CENPP, BUB3, NUP98, PCM1, SDCCAG8, PDS5A"
"515","Mitotic Prophase",0.902945113788487,0.977870017908165,0.521574530195325,0.70744641738997,4046,77,"NUP93, RANBP2, AAAS"
"516","Mitotic Spindle Checkpoint",0.935655646771688,0.979935535138707,0.502445577747492,0.706023733394455,4216,100,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"517","Molecules associated with elastic fibres",0.108499095840868,0.977870017908165,-0.987847691061302,-1.23519924436564,599,26,"FBLN2"
"518","Muscle contraction",0.0479704797047971,0.79421098334342,0.904126200477844,1.35416652966568,220,169,"KCNIP4, KCND2, SLC8A3, CALD1, TRPC1, KCNJ4, ATP1A1"
"519","MyD88 cascade initiated on plasma membrane",0.648258437105216,0.977870017908165,-0.699193646783515,-0.90789408714562,3591,74,"UBB, CUL1, CHUK"
"520","MyD88 dependent cascade initiated on endosome",0.637382501807665,0.977870017908165,-0.699186464651683,-0.914817535932714,3525,79,"UBB, CUL1, CHUK"
"521","MyD88-independent TLR4 cascade",0.744156778137361,0.977870017908165,-0.620022938852429,-0.826942455749087,4138,88,"UBB, CUL1, CHUK"
"522","MyD88:MAL(TIRAP) cascade initiated on plasma membrane",0.627302275189599,0.977870017908165,-0.699183590436208,-0.920115269215329,3473,81,"UBB, CUL1, CHUK"
"523","Myogenesis",0.557179393496529,0.977870017908165,-0.960307816929931,-1.21113193416952,3049,24,"MEF2D, NEO1, MAPK14"
"524","N-Glycan antennae elongation",0.402122130792551,0.977870017908165,0.973622073804223,1.47518320185901,1856,15,"MGAT5, ST3GAL4"
"525","N-glycan antennae elongation in the medial/trans-Golgi",0.389710752925591,0.977870017908165,0.973268529769137,1.32436633364455,1764,24,"MGAT5, ST3GAL4, MAN2A2"
"526","N-glycan trimming in the ER and Calnexin/Calreticulin cycle",0.536419088625762,0.977870017908165,-0.943155847063773,-1.16026192589339,2989,33,"UBB, OS9, UGGT1"
"527","NCAM signaling for neurite out-growth",0.91334052499101,0.977870017908165,-0.532648464047332,-0.666016229937261,5079,53,"FGFR1, CACNA1H, SPTBN2, PTPRA"
"528","NCAM1 interactions",0.727868112014453,0.977870017908165,0.666077255964327,0.863566625416653,3222,33,"GFRA1, AGRN"
"529","NEP/NS2 Interacts with the Cellular Export Machinery",0.541918175720993,0.977870017908165,0.85382458642823,1.12004007668805,2423,30,"NUP93, RANBP2, AAAS"
"530","NIK-->noncanonical NF-kB signaling",0.831416247304098,0.977870017908165,-0.595004749052853,-0.748892765472711,4625,56,"UBB, CUL1, PSMB2, CHUK"
"531","NOD1/2 Signaling Pathway",0.67520750631541,0.977870017908165,-0.807090955358967,-1.00510141631291,3741,27,"CHUK, ITCH, MAPK14"
"532","NOTCH1 Intracellular Domain Regulates Transcription",0.905097613882863,0.977870017908165,-0.540662524390472,-0.667371090953546,5006,46,"MAML3, UBB, FBXW7, NCOR2, CUL1, TLE4, CREBBP, HDAC9"
"533","NOTCH2 Activation and Transmission of Signal to the Nucleus",0.238138520269042,0.977870017908165,-0.979144168466523,-1.25302798764092,1309,22,"UBB, NEURL1, MIB1"
"534","NOTCH3 Activation and Transmission of Signal to the Nucleus",0.222020348837209,0.977870017908165,-0.979207452912982,-1.2284542665384,1221,25,"UBB, NEURL1, YBX1, MIB1"
"535","NOTCH3 Intracellular Domain Regulates Transcription",0.670361338949235,0.977870017908165,0.672295566084365,0.920275823788629,3023,23,"MAML2, DLGAP5"
"536","NOTCH4 Intracellular Domain Regulates Transcription",0.622334579028358,0.977870017908165,0.686614755132213,0.981182357816309,2830,19,"MAML2, ACTA2"
"537","NR1H2 and NR1H3-mediated signaling",0.8291719058739,0.977870017908165,-0.604016887324293,-0.743126021514797,4615,40,"AGO2, NCOR2, KDM1A, APOD"
"538","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux",0.820522052205221,0.977870017908165,-0.604028900148366,-0.744257085932271,4557,32,"AGO2, NCOR2, KDM1A, APOD"
"539","NRAGE signals death through JNK",0.978784609852571,0.985366254683472,-0.476291379737121,-0.595548115681688,5443,53,"ARHGEF12, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"540","NRIF signals cell death from the nucleus",0.0258124419684308,0.605187072507423,-0.997166565472576,-1.39325540764119,138,15,"UBB"
"541","NS1 Mediated Effects on Host Pathways",0.499548532731377,0.977870017908165,0.853814647739263,1.09848309998928,2212,39,"NUP93, RANBP2, AAAS"
"542","Neddylation",0.571860816944024,0.977870017908165,-0.621920533015337,-0.941887216977755,3023,216,"UBB, FBXO10, CUL3, FBXW7, CUL1, FBXW4, FBXL7, PSMB2"
"543","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters",0.570639160066311,0.977870017908165,-0.959986504723347,-1.27478172438005,3097,18,"PACS1, AP1M1, ATP6V1H"
"544","Negative epigenetic regulation of rRNA expression",0.268117245099802,0.977870017908165,-0.965039220989992,-1.19928644495533,1490,50,"HDAC2"
"545","Negative regulation of FGFR1 signaling",0.0423069969264147,0.751486996252248,-0.9949358541526,-1.23149864851466,233,28,"UBB, FGFR1"
"546","Negative regulation of FGFR2 signaling",0.387050099475493,0.977870017908165,-0.96677471636953,-1.19137663536518,2139,30,"UBB, FGFR2"
"547","Negative regulation of FGFR3 signaling",0.0238181162035366,0.605187072507423,-0.997164269799473,-1.2418070270981,131,27,"UBB"
"548","Negative regulation of FGFR4 signaling",0.0238181162035366,0.605187072507423,-0.997164269799473,-1.2418070270981,131,27,"UBB"
"549","Negative regulation of MAPK pathway",0.490118577075099,0.977870017908165,-0.954411420931979,-1.16864685220327,2727,38,"UBB"
"550","Negative regulation of MET activity",0.640291704649043,0.977870017908165,-0.87357733593144,-1.12562559976482,3511,21,"UBB, SH3GL1"
"551","Negative regulation of NMDA receptor-mediated neuronal transmission",0.583204419889503,0.977870017908165,0.79054873116006,1.11228435842223,2638,20,"PPM1E, ACTN2"
"552","Negative regulation of NOTCH4 signaling",0.861281036344009,0.977870017908165,-0.575972694652469,-0.717166220522398,4786,51,"UBB, FBXW7, CUL1, PSMB2"
"553","Negative regulation of the PI3K/AKT network",0.442838078291815,0.977870017908165,0.732640792541481,1.02648477506399,1990,98,"NRG1, STRN, AKT1"
"554","Negative regulators of DDX58/IFIH1 signaling",0.680130411157399,0.977870017908165,-0.795610381051363,-0.977762520771563,3754,31,"UBB, UBE2K, ITCH"
"555","Nephrin family interactions",0.663714854992251,0.977870017908165,0.66215074014945,0.919739089171274,2997,21,"KIRREL3, CASK, ACTN1, ACTN2"
"556","Netrin-1 signaling",0.728744939271255,0.977870017908165,0.657567300144254,0.848636498377561,3239,48,"UNC5C, TRPC1, TRPC4, ABLIM1"
"557","Neurexins and neuroligins",0.75237753454154,0.977870017908165,-0.654407919472161,-0.822920754240355,4192,55,"NRXN3, SHANK1, APBA2, NLGN1, STXBP1, SHANK2, GRIN2B, EPB41L1, NRXN1"
"558","Neurodegenerative Diseases",0.558932866827028,0.977870017908165,0.798845758978079,1.16010979346164,2555,18,"PRDX1, APP"
"559","Neuronal System",0.787571080422421,0.977870017908165,0.524382699633939,0.836879841650105,3877,352,"LRRTM4, KCND2, PTPRD, NRG1, SLC1A3, IL1RAPL1, ADCY1, PPM1E, ARHGEF9, DLGAP1, RPS6KA2, RIMS1, KCNAB2, CREB1, SYT10, COMT, CASK"
"560","Neurotransmitter receptors and postsynaptic signal transmission",0.777121609798775,0.977870017908165,0.549559885905009,0.819614934435235,3552,164,"NRG1, ADCY1, PPM1E, ARHGEF9, RPS6KA2, CREB1, CASK, KCNJ4, GRIK2"
"561","Neurotransmitter release cycle",0.525891055817081,0.977870017908165,0.797917196821362,1.02800129494268,2345,47,"SLC1A3, RIMS1, CASK, ABAT"
"562","Neutrophil degranulation",0.802280594583588,0.977870017908165,0.522525135309364,0.834797433772507,3939,366,"CST3, TYROBP, VPS35L, CTSS, CDK13, SIRPA, SIRPB1, KCNAB2, GDI2, GALNS, PSAP, CD47, ILF2, ACTR10, PSMD14, RAP1A, VCP, RHOA"
"563","Nicotinamide salvaging",0.713143707008738,0.977870017908165,-0.532721630009445,-0.728678728175773,3835,16,"RNLS, PTGS2, PTGIS, PARP9, PARP8, PARP6, PARP4, PARP16, PARP14, PARP10, NUDT12, NNMT, NAXE, NAXD, NAPRT, NAMPT"
"564","Nicotinate metabolism",0.411001788908766,0.977870017908165,0.971914663786119,1.29879883887383,1837,26,"NADK, CD38"
"565","Nitric oxide stimulates guanylate cyclase",0.0696260821514091,0.894221428758959,-0.993387314439946,-1.31913520393077,377,18,"PDE10A, PRKG1"
"566","NoRC negatively regulates rRNA expression",0.289297960656921,0.977870017908165,-0.965046311946454,-1.19261191071287,1602,47,"HDAC2"
"567","Non-integrin membrane-ECM interactions",0.488613303269448,0.977870017908165,0.856171683195576,1.09935481662003,2166,40,"LAMC1, CASK, ACTN1, AGRN"
"568","Nonhomologous End-Joining (NHEJ)",0.068046804680468,0.894221428758959,-0.990611914088883,-1.22058718761385,377,32,"SUMO1"
"569","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",0.968299711815562,0.982773823940463,-0.494965786874011,-0.655411951764566,5375,84,"PPP2R2A, SMG6"
"570","Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)",0.153240324032403,0.977870017908165,0.970488696358468,1.28286653357294,680,64,"ETF1, NCBP2"
"571","Nonsense-Mediated Decay (NMD)",0.968299711815562,0.982773823940463,-0.494965786874011,-0.655411951764566,5375,84,"PPP2R2A, SMG6"
"572","Norepinephrine Neurotransmitter Release Cycle",0.637054735013032,0.977870017908165,0.573981292862614,0.845931266438786,2932,17,"RIMS1, CPLX1"
"573","Notch-HLH transcription pathway",0.748654708520179,0.977870017908165,0.6046209987308,0.803853439245754,3338,27,"MAML2, HDAC1"
"574","Nuclear Envelope Breakdown",0.672452660054103,0.977870017908165,0.693303326607516,0.895967257813952,2982,49,"NUP93, RANBP2, AAAS"
"575","Nuclear Events (kinase and transcription factor activation)",0.455950540958269,0.977870017908165,0.961251960500025,1.30801489588698,2064,24,"RPS6KA2, CREB1, ATF1"
"576","Nuclear Pore Complex (NPC) Disassembly",0.531842818428184,0.977870017908165,0.85382127487452,1.10697603085823,2354,33,"NUP93, RANBP2, AAAS"
"577","Nuclear Receptor transcription pathway",0.0306582506762849,0.608916882116728,-0.992699249645102,-1.2264017319068,169,45,"NR3C2, NCOR2"
"578","Nuclear import of Rev protein",0.538272706985048,0.977870017908165,0.853823482726092,1.11581819523226,2411,31,"NUP93, RANBP2, AAAS"
"579","Nuclear signaling by ERBB4",0.164245810055866,0.977870017908165,0.985535922632629,1.29885213213872,734,29,"NRG1, APOE, GFAP, TAB2"
"580","Nucleobase catabolism",0.671647164716472,0.977870017908165,-0.798904406889235,-0.984373869634025,3730,32,"UPP2"
"581","Nucleosome assembly",0.498173182316405,0.977870017908165,-0.963277980288916,-1.21487787857438,2726,24,"CENPP, RBBP7"
"582","Nucleotide Excision Repair",0.0307944606413994,0.608916882116728,-0.968024439918534,-1.32650121873755,168,108,"UBB, SUMO1, SUMO2, RNF111"
"583","Nucleotide salvage",0.801165331391114,0.977870017908165,-0.563752214067604,-0.716259171043558,4399,23,"UPP2, APRT"
"584","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.885745179311588,0.977870017908165,-0.557697555918871,-0.686892734941878,4914,44,"HSP90AB1, CHUK, ITCH, MAPK14"
"585","O-glycosylation of TSR domain-containing proteins",0.0260711856721832,0.605187072507423,0.996217238584166,1.28641046971158,114,34,"ADAMTS17, ADAMTS1"
"586","O-linked glycosylation",0.776519237684286,0.977870017908165,-0.601660439122782,-0.802451860855564,4318,88,"GALNT2, ST6GALNAC3"
"587","O-linked glycosylation of mucins",0.42795311091073,0.977870017908165,-0.954078285152689,-1.17868857229845,2372,45,"GALNT2, ST6GALNAC3"
"588","Olfactory Signaling Pathway",0.0656855707106963,0.894221428758959,-0.988242448814109,-1.21508517226292,365,39,"GNB1"
"589","Oncogene Induced Senescence",0.0202861800398479,0.605187072507423,-0.997163503748227,-1.2254605071365,111,31,"UBB"
"590","Oncogenic MAPK signaling",0.324721923214926,0.977870017908165,-0.92655096820945,-1.17924731587677,1809,63,"SPRED2, SPRED1, AKAP9, IQGAP1, FXR1, CAMK2A, CAMK2G, NF1"
"591","Opioid Signalling",0.842010122921186,0.977870017908165,-0.574149437392173,-0.751218737957011,4657,79,"PDE4A, GNB1, OPRM1, CAMKK1, CAMK2A, CAMK2G, ADCY8, GNAO1"
"592","Orc1 removal from chromatin",0.756440281030445,0.977870017908165,-0.642055152983076,-0.820411544780862,4198,66,"UBB, ORC3, CUL1, PSMB2"
"593","Organelle biogenesis and maintenance",0.189015151515152,0.977870017908165,-0.749546624146445,-1.16791597899517,997,266,"AHI1, PRKAG2, CRTC3, YWHAG, DYNLL1, MEF2D, AKAP9, TTC26, CREBBP, HSPA9, ARF4, KIF3A, KIF3B, IFT20, PCM1, SDCCAG8"
"594","Other interleukin signaling",0.839012709522932,0.977870017908165,-0.21812865497076,-0.289656595746063,4554,18,"VAMP2, TYK2, TXLNA, STXBP2, STX4, STX3, STX1A, SNAP25"
"595","Other semaphorin interactions",0.494834029457024,0.977870017908165,0.929207340603977,1.3278506506585,2250,19,"TYROBP, TREM2, CD72"
"596","Ovarian tumor domain proteases",0.536712034383954,0.977870017908165,-0.930080892125784,-1.14158086827465,2996,35,"UBB"
"597","Oxidative Stress Induced Senescence",0.275089605734767,0.977870017908165,-0.960278792800108,-1.2167568618049,1534,60,"UBB, SCMH1, RBBP7, MAPK14"
"598","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha",0.985753052917232,0.987637857989731,0.472041839416916,0.61857767055983,4358,60,"PSMA1, PSMB3, UBE2D2, PSMD14, PSME4, PSMD9"
"599","PCNA-Dependent Long Patch Base Excision Repair",0.804089830199014,0.977870017908165,-0.442455122148738,-0.575196808454552,4403,20,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLB, PCNA"
"600","PCP/CE pathway",0.484178353110392,0.977870017908165,-0.763490461609855,-1.01828922399745,2692,88,"PRICKLE1, UBB, ROR1, CLTC, PSMB2, DVL2"
"601","PERK regulates gene expression",0.847237754417356,0.977870017908165,0.460195813639433,0.609074826713405,3787,28,"ASNS, ATF3, ATF4, ATF6, CEBPB, CEBPG, DCP2, DDIT3, DIS3, EIF2AK3, EIF2S1, EIF2S2, EIF2S3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"602","PI Metabolism",0.2564332065339,0.977870017908165,0.864870609114907,1.18151103708878,1145,80,"INPP4B, PLEKHA1"
"603","PI-3K cascade:FGFR1",0.0515005557613931,0.79421098334342,-0.994872140881182,-1.34261860193811,277,17,"FGFR1"
"604","PI-3K cascade:FGFR2",0.443792407848891,0.977870017908165,-0.966731898238748,-1.26916230917047,2419,19,"FGFR2"
"605","PI-3K cascade:FGFR3",0.651957603287908,0.977870017908165,0.446624949399541,0.670704755542019,3013,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, GAB1, GRB2"
"606","PI-3K cascade:FGFR4",0.654120700843608,0.977870017908165,0.384057482121171,0.576746059543865,3023,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF9, FGFR4, FRS2, GAB1, GRB2"
"607","PI3K Cascade",0.331001076426265,0.977870017908165,-0.966826565772583,-1.18547420436058,1844,37,"FGFR1, PDPK1, FGFR2"
"608","PI3K events in ERBB2 signaling",0.0201385881333911,0.605187072507423,0.998583282736288,1.51300317031022,92,15,"NRG1, BTC"
"609","PI3K/AKT Signaling in Cancer",0.650839865621501,0.977870017908165,0.63556288667921,0.883881257426636,2905,93,"NRG1, CREB1, STRN"
"610","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.458660094107103,0.977870017908165,0.732648939910691,1.01570719139013,2046,91,"NRG1, STRN, AKT1"
"611","PIP3 activates AKT signaling",0.917361637604246,0.977870017908165,-0.497142151517697,-0.768429153565091,4839,248,"UBB, AGO2, FGFR1, KDM1A, PDPK1, PSMB2, CHUK, CNOT6L, SCMH1, FGFR2, HDAC2, RBBP7"
"612","PIWI-interacting RNA (piRNA) biogenesis",0.883435582822086,0.977870017908165,-0.354878881311938,-0.441944323446825,4895,27,"TDRKH, TDRD9, TDRD6, TDRD12, TDRD1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, PLD6, PIWIL2, PIWIL1"
"613","PKA activation",0.476180164573408,0.977870017908165,0.938326766083619,1.42170552663495,2198,15,"ADCY1, ADCY2"
"614","PKA activation in glucagon signalling",0.476180164573408,0.977870017908165,0.938326766083619,1.42170552663495,2198,15,"ADCY1, ADCY2"
"615","PKA-mediated phosphorylation of CREB",0.483275412684622,0.977870017908165,0.937671697504812,1.38193668754969,2224,17,"ADCY1, CREB1, ADCY2"
"616","PKMTs methylate histone lysines",0.595048789302494,0.977870017908165,-0.830041549524946,-1.02231103302879,3292,42,"DOT1L, ATF7IP, RBBP7, AEBP2"
"617","PLC beta mediated events",0.640492170022371,0.977870017908165,0.722996057927026,0.932325426802924,2862,46,"ADCY1, CREB1, ADCY2"
"618","PPARA activates gene expression",0.426591282144811,0.977870017908165,-0.767283089474792,-1.05023213501536,2338,107,"NCOR2, CREBBP, CLOCK, HMGCR, NRF1"
"619","PTEN Regulation",0.560431523130371,0.977870017908165,-0.666615713152946,-0.948368736371891,3064,135,"UBB, AGO2, KDM1A, PSMB2, CNOT6L, SCMH1, HDAC2, RBBP7, PREX2, NEDD4, VAPA"
"620","Paradoxical activation of RAF signaling by kinase inactive BRAF",0.68397412863816,0.977870017908165,-0.76353062870882,-0.934919308624811,3806,38,"IQGAP1, CAMK2A, CAMK2G"
"621","Pausing and recovery of HIV elongation",0.922296685383083,0.977870017908165,-0.220878529553372,-0.271447875724083,5091,31,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"622","Pausing and recovery of Tat-mediated HIV elongation",0.899041071105482,0.977870017908165,-0.267658762961014,-0.331268788481901,4968,29,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"623","Peptide chain elongation",0.798670977011494,0.977870017908165,-0.619950072325137,-0.782137508016036,4446,58,"RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"624","Peptide hormone metabolism",0.276096687555953,0.977870017908165,-0.959258256632377,-1.21884785072537,1541,62,"AOPEP, KIF5A"
"625","Peptide ligand-binding receptors",0.947521865889213,0.980957939302813,-0.503046994559155,-0.689334301746697,5199,108,"OPRM1, CX3CL1, SST, CCK"
"626","Peroxisomal lipid metabolism",0.82737030411449,0.977870017908165,0.388016992459337,0.518518793930249,3699,26,"ABCD1, ACAA1, ACBD4, ACBD5, ACOT6, ACOT8, ACOX1, ACOX2, ACOX3, ACOXL, ALDH3A2, AMACR"
"627","Peroxisomal protein import",0.530308464849354,0.977870017908165,-0.804900783370132,-1.01812490928229,2956,59,"UBB"
"628","Phase 0 - rapid depolarisation",0.445441493180187,0.977870017908165,-0.960200013514427,-1.18060583233204,2481,39,"SCN1B, CAMK2A, CAMK2G, SCN1A"
"629","Phase 2 - plateau phase",0.188638018936635,0.977870017908165,-0.982180222747216,-1.24788085014232,1035,23,"AKAP9, KCNQ1"
"630","Phase I - Functionalization of compounds",0.65408947130592,0.977870017908165,0.680969778175407,0.893562152801526,2894,59,"CYP7B1, ACSS1"
"631","Phase II - Conjugation of compounds",0.737932276657061,0.977870017908165,-0.651958597816528,-0.833048961739487,4096,65,"GSTZ1, CHAC2, PODXL2"
"632","Phospholipid metabolism",0.269905821917808,0.977870017908165,0.741093899466998,1.12707999509708,1260,194,"INPP4B, PLA2G3, PTDSS2, GPCPD1, OSBPL10, PLEKHA1, PLD3, PLA2G4E"
"633","Phosphorylation of the APC/C",0.583369423993071,0.977870017908165,0.634311542872563,0.961076949636858,2693,15,"ANAPC1, ANAPC10, ANAPC15, ANAPC16, ANAPC2, ANAPC4, ANAPC5, ANAPC7, CDC16, CDC23, CDC26, CDC27"
"634","Pink/Parkin Mediated Mitophagy",0.598386209426004,0.977870017908165,-0.949220610680606,-1.24617282657004,3262,19,"UBB"
"635","Plasma lipoprotein assembly, remodeling, and clearance",0.625649130729284,0.977870017908165,0.711889265661805,0.927622357404237,2770,55,"APOE, PCSK5, CLTA, LPA"
"636","Plasma lipoprotein clearance",0.705474860335196,0.977870017908165,0.667612824969295,0.879856655897621,3156,29,"APOE, CLTA, AMN"
"637","Plasma lipoprotein remodeling",0.460039849457605,0.977870017908165,0.970720784702723,1.34834833856804,2077,21,"APOE, PCSK5, LPA"
"638","Platelet Aggregation (Plug Formation)",0.63329745245784,0.977870017908165,-0.839559192337846,-1.03281824359781,3529,33,"PDPK1"
"639","Platelet activation, signaling and aggregation",0.295196671709531,0.977870017908165,-0.725269194102223,-1.10480282167402,1560,224,"DGKZ, DGKB, APLP2, TMSB4X, PDPK1, GNB1, PPIA, MGLL, DGKD, DAGLB, VTI1B, ACTN4, CLU, MANF, MAPK14"
"640","Platelet calcium homeostasis",0.087219730941704,0.977870017908165,0.991560326784147,1.3182955613157,388,27,"SLC8A3, ATP2A1"
"641","Platelet degranulation",0.532919934342513,0.977870017908165,-0.71332535486077,-0.976376542989915,2921,107,"APLP2, TMSB4X, PPIA, VTI1B, ACTN4, CLU, MANF"
"642","Platelet homeostasis",0.534588917059037,0.977870017908165,-0.763688665129,-0.993702750493135,2951,76,"PDE10A, PRKG1, GNB1"
"643","Platelet sensitization by LDL",0.559651722860319,0.977870017908165,-0.960191619998651,-1.29581589177221,3020,17,"MAPK14"
"644","Positive epigenetic regulation of rRNA expression",0.330441070137382,0.977870017908165,-0.96329096809086,-1.18904587479084,1827,46,"SF3B1, HDAC2, RBBP7"
"645","Post NMDA receptor activation events",0.865115228197018,0.977870017908165,0.552309220450782,0.724734976287023,3828,59,"NRG1, ADCY1, RPS6KA2, CREB1"
"646","Post-translational modification: synthesis of GPI-anchored proteins",0.217254549539429,0.977870017908165,0.924908192319918,1.22723670151477,966,66,"THY1, CNTN5, CNTN3, PIGB"
"647","Post-translational protein phosphorylation",0.595596495169625,0.977870017908165,0.670498806628042,0.923102777020248,2650,85,"APOE, CST3, MIA3, LAMC1, IGFBP5"
"648","Potassium Channels",0.852392720736913,0.977870017908165,0.544518018953717,0.746231019652186,3793,82,"KCND2, KCNAB2, KCNJ4, KCNG2"
"649","Pre-NOTCH Expression and Processing",0.830755436000897,0.977870017908165,0.582827946048582,0.75088979865772,3705,47,"MAML2, ST3GAL4"
"650","Pre-NOTCH Processing in Golgi",0.717791411042945,0.977870017908165,-0.514840056226211,-0.704219570318943,3860,16,"FURIN, ST3GAL3"
"651","Pre-NOTCH Transcription and Translation",0.785248482122779,0.977870017908165,0.592269767589694,0.770529961167447,3491,32,"MAML2, AGO1"
"652","Prefoldin mediated transfer of substrate  to CCT/TriC",0.570647219690064,0.977870017908165,-0.95997840318553,-1.23695547194438,3129,21,"TUBB2A, PFDN1"
"653","Presynaptic function of Kainate receptors",0.126343090033346,0.977870017908165,-0.988259901491127,-1.33369512801543,681,17,"GNB1"
"654","Presynaptic phase of homologous DNA pairing and strand exchange",0.951005025125628,0.980957939302813,-0.287186764178453,-0.353108064971457,5298,39,"XRCC2, WRN, TOPBP1, TOP3A, RPA3, RPA2, RPA1, RMI2, RMI1, RHNO1, RFC5, RFC4, RFC3, RFC2, RBBP8, RAD9B, RAD9A, RAD51D, RAD51C, RAD51B, RAD51, RAD50, RAD17, RAD1"
"655","Processing of Capped Intron-Containing Pre-mRNA",0.347798340778558,0.977870017908165,0.691912960526736,1.06679214393277,1634,233,"SRSF2, SRSF1, SRSF7, SRSF11, NUP93, LSM7, HNRNPU, POLDIP3, RANBP2, U2AF1, CPSF7, SRSF10, RNPS1, ELAVL1, FYTTD1, SRSF4, TRA2B, NCBP2"
"656","Processing of Capped Intronless Pre-mRNA",0.749367088607595,0.977870017908165,-0.691858590715452,-0.865096123817906,4143,26,"SYMPK"
"657","Processing of DNA double-strand break ends",0.160329985652798,0.977870017908165,-0.968604100412748,-1.22519443667841,893,59,"UBB, SUMO1, SUMO2"
"658","Processing of Intronless Pre-mRNAs",0.696629213483146,0.977870017908165,-0.691866389768122,-0.918740654217194,3781,18,"SYMPK"
"659","Programmed Cell Death",0.846777729066199,0.977870017908165,0.526880991893426,0.78193484160891,3862,157,"BCL2L1, PSMA1, NMT1, YWHAZ, PSMB3, PSMD14, PSME4, ADD1, PSMD9"
"660","Protein folding",0.13565123401189,0.977870017908165,-0.960143699586525,-1.27346991347463,752,85,"FBXW7, FBXW4, GNB1, XRN2, TUBB2A, GNAO1, PFDN1"
"661","Protein localization",0.490955600219258,0.977870017908165,-0.687273528782014,-0.99265075666694,2686,150,"UBB, HSPA9, SGTA, TIMM23"
"662","Protein ubiquitination",0.510573476702509,0.977870017908165,-0.814386113465945,-1.03318343167583,2848,61,"UBB, SELENOS, UBE2K"
"663","Protein-protein interactions at synapses",0.930282831922176,0.977870017908165,-0.515196923899776,-0.683322488481236,5163,85,"NRXN3, SHANK1, APBA2, NLGN1, STXBP1, SHANK2, GRIN2B, EPB41L1, NRXN1"
"664","Purine catabolism",0.688966116420504,0.977870017908165,0.315982489075517,0.465693691554006,3171,17,"ADPRM, DNPH1, GDA, GPX1, ITPA, NT5C, NT5C1A, NT5C2, NT5E, NUDT1, NUDT15, NUDT16, NUDT18, NUDT5, NUDT9, PNP"
"665","Pyruvate metabolism",0.664020209310718,0.977870017908165,-0.828212676695743,-1.03140510846756,3679,27,"GSTZ1, LDHB"
"666","Pyruvate metabolism and Citric Acid (TCA) cycle",0.834652752788773,0.977870017908165,-0.599124675836878,-0.745993661471915,4638,51,"GSTZ1, SDHB, LDHB"
"667","RAB GEFs exchange GTP for GDP on RABs",0.592145559358674,0.977870017908165,-0.714462590018795,-0.942807786040147,3286,82,"RAB6B, MADD, RAB7A, CCZ1B, CCZ1"
"668","RAB geranylgeranylation",0.163825587654764,0.977870017908165,-0.969897855644998,-1.21965069668971,912,55,"RAB6B, RAB7A"
"669","RAF activation",0.723900850370906,0.977870017908165,-0.739642821887035,-0.915421482208455,4000,29,"CAMK2A, CAMK2G"
"670","RAF-independent MAPK1/3 activation",0.311602209944751,0.977870017908165,0.97907949790795,1.37754292461752,1409,20,"PEA15, DUSP1"
"671","RAF/MAP kinase cascade",0.724248724248724,0.977870017908165,-0.569858210527897,-0.862500232456964,3831,215,"SPRED2, UBB, CUL3, FGFR1, SPRED1, RASGRF1, SHC3, IQGAP1, PSMB2, SPTBN2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"672","RET signaling",0.74683830171635,0.977870017908165,0.646067468005009,0.835330090381545,3306,37,"GFRA1, ARTN"
"673","RHO GTPase Effectors",0.842981460461597,0.977870017908165,-0.524918282496361,-0.800839292305244,4455,227,"YWHAG, KDM1A, PDPK1, DYNLL1, CENPP, IQGAP1, SCAI, BUB3, PAK2, LIMK2, DVL2, NUP98"
"674","RHO GTPases Activate Formins",0.922514943546602,0.977870017908165,0.504865493654415,0.72097333372486,4166,113,"CKAP5, DIAPH2, RANBP2, DYNC1I2, RHOA"
"675","RHO GTPases Activate NADPH Oxidases",0.567577480286081,0.977870017908165,-0.960186247385114,-1.26056893041928,3094,19,"MAPK14"
"676","RHO GTPases Activate ROCKs",0.674341499355314,0.977870017908165,-0.75030895428389,-0.996347488067503,3660,18,"LIMK2"
"677","RHO GTPases Activate WASPs and WAVEs",0.202806699864192,0.977870017908165,0.980814699723029,1.2693524641369,895,35,"WIPF3, ABI1"
"678","RHO GTPases activate CIT",0.421386398425541,0.977870017908165,0.972672064777328,1.41254600840373,1926,18,"RHOA, CDKN1B"
"679","RHO GTPases activate PAKs",0.644198895027624,0.977870017908165,0.676718979703714,0.952128447625694,2914,20,"PAK3, CALM1"
"680","RHO GTPases activate PKNs",0.759269307288841,0.977870017908165,-0.692691748000972,-0.853618480195326,4197,30,"YWHAG, KDM1A, PDPK1"
"681","RMTs methylate histone arginines",0.762972337732779,0.977870017908165,-0.683546063681439,-0.846070678936552,4219,28,"DNMT3A, SMARCA4, RBBP7"
"682","RNA Pol II CTD phosphorylation and interaction with CE",0.844618834080717,0.977870017908165,0.262267533889977,0.34868894656738,3766,27,"CCNH, CDK7, ERCC2, ERCC3, GTF2F1, GTF2F2, GTF2H1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, MNAT1, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, POLR2K, POLR2L, RNGTT, RNMT"
"683","RNA Pol II CTD phosphorylation and interaction with CE during HIV infection",0.844618834080717,0.977870017908165,0.262267533889977,0.34868894656738,3766,27,"CCNH, CDK7, ERCC2, ERCC3, GTF2F1, GTF2F2, GTF2H1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, MNAT1, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, POLR2K, POLR2L, RNGTT, RNMT"
"684","RNA Polymerase I Promoter Clearance",0.300305700413595,0.977870017908165,-0.963213416283473,-1.19701745651627,1669,50,"HDAC2, RBBP7"
"685","RNA Polymerase I Promoter Escape",0.923312331233123,0.977870017908165,-0.222886836417668,-0.274631076963587,5128,32,"ZNRD1, UBTF, TWISTNB, TBP, TAF1D, TAF1C, TAF1B, TAF1A, RRN3, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1E, POLR1D, POLR1C, POLR1B, POLR1A"
"686","RNA Polymerase I Transcription",0.300305700413595,0.977870017908165,-0.963213416283473,-1.19701745651627,1669,50,"HDAC2, RBBP7"
"687","RNA Polymerase I Transcription Initiation",0.331344902386117,0.977870017908165,-0.96322336398053,-1.18896242711909,1832,46,"HDAC2, RBBP7"
"688","RNA Polymerase I Transcription Termination",0.907759088442756,0.977870017908165,-0.262520259319287,-0.3235091877842,5018,30,"ZNRD1, UBTF, TWISTNB, TTF1, TBP, TAF1D, TAF1C, TAF1B, TAF1A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1E, POLR1D, POLR1C, POLR1B, POLR1A"
"689","RNA Polymerase II HIV Promoter Escape",0.970582927269446,0.982773823940463,-0.265870418612814,-0.328564778724787,5377,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1, TAF1L, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"690","RNA Polymerase II Pre-transcription Events",0.0946308724832215,0.977870017908165,0.970390947896199,1.32271024119499,422,79,"NCBP2, AFF4"
"691","RNA Polymerase II Promoter Escape",0.970582927269446,0.982773823940463,-0.265870418612814,-0.328564778724787,5377,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1, TAF1L, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"692","RNA Polymerase II Transcription Elongation",0.196259576385759,0.977870017908165,0.970437017994859,1.2686853253736,870,56,"NCBP2, AFF4"
"693","RNA Polymerase II Transcription Initiation",0.970582927269446,0.982773823940463,-0.265870418612814,-0.328564778724787,5377,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1, TAF1L, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"694","RNA Polymerase II Transcription Initiation And Promoter Clearance",0.970582927269446,0.982773823940463,-0.265870418612814,-0.328564778724787,5377,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1, TAF1L, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"695","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening",0.970582927269446,0.982773823940463,-0.265870418612814,-0.328564778724787,5377,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1, TAF1L, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"696","RNA Polymerase II Transcription Termination",0.245415440344125,0.977870017908165,0.923087254598955,1.2135255452833,1083,62,"SRSF2, SRSF1, SRSF7, SRSF11, POLDIP3, U2AF1, CPSF7, RNPS1, FYTTD1, SRSF4, NCBP2"
"697","RNA Polymerase III Abortive And Retractive Initiation",0.256101938262742,0.977870017908165,-0.97053854990202,-1.19331749259571,1426,39,"NFIX"
"698","RNA Polymerase III Chain Elongation",0.701617401003904,0.977870017908165,-0.566902239913642,-0.775432383274817,3773,16,"POLR3K, POLR3H, POLR3F, POLR3E, POLR3D, POLR3C, POLR3B, POLR3A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1D, POLR1C"
"699","RNA Polymerase III Transcription",0.256101938262742,0.977870017908165,-0.97053854990202,-1.19331749259571,1426,39,"NFIX"
"700","RNA Polymerase III Transcription Initiation",0.929350742264353,0.977870017908165,-0.305962617416596,-0.376321822024092,5195,34,"ZNF143, TBP, SNAPC5, SNAPC4, SNAPC3, SNAPC2, SNAPC1, POU2F1, POLR3K, POLR3H, POLR3F, POLR3E, POLR3D, POLR3C, POLR3B, POLR3A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1D, POLR1C"
"701","RNA Polymerase III Transcription Initiation From Type 1 Promoter",0.82871198568873,0.977870017908165,0.331508755894389,0.443005135404451,3705,26,"BDP1, BRF1, CRCP, GTF3C2, GTF3A, GTF3C1, GTF3C3, GTF3C4, GTF3C5, GTF3C6, POLR1C, POLR1D, POLR2E, POLR2F, POLR2H, POLR2K, POLR2L, POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3H, POLR3K"
"702","RNA Polymerase III Transcription Initiation From Type 2 Promoter",0.815918185860382,0.977870017908165,0.329945318301492,0.443805253743297,3669,25,"BDP1, BRF1, CRCP, GTF3C2, GTF3C1, GTF3C3, GTF3C4, GTF3C5, GTF3C6, POLR1C, POLR1D, POLR2E, POLR2F, POLR2H, POLR2K, POLR2L, POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3H, POLR3K"
"703","RNA Polymerase III Transcription Initiation From Type 3 Promoter",0.850271247739602,0.977870017908165,-0.514307526122271,-0.643087262729014,4701,26,"ZNF143, TBP, SNAPC5, SNAPC4, SNAPC3, SNAPC2, SNAPC1, POU2F1, POLR3K, POLR3H, POLR3F, POLR3E, POLR3D, POLR3C, POLR3B, POLR3A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1D, POLR1C"
"704","RNA Polymerase III Transcription Termination",0.374293527803099,0.977870017908165,-0.970574340284808,-1.25060859406862,2052,21,"NFIX"
"705","RNA polymerase II transcribes snRNA genes",0.0226781857451404,0.605187072507423,-0.986019345962284,-1.27184585683723,125,70,"RPRD2"
"706","RORA activates gene expression",0.751151224903297,0.977870017908165,-0.53463322184122,-0.709948168121407,4077,18,"CREBBP"
"707","ROS and RNS production in phagocytes",0.612588171459577,0.977870017908165,-0.885611049211303,-1.09135695647248,3386,30,"ATP6V0C, ATP6V0B, ATP6V1C1"
"708","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known",0.32454251883746,0.977870017908165,-0.967231943787582,-1.18597125853432,1808,37,"YAF2, SCMH1, SMARCA4"
"709","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function",0.957724308522599,0.982248804367443,0.131517627988653,0.171101545836687,4258,32,"AGO1, AGO3, AGO4, ASH2L, CBFB, DPY30, EP300, GATA1, H3-3A, HDAC1, ITGA2B, KAT2B, KMT2A, KMT2B, KMT2C, KMT2D, KMT2E, MOV10, MYL9, NR4A3, PRKCQ, PRMT1, PRMT6, RBBP5, RUNX1, SETD1B, SIN3A, SIN3B"
"710","RUNX1 regulates transcription of genes involved in differentiation of HSCs",0.935698847262248,0.979935535138707,-0.512984385392246,-0.655472772459456,5194,65,"UBB, PSMB2, ITCH"
"711","RUNX2 regulates bone development",0.913334539533201,0.977870017908165,-0.205238659622178,-0.254014332916091,5047,29,"ZNF521, YES1, YAP1, WWTR1, UCMA, SRC, SP7, SMAD6, SMAD4, SMAD1, SATB2, RUNX2, RBM14, RB1, MAPK3, MAPK1, MAF, HEY2, HEY1, HES1, HDAC6, HDAC4, HDAC3, GLI3, GLI2"
"712","RUNX2 regulates osteoblast differentiation",0.919337217771304,0.977870017908165,-0.169185167794098,-0.214953351868405,5048,23,"ZNF521, YES1, YAP1, WWTR1, UCMA, SRC, SP7, SATB2, RUNX2, RB1, MAPK3, MAPK1, MAF, HEY2, HEY1, HES1, HDAC6, HDAC3, GLI3"
"713","Rab regulation of trafficking",0.878835037794575,0.977870017908165,0.524275446945972,0.74620414259383,3952,111,"TBC1D14, GDI2, TBC1D24, TBC1D20, GAPVD1"
"714","Ras activation upon Ca2+ influx through NMDA receptor",0.437924078488905,0.977870017908165,-0.967069302921925,-1.26960526683806,2387,19,"RASGRF1, CAMK2A, GRIN2B, CAMK2G"
"715","Receptor-type tyrosine-protein phosphatases",0.0228621675093427,0.605187072507423,0.997975571900938,1.42612144199012,103,19,"PTPRD, IL1RAPL1"
"716","Recognition and association of DNA glycosylase with site containing an affected pyrimidine",0.70380687093779,0.977870017908165,-0.415826755717466,-0.580999098952627,3789,15,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MBD4"
"717","Recognition of DNA damage by PCNA-containing replication complex",0.0217115976117243,0.605187072507423,-0.997163886825579,-1.23414331386837,119,29,"UBB"
"718","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks",0.675699928212491,0.977870017908165,-0.762899329617654,-0.938016439650123,3764,39,"UBB, SUMO1"
"719","Recruitment of NuMA to mitotic centrosomes",0.91487826871055,0.977870017908165,-0.53068672875005,-0.68980375219359,5072,75,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"720","Recruitment of mitotic centrosome proteins and complexes",0.784375,0.977870017908165,0.585899533929982,0.792261031815652,3513,76,"CKAP5, CDK11A, CDK11B, DYNC1I2, TUBGCP4, ODF2"
"721","Recycling pathway of L1",0.77780269058296,0.977870017908165,0.563677534428592,0.749418438372389,3468,27,"RPS6KA2, CLTA, AP2A1"
"722","Regulation of APC/C activators between G1/S and early anaphase",0.813131313131313,0.977870017908165,-0.597328440059163,-0.771774472605025,4507,71,"UBB, CUL1, PSMB2, BUB3"
"723","Regulation of Apoptosis",0.91044776119403,0.977870017908165,-0.535551009799979,-0.665547112143656,5062,50,"UBB, PSMB2, PAK2"
"724","Regulation of Complement cascade",0.505256094833371,0.977870017908165,0.893020723815022,1.18192392561675,2258,28,"C1QB, C1QA"
"725","Regulation of FZD by ubiquitination",0.0268395106810298,0.605187072507423,-0.99716560939398,-1.29632689805599,146,20,"UBB"
"726","Regulation of Glucokinase by Glucokinase Regulatory Protein",0.538272706985048,0.977870017908165,0.853823482726092,1.11581819523226,2411,31,"NUP93, RANBP2, AAAS"
"727","Regulation of HSF1-mediated heat shock response",0.586362814252125,0.977870017908165,-0.730444147680555,-0.95404882275085,3241,78,"UBB, HSPA8, HSPA4, HSPA9, ST13, NUP98"
"728","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",0.577603583426652,0.977870017908165,0.670485199496231,0.932447934952812,2578,93,"APOE, CST3, MIA3, LAMC1, IGFBP5"
"729","Regulation of KIT signaling",0.771332961517011,0.977870017908165,-0.264986169207934,-0.36245906658452,4148,16,"YES1, SRC, SOS1, SOCS6, SOCS1, SH2B3, SH2B2, PTPN6, PRKCA, LYN, LCK, KITLG, KIT, GRB2, FYN"
"730","Regulation of MECP2 expression and activity",0.661059866160246,0.977870017908165,-0.827395525668694,-1.0196167533105,3654,30,"AGO2, NCOR2, CAMK2A, CAMK2G, HDAC2"
"731","Regulation of PLK1 Activity at G2/M Transition",0.582504970178926,0.977870017908165,-0.728563088513942,-0.955834851147391,3222,80,"UBB, YWHAG, CUL1, DYNLL1, AKAP9, PCM1, SDCCAG8"
"732","Regulation of PTEN gene transcription",0.24371408045977,0.977870017908165,-0.963328822733424,-1.21534884573348,1356,58,"KDM1A, SCMH1, HDAC2, RBBP7"
"733","Regulation of PTEN stability and activity",0.935326968113853,0.979935535138707,-0.515402184076026,-0.658575669172129,5191,66,"UBB, PSMB2"
"734","Regulation of RAS by GAPs",0.608132421734437,0.977870017908165,-0.74270704288501,-0.946304354950302,3379,64,"SPRED2, UBB, CUL3, SPRED1, PSMB2"
"735","Regulation of RUNX1 Expression and Activity",0.19155242682475,0.977870017908165,-0.982997098711288,-1.32659277121982,1033,17,"AGO2, CCND2"
"736","Regulation of RUNX2 expression and activity",0.734366552531988,0.977870017908165,-0.650564130361813,-0.835150925086035,4074,68,"UBB, FBXW7, CUL1, PSMB2, WWP1"
"737","Regulation of RUNX3 expression and activity",0.915976970133141,0.977870017908165,-0.530829667626292,-0.660956864808342,5090,51,"UBB, PSMB2"
"738","Regulation of TNFR1 signaling",0.278210469117913,0.977870017908165,-0.973053285608158,-1.19583034113259,1535,31,"UBB, MADD, CHUK, SPPL2A"
"739","Regulation of TP53 Activity",0.0206468116206834,0.605187072507423,-0.960307734204793,-1.38700264024551,112,150,"PRKAG2, UBB, JMY, PDPK1, BRD1, HDAC2, RBBP7, MAPK14"
"740","Regulation of TP53 Activity through Acetylation",0.472066534080636,0.977870017908165,-0.963335584064821,-1.19238488078444,2610,28,"BRD1, HDAC2, RBBP7"
"741","Regulation of TP53 Activity through Methylation",0.0530484435439307,0.79421098334342,-0.994804318488529,-1.32101686669959,287,18,"UBB, JMY"
"742","Regulation of TP53 Activity through Phosphorylation",0.00395541172240201,0.605187072507423,-0.990922702535565,-1.32595986446439,21,90,"PRKAG2, UBB"
"743","Regulation of TP53 Degradation",0.069967707212056,0.894221428758959,-0.990138466734211,-1.21805952631335,389,33,"UBB, PDPK1"
"744","Regulation of TP53 Expression and Degradation",0.0683240922911823,0.894221428758959,-0.990137800594434,-1.21783002224511,381,34,"UBB, PDPK1"
"745","Regulation of actin dynamics for phagocytic cup formation",0.440150970524802,0.977870017908165,-0.876949574224269,-1.10375789918711,2448,56,"HSP90AB1"
"746","Regulation of activated PAK-2p34 by proteasome mediated degradation",0.904710341093665,0.977870017908165,-0.540465166089125,-0.667911152474374,5012,47,"UBB, PSMB2, PAK2"
"747","Regulation of beta-cell development",0.699397455925017,0.977870017908165,0.686614208248145,0.89730095525383,3133,31,"MAML2, AKT1"
"748","Regulation of cholesterol biosynthesis by SREBP (SREBF)",0.590163934426229,0.977870017908165,-0.79157974866412,-0.986403811561132,3275,52,"SEC23A, ACACA, CREBBP, INSIG2, HMGCR"
"749","Regulation of expression of SLITs and ROBOs",0.458434399117971,0.977870017908165,0.696125909050687,1.01109081746385,2078,133,"ROBO2, PSMA1, PSMB3, ETF1, RNPS1, PSMD14, PSME4, PSMD9, NCBP2"
"750","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells",0.566478995236033,0.977870017908165,0.686614937230133,1.04032442238059,2615,15,"MAML2, EP300"
"751","Regulation of insulin secretion",0.373650107991361,0.977870017908165,-0.867765965561488,-1.11931327972743,2075,70,"GNB1, IQGAP1, STXBP1, ADCY8"
"752","Regulation of lipid metabolism by PPARalpha",0.418507026829713,0.977870017908165,-0.767277927539798,-1.05324033750747,2292,109,"NCOR2, CREBBP, CLOCK, HMGCR, NRF1"
"753","Regulation of mRNA stability by proteins that bind AU-rich elements",0.990114580993035,0.991060249169724,0.478503828526946,0.655762320878289,4406,82,"PSMA1, YWHAZ, PSMB3, ELAVL1, PSMD14, PSME4, PSMD9"
"754","Regulation of mitotic cell cycle",0.44981884057971,0.977870017908165,-0.808186239463283,-1.05342575138878,2482,77,"PTTG1, UBB, CUL1, PSMB2, BUB3"
"755","Regulation of ornithine decarboxylase (ODC)",0.527215474583896,0.977870017908165,0.794238621318167,1.02502037787434,2343,48,"PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"756","Regulation of pyruvate dehydrogenase (PDH) complex",0.137233054781801,0.977870017908165,-0.987384470080281,-1.37958772385065,738,15,"GSTZ1"
"757","Regulation of signaling by CBL",0.89700415482178,0.977870017908165,0.166914080071975,0.242398055922397,4101,18,"BLNK, CBL, CRK, CRKL, FYN, GRB2, HCK, LYN, PIK3CA, PIK3CB, PIK3CD, PIK3R1, PIK3R2, PIK3R3"
"758","Reproduction",0.911287414352687,0.977870017908165,-0.533170620473772,-0.690295333273473,5053,72,"SYCP3, SYNE1"
"759","Resolution of AP sites via the multiple-nucleotide patch replacement pathway",0.854219948849105,0.977870017908165,-0.42041312272175,-0.530221403487121,4675,24,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLB, PCNA, PARP2, PARP1, PARG"
"760","Resolution of Abasic Sites (AP sites)",0.153794037940379,0.977870017908165,0.983311938382542,1.27136884464824,680,37,"PNKP, ADPRHL2"
"761","Resolution of D-Loop Structures",0.940258342303552,0.979935535138707,-0.187154216941451,-0.230235451398177,5240,33,"XRCC3, XRCC2, WRN, TOP3A, SPIDR, SLX4, SLX1A, RTEL1, RMI2, RMI1, RBBP8, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50"
"762","Resolution of D-loop Structures through Holliday Junction Intermediates",0.942574257425743,0.979935535138707,-0.171957314602188,-0.211878024112965,5235,32,"XRCC3, XRCC2, WRN, TOP3A, SPIDR, SLX4, SLX1A, RMI2, RMI1, RBBP8, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50"
"763","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)",0.894575045207957,0.977870017908165,-0.21041670994412,-0.263103880766931,4946,26,"XRCC3, XRCC2, WRN, TOP3A, RTEL1, RMI2, RMI1, RBBP8, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50"
"764","Resolution of Sister Chromatid Cohesion",0.949598572702944,0.980957939302813,0.496673467688357,0.693246158351871,4257,96,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"765","Respiratory electron transport",0.838760035682426,0.977870017908165,0.54799230329264,0.764875886831917,3760,96,"NDUFS1, NDUFS4, COX19, SDHA, COX7C, ACAD9"
"766","Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",0.898125689084895,0.977870017908165,0.514268292589739,0.735113266408003,4072,114,"ATP5MG, NDUFS1, NDUFS4, COX19, SDHA, COX7C"
"767","Response of EIF2AK1 (HRI) to heme deficiency",0.619532265049805,0.977870017908165,0.529069688996829,0.80161978535609,2860,15,"ASNS, ATF3, ATF4, ATF5, CEBPB, CEBPG, CHAC1, DDIT3, EIF2AK1, EIF2S1, EIF2S2, EIF2S3"
"768","Response of EIF2AK4 (GCN2) to amino acid deficiency",0.994949494949495,0.994949494949495,-0.466529385563738,-0.602776372848643,5515,71,"TRIB3, RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"769","Response of Mtb to phagocytosis",0.569351027085984,0.977870017908165,-0.959975701943845,-1.22849776440455,3131,22,"UBB, RAB7A, ATP6V1H"
"770","Response to elevated platelet cytosolic Ca2+",0.601966496722505,0.977870017908165,-0.6717924698384,-0.926567660159387,3305,112,"APLP2, TMSB4X, PPIA, VTI1B, ACTN4, CLU, MANF"
"771","Retinoid metabolism and transport",0.0195637508432651,0.605187072507423,0.997365932729974,1.29755117595088,86,32,"APOE, AGRN"
"772","Retrograde transport at the Trans-Golgi-Network",0.684220018034265,0.977870017908165,-0.740646691148249,-0.915010649076231,3793,45,"GOLGA1, VPS54, RAB6B"
"773","Rev-mediated nuclear export of HIV RNA",0.531842818428184,0.977870017908165,0.85382127487452,1.10697603085823,2354,33,"NUP93, RANBP2, AAAS"
"774","Rho GTPase cycle",0.980744544287548,0.985446100108677,-0.481122244838646,-0.680572622048512,5347,131,"ARHGEF12, RHOF, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"775","Ribosomal scanning and start codon recognition",0.81605471562275,0.977870017908165,-0.618231740075355,-0.764797740815802,4533,48,"EIF4E, EIF5, EIF4A2"
"776","Role of phospholipids in phagocytosis",0.266016404344935,0.977870017908165,0.980965237934526,1.34280015813003,1199,23,"PLD3, AHCYL1"
"777","S Phase",0.614724150529777,0.977870017908165,-0.631810073062592,-0.912062100067032,3364,149,"UBB, ORC3, CUL1, PSMB2, MAX"
"778","S33 mutants of beta-catenin aren't phosphorylated",0.644001732351667,0.977870017908165,0.361465290427039,0.547674029625871,2973,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"779","S37 mutants of beta-catenin aren't phosphorylated",0.644001732351667,0.977870017908165,0.361465290427039,0.547674029625871,2973,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"780","S45 mutants of beta-catenin aren't phosphorylated",0.644001732351667,0.977870017908165,0.361465290427039,0.547674029625871,2973,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"781","SCF(Skp2)-mediated degradation of p27/p21",0.840941768511862,0.977870017908165,-0.588379939845817,-0.740554560280762,4678,56,"UBB, CUL1, PSMB2"
"782","SCF-beta-TrCP mediated degradation of Emi1",0.862367141055666,0.977870017908165,-0.576766087296204,-0.718720088340183,4786,52,"UBB, CUL1, PSMB2"
"783","SHC-mediated cascade:FGFR1",0.0515005557613931,0.79421098334342,-0.994872140881182,-1.34261860193811,277,17,"FGFR1"
"784","SHC-mediated cascade:FGFR2",0.443792407848891,0.977870017908165,-0.966731898238748,-1.26916230917047,2419,19,"FGFR2"
"785","SHC-mediated cascade:FGFR3",0.656932727666018,0.977870017908165,0.371061597625152,0.557229905003744,3036,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, GRB2, HRAS, KRAS"
"786","SHC-mediated cascade:FGFR4",0.656932727666018,0.977870017908165,0.371061597625152,0.557229905003744,3036,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF9, FGFR4, GRB2, HRAS, KLB, KRAS"
"787","SHC1 events in ERBB2 signaling",0.644675669692274,0.977870017908165,0.695702768660941,0.9663434501904,2911,21,"NRG1, BTC"
"788","SLC transporter disorders",0.133199464524766,0.977870017908165,0.948347849200477,1.28630761188648,596,77,"SLC1A3, NUP93, SLC4A4, RANBP2, AAAS"
"789","SLC-mediated transmembrane transport",0.0580204778156997,0.844520288206295,0.869917206640652,1.3275741334825,271,204,"AHCYL2, SLC1A3, SLC4A3, SLC24A2, SLC8A3, SLC4A4, SLC6A15, SLC4A10"
"790","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription",0.364935769857065,0.977870017908165,-0.968127490039841,-1.19820631752765,2016,29,"UBB, SMAD7, RNF111"
"791","SRP-dependent cotranslational protein targeting to membrane",0.103224644208251,0.977870017908165,-0.964895635673624,-1.27328026790783,572,82,"SRP9, SRP14"
"792","SUMO E3 ligases SUMOylate target proteins",0.523408924652524,0.977870017908165,-0.674745899105378,-0.97287456468008,2861,148,"NR3C2, NCOR2, SUMO1, CREBBP, SMC6, DNMT3A, NUP98, SCMH1, SUMO2, HDAC2"
"793","SUMOylation",0.516306339318432,0.977870017908165,-0.67354568453237,-0.976112104969655,2817,154,"NR3C2, NCOR2, SUMO1, CREBBP, SMC6, DNMT3A, NUP98, SCMH1, SUMO2, HDAC2"
"794","SUMOylation of DNA damage response and repair proteins",0.943124550035997,0.979935535138707,-0.511356466182643,-0.659588075573318,5239,70,"SUMO1, SMC6, NUP98, SCMH1, SUMO2"
"795","SUMOylation of DNA methylation proteins",0.391708496002975,0.977870017908165,-0.969572257455134,-1.32622112495112,2106,16,"SUMO1, DNMT3A, SCMH1"
"796","SUMOylation of DNA replication proteins",0.896435776731675,0.977870017908165,0.518045604617081,0.667530161562466,3998,43,"NUP93, RANBP2, AAAS"
"797","SUMOylation of RNA binding proteins",0.948545861297539,0.980957939302813,0.483774958027612,0.62384253589552,4239,46,"NUP93, RANBP2, AAAS"
"798","SUMOylation of SUMOylation proteins",0.867150306053049,0.977870017908165,0.51805554867922,0.668962607653995,3824,34,"NUP93, RANBP2, AAAS"
"799","SUMOylation of chromatin organization proteins",0.975197699496765,0.983645032793657,-0.483986401555988,-0.606885703687934,5425,54,"SUMO1, NUP98, SCMH1, SUMO2, HDAC2"
"800","SUMOylation of intracellular receptors",0.384084302325581,0.977870017908165,-0.968676162829947,-1.2152423488838,2113,25,"NR3C2, SUMO1, SUMO2"
"801","SUMOylation of transcription cofactors",0.813287720561757,0.977870017908165,-0.623995871561392,-0.767247668756012,4516,41,"NCOR2, SUMO1, CREBBP, SCMH1, SUMO2, DDX5"
"802","SUMOylation of ubiquitinylation proteins",0.840108401084011,0.977870017908165,0.553838695141923,0.716083304268948,3719,37,"NUP93, RANBP2, AAAS"
"803","Scavenging by Class A Receptors",0.0300670560242267,0.608916882116728,0.99736877614357,1.49776671027439,138,16,"APOE, APOA1"
"804","Selective autophagy",0.449559431756878,0.977870017908165,-0.907411089995165,-1.12767004341746,2499,50,"PRKAG2, UBB, DYNLL1, HSPA8"
"805","Selenoamino acid metabolism",0.0412762159750112,0.745818523134684,0.980963349366574,1.33054619603522,184,77,"SEPSECS, AHCY"
"806","Selenocysteine synthesis",0.0776545166402536,0.927755898997253,0.980982674607472,1.28963706213635,342,62,"SEPSECS, EEFSEC"
"807","Sema3A PAK dependent Axon repulsion",0.635283194057567,0.977870017908165,-0.738659110541242,-1.0320650890228,3420,15,"HSP90AB1, PAK2"
"808","Sema4D in semaphorin signaling",0.602876911871814,0.977870017908165,-0.933974391628129,-1.18663431704634,3310,23,"ARHGEF12, ARHGEF11, LIMK2"
"809","Sema4D induced cell migration and growth-cone collapse",0.60407115349349,0.977870017908165,-0.933981643038937,-1.22616653175686,3293,19,"ARHGEF12, ARHGEF11, LIMK2"
"810","Semaphorin interactions",0.90420769919427,0.977870017908165,-0.537842786476241,-0.683391067829964,5049,62,"HSP90AB1, ARHGEF12, ARHGEF11, PAK2, LIMK2, SEMA7A"
"811","Senescence-Associated Secretory Phenotype (SASP)",0.665885745179312,0.977870017908165,-0.761074748117148,-0.937383909398802,3694,44,"UBB"
"812","Separation of Sister Chromatids",0.445913682277319,0.977870017908165,-0.705162686550901,-1.02334314472279,2427,156,"PTTG1, UBB, DYNLL1, CENPP, PSMB2, BUB3, NUP98"
"813","Serotonin Neurotransmitter Release Cycle",0.655587141919965,0.977870017908165,0.573980459708432,0.833553092170371,2997,18,"RIMS1, CPLX1"
"814","Sialic acid metabolism",0.577317731773177,0.977870017908165,-0.909454748359977,-1.12058899935981,3206,32,"ST3GAL5, ST6GALNAC3, ST3GAL3"
"815","Signal amplification",0.551598837209302,0.977870017908165,-0.960237629109566,-1.20465587640415,3035,25,"GNB1, MAPK14"
"816","Signal transduction by L1",0.0528714676390155,0.79421098334342,-0.994870756563407,-1.28191511613696,289,21,"FGFR1"
"817","Signaling by BMP",0.161325564457393,0.977870017908165,-0.98400269996625,-1.25019634618753,885,23,"BMPR1A, SMAD7"
"818","Signaling by BRAF and RAF fusions",0.466391085549964,0.977870017908165,-0.857619700688744,-1.07942867749383,2594,56,"AKAP9, IQGAP1, FXR1, CAMK2A, CAMK2G"
"819","Signaling by EGFR",0.457318173614871,0.977870017908165,-0.918727362136073,-1.13537058399959,2533,47,"UBB, PTPN12, ARHGEF7, SH3GL1"
"820","Signaling by EGFR in Cancer",0.0270859843664788,0.605187072507423,-0.997165226781857,-1.27608985244413,148,22,"UBB"
"821","Signaling by ERBB2",0.937009639094374,0.979935535138707,0.496670420003833,0.639888245243539,4179,47,"NRG1, RHOA"
"822","Signaling by ERBB2 KD Mutants",0.0159609842606961,0.605187072507423,0.998582517718529,1.36691567738084,71,23,"NRG1, BTC"
"823","Signaling by ERBB2 in Cancer",0.65820269375138,0.977870017908165,0.695702481643737,0.946670848527776,2980,24,"NRG1, BTC"
"824","Signaling by ERBB4",0.575033799008562,0.977870017908165,0.745060982155087,0.969748343150346,2551,54,"NRG1, APOE, GFAP, TAB2"
"825","Signaling by Erythropoietin",0.856154406409323,0.977870017908165,-0.239140706393344,-0.303833350627918,4701,23,"VAV1, STAT5B, SOS1, SHC1, RAPGEF1, PLCG2, PLCG1, PIK3R1, PIK3CG, PIK3CD, PIK3CB, PIK3CA, NRAS, LYN, KRAS, JAK2, IRS2, HRAS, GRB2, GAB1, EPOR, EPO"
"826","Signaling by FGFR",0.0519739224918508,0.79421098334342,-0.975441763026982,-1.2692334024652,286,76,"SPRED2, UBB, FGFR1, SPRED1"
"827","Signaling by FGFR in disease",0.219647988505747,0.977870017908165,-0.964819303484897,-1.21722925667743,1222,58,"FGFR1, ZMYM2, LRRFIP1, MYO18A, FGFR2"
"828","Signaling by FGFR1",0.02270679401694,0.605187072507423,-0.994592402325267,-1.22499782926249,125,44,"SPRED2, UBB, FGFR1, SPRED1"
"829","Signaling by FGFR1 in disease",0.316222500447147,0.977870017908165,-0.969062415563361,-1.19190813884079,1767,34,"FGFR1, ZMYM2, LRRFIP1, MYO18A"
"830","Signaling by FGFR2",0.192903458213256,0.977870017908165,-0.964132150537107,-1.23193296272875,1070,65,"UBB, FGFR2"
"831","Signaling by FGFR2 IIIa TM",0.610306253438474,0.977870017908165,-0.923656825052828,-1.21261171903071,3327,19,"FGFR2"
"832","Signaling by FGFR2 in disease",0.509152907394113,0.977870017908165,-0.923611865120722,-1.13561918290497,2836,39,"FGFR2"
"833","Signaling by FGFR3",0.0150916277398491,0.605187072507423,-0.997162162162162,-1.22099379406952,83,38,"UBB"
"834","Signaling by FGFR3 in disease",0.740994475138122,0.977870017908165,0.332777702793899,0.46821077444041,3352,20,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, GAB1, GRB2, HRAS, KRAS, NRAS, PIK3CA, PIK3R1, PLCG1"
"835","Signaling by FGFR3 point mutants in cancer",0.740994475138122,0.977870017908165,0.332777702793899,0.46821077444041,3352,20,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, GAB1, GRB2, HRAS, KRAS, NRAS, PIK3CA, PIK3R1, PLCG1"
"836","Signaling by FGFR4",0.0156081808396125,0.605187072507423,-0.997162353895007,-1.2226704250285,86,37,"UBB"
"837","Signaling by Hedgehog",0.809891524177238,0.977870017908165,-0.563539853586676,-0.79181455064681,4404,126,"UBB, CUL3, OS9, CUL1, PSMB2, SPOP, KIF3A, ITCH, ADCY8"
"838","Signaling by Hippo",0.36132919481468,0.977870017908165,-0.971521122958564,-1.26298876721805,1978,20,"DVL2, WWC1"
"839","Signaling by Insulin receptor",0.307082357181474,0.977870017908165,-0.914127350918081,-1.1734958432785,1703,68,"ATP6V0C, FGFR1, ATP6V0B, PDPK1, ATP6V1C1, FGFR2"
"840","Signaling by Interleukins",0.152191724702991,0.977870017908165,0.757714257758345,1.20564009641844,742,339,"IL12B, IL1RAPL1, BCL2L1, PSMA1, CEBPD, YWHAZ, RPS6KA2, PSMB3, IL1R1, CREB1, PSMD14, PSME4, TAB2"
"841","Signaling by Ligand-Responsive EGFR Variants in Cancer",0.027076809725548,0.605187072507423,-0.997165991902834,-1.32415297131429,146,18,"UBB"
"842","Signaling by MET",0.615536419088626,0.977870017908165,-0.739363877609669,-0.941009073480724,3430,63,"UBB, SH3GL1"
"843","Signaling by NODAL",0.504735376044568,0.977870017908165,-0.962490723875059,-1.34480582510093,2717,15,"FURIN"
"844","Signaling by NOTCH",0.835459419486042,0.977870017908165,-0.534736193018757,-0.784332958637378,4518,168,"MAML3, UBB, AGO2, NEURL1, FBXW7, NCOR2, YBX1, CUL1, PSMB2, TLE4, CREBBP, MIB1, HDAC9, WWC1, ITCH, HDAC2, FURIN, ST3GAL3"
"845","Signaling by NOTCH1",0.835196538045438,0.977870017908165,-0.581603023593711,-0.753000704817024,4631,72,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, TLE4, CREBBP, MIB1, HDAC9, ITCH, HDAC2"
"846","Signaling by NOTCH1 HD Domain Mutants in Cancer",0.245682451253482,0.977870017908165,-0.979154017405384,-1.36808801748896,1322,15,"UBB, NEURL1, MIB1"
"847","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer",0.860014357501795,0.977870017908165,-0.572616604027207,-0.721852514946058,4791,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"848","Signaling by NOTCH1 PEST Domain Mutants in Cancer",0.860014357501795,0.977870017908165,-0.572616604027207,-0.721852514946058,4791,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"849","Signaling by NOTCH1 in Cancer",0.860014357501795,0.977870017908165,-0.572616604027207,-0.721852514946058,4791,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"850","Signaling by NOTCH2",0.86035529570497,0.977870017908165,0.510957431590246,0.66474439768163,3825,32,"MAML2, CREB1"
"851","Signaling by NOTCH3",0.925825663237683,0.977870017908165,-0.515382072600697,-0.636913265967261,5129,47,"MAML3, UBB, NEURL1, YBX1, CREBBP, MIB1, WWC1"
"852","Signaling by NOTCH4",0.861073825503356,0.977870017908165,0.542180412541103,0.739029548655843,3848,79,"MAML2, PSMA1, YWHAZ, PSMB3, PSMD14, PSMD9"
"853","Signaling by NTRK1 (TRKA)",0.972991071428571,0.983570292566566,0.488150988345678,0.660084166844201,4358,76,"RPS6KA2, CREB1, CLTA, RAP1A, RHOA"
"854","Signaling by NTRK2 (TRKB)",0.577367718986216,0.977870017908165,0.819659424578335,1.10251347338614,2596,25,"NTF3, BDNF"
"855","Signaling by NTRK3 (TRKC)",0.597523892267593,0.977870017908165,0.677999309668372,0.999232591382851,2750,17,"NTF3, BAX"
"856","Signaling by NTRKs",0.784139006460236,0.977870017908165,0.57080726049584,0.79821890456189,3519,97,"NTF3, PCSK5, RPS6KA2, CREB1, CLTA, RAP1A, RHOA"
"857","Signaling by Non-Receptor Tyrosine Kinases",0.758566275924256,0.977870017908165,0.634228996277234,0.819624532022905,3364,49,"NRG1, RHOA"
"858","Signaling by Nuclear Receptors",0.425084491175366,0.977870017908165,-0.683123424376659,-1.0247834862806,2263,200,"HSP90AB1, AGO2, NCOR2, KDM1A, PDPK1, GNB1, CREBBP, APOD"
"859","Signaling by PDGF",0.34001082837033,0.977870017908165,-0.962477182070178,-1.18943695957044,1883,47,"PTPN12, FURIN"
"860","Signaling by PTK6",0.758566275924256,0.977870017908165,0.634228996277234,0.819624532022905,3364,49,"NRG1, RHOA"
"861","Signaling by RAS mutants",0.68397412863816,0.977870017908165,-0.76353062870882,-0.934919308624811,3806,38,"IQGAP1, CAMK2A, CAMK2G"
"862","Signaling by ROBO receptors",0.352343918772953,0.977870017908165,0.711890050417288,1.07316593828625,1630,177,"ROBO2, PSMA1, PAK6, PAK3, PSMB3, ETF1, RNPS1, PSMD14, PSME4, RHOA, PSMD9, NCBP2"
"863","Signaling by Receptor Tyrosine Kinases",0.774751491053678,0.977870017908165,-0.523996308178405,-0.857573399988196,3896,409,"SPRED2, ATP6V0C, UBB, PTPN12, FGFR1, SPRED1, ATP6V0B, CLTC, PDPK1, SHC3, ARHGEF7, PTPRO, PAK2, SH3GL1, WWP1, MAP2K5, ATP6V1C1, GRIN2B, FGFR2, ITCH"
"864","Signaling by Retinoic Acid",0.867426782919741,0.977870017908165,0.285386277687736,0.374367374081186,3879,30,"ADH4, ALDH1A2, ALDH1A1, ALDH8A1, CPT1A, CYP26B1, DHRS3, DHRS4, DLAT, DLD, FABP5, PDHA1, PDHB, PDHX, PDK1, PDK2, PDK3, PDK4, PPARD, RARA, RARB, RARG, RDH10, RDH11, RDH13, RDH14, RDH5, RXRA, RXRB, RXRG"
"865","Signaling by Rho GTPases",0.854441599369707,0.977870017908165,-0.510235272018237,-0.820712041015895,4337,348,"YWHAG, ARHGEF12, KDM1A, PDPK1, DYNLL1, RHOF, CENPP, ARHGEF11, IQGAP1, SCAI, ARHGEF7, ARHGEF18, BUB3, PAK2, LIMK2, DVL2, NUP98, FGD4"
"866","Signaling by SCF-KIT",0.953475839770074,0.982248804367443,-0.262947695634545,-0.32350631087318,5307,40,"YES1, VAV1, TEC, STAT5B, STAT3, STAT1, SRC, SOS1, SOCS6, SOCS1, SH2B3, SH2B2, RAC1, PTPRU, PTPN6, PTPN11, PRKCA, PIK3R3, PIK3R2, PIK3R1, PIK3CA, NRAS, MMP9, LYN, LCK, KRAS, KITLG, KIT, JAK2, HRAS, GRB7, GRB2, GRB10, GRAP2, GAB2, FYN, FES, FER"
"867","Signaling by TGF-beta Receptor Complex",0.23866090712743,0.977870017908165,-0.949855774170088,-1.22519921735629,1325,70,"UBB, PMEPA1, NCOR2, SKIL, SMAD7, ARHGEF18, RNF111, ZFYVE9, FURIN, PARD3"
"868","Signaling by TGF-beta family members",0.124977424598158,0.977870017908165,-0.951375588089134,-1.28016243008626,691,93,"UBB, PMEPA1, BMPR1A, NCOR2, SKIL, SMAD7, ARHGEF18, RNF111, ZFYVE9, FURIN, PARD3"
"869","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",0.281852586051541,0.977870017908165,-0.966810869271326,-1.19078047790821,1563,44,"FGFR1, PDPK1, FGFR2"
"870","Signaling by VEGF",0.869580990386359,0.977870017908165,-0.547349998699749,-0.738609907467042,4793,95,"PDPK1, PAK2"
"871","Signaling by WNT",0.177431610942249,0.977870017908165,-0.766692534739455,-1.18447439942214,933,247,"PRICKLE1, UBB, AGO2, CUL3, ROR1, PRKG1, CLTC, CUL1, GNB1, PSMB2, TLE4, CREBBP, DVL2, CAMK2A, SMARCA4, CHD8, GNAO1"
"872","Signaling by WNT in cancer",0.8994827973915,0.977870017908165,0.205292617857625,0.267081187529708,3999,32,"AMER1, APC, AXIN1, CSNK1A1, CTBP1, CTBP2, CTNNB1, DKK2, FZD4, FZD5, FZD6, FZD8, GSK3B, KREMEN1, KREMEN2, LRP5, LRP6, PORCN, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"873","Signaling by cytosolic FGFR1 fusion mutants",0.401815487217488,0.977870017908165,-0.96903042979556,-1.30774420895457,2168,17,"ZMYM2, LRRFIP1, MYO18A"
"874","Signaling by high-kinase activity BRAF mutants",0.756194610236933,0.977870017908165,-0.69756511810273,-0.859624035756941,4180,30,"IQGAP1"
"875","Signaling by moderate kinase activity BRAF mutants",0.68397412863816,0.977870017908165,-0.76353062870882,-0.934919308624811,3806,38,"IQGAP1, CAMK2A, CAMK2G"
"876","Signaling by the B Cell Receptor (BCR)",0.81016333938294,0.977870017908165,-0.575393713542498,-0.784711628631611,4463,103,"UBB, CUL1, PSMB2, PPIA, CHUK"
"877","Signaling downstream of RAS mutants",0.68397412863816,0.977870017908165,-0.76353062870882,-0.934919308624811,3806,38,"IQGAP1, CAMK2A, CAMK2G"
"878","Signalling to ERKs",0.687556602064843,0.977870017908165,-0.7848512217064,-0.964540090530504,3795,31,"SHC3, MAPK14"
"879","Signalling to RAS",0.558540200074102,0.977870017908165,-0.960259091829161,-1.29590694762856,3014,17,"SHC3, MAPK14"
"880","Smooth Muscle Contraction",0.678371728919705,0.977870017908165,0.696549153712063,0.921891383016682,3032,28,"CALD1, ACTA2"
"881","Sphingolipid de novo biosynthesis",0.334611048478016,0.977870017908165,0.965087998373589,1.23920722945918,1483,40,"ACER3, ACER1"
"882","Sphingolipid metabolism",0.0746702436843282,0.920640180955011,0.973873197420684,1.32388030623773,333,78,"PSAP, ACER3, ACER1"
"883","Spry regulation of FGF signaling",0.0258412344301915,0.605187072507423,-0.99716637430846,-1.36396550182851,138,16,"UBB"
"884","Stabilization of p53",0.927760763826338,0.977870017908165,-0.518822023658092,-0.64651479844181,5149,52,"UBB, PSMB2"
"885","Stimuli-sensing channels",0.778418303008467,0.977870017908165,-0.602147763858091,-0.79864822429135,4320,85,"UBB, WNK2, TTYH1, WWP1, TRPM7, UNC80"
"886","Striated Muscle Contraction",0.144122965641953,0.977870017908165,-0.984472049689441,-1.23097836121786,796,26,"TMOD1"
"887","Sulfur amino acid metabolism",0.182499086591158,0.977870017908165,-0.982246523558796,-1.23880084170538,998,24,"GOT2"
"888","Surfactant metabolism",0.652173913043478,0.977870017908165,0.405933747132641,0.609598041943004,3014,16,"ABCA3, ADGRF5, ADORA2A, ADORA2B, ADRA2A, ADRA2C, CCDC59, CKAP4, CSF2RA, CTSH"
"889","Switching of origins to a post-replicative state",0.713076368876081,0.977870017908165,-0.642036901999849,-0.849437477970286,3958,83,"UBB, ORC3, CUL1, PSMB2"
"890","Synaptic adhesion-like molecules",0.47664379012619,0.977870017908165,0.958790871911915,1.33177747870366,2152,21,"PTPRD, DLG1"
"891","Syndecan interactions",0.257161600699759,0.977870017908165,0.982118758434548,1.42626480418427,1175,18,"CASK, ACTN1, FGF2"
"892","Synthesis of DNA",0.668241279069767,0.977870017908165,-0.642006749703832,-0.884403903757078,3677,111,"UBB, ORC3, CUL1, PSMB2"
"893","Synthesis of IP3 and IP4 in the cytosol",0.139240506329114,0.977870017908165,-0.984877126654064,-1.23148486719559,769,26,"SYNJ1"
"894","Synthesis of PA",0.318980983135988,0.977870017908165,-0.969267139479905,-1.19238380534802,1777,33,"LCLAT1"
"895","Synthesis of PC",0.230741279069767,0.977870017908165,-0.978532370215351,-1.22760734874003,1269,25,"LPIN2"
"896","Synthesis of PIPs at the Golgi membrane",0.513354208878246,0.977870017908165,-0.963090418353576,-1.27890346187365,2786,18,"PI4KA, SACM1L"
"897","Synthesis of PIPs at the early endosome membrane",0.00540774388924941,0.605187072507423,0.99952772905141,1.5010088488612,24,16,"INPP4B, FIG4"
"898","Synthesis of PIPs at the plasma membrane",0.36838549876154,0.977870017908165,0.890882073748452,1.15240304169022,1635,50,"INPP4B, PLEKHA1"
"899","Synthesis of active ubiquitin: roles of E1 and E2 enzymes",0.687036702223829,0.977870017908165,-0.792696219963936,-0.981173127386905,3799,28,"UBB, UBE2K"
"900","Synthesis of bile acids and bile salts",0.567012585559726,0.977870017908165,0.829246525506085,1.12838969624599,2567,24,"CYP7B1, ABCB11"
"901","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",0.018189692507579,0.605187072507423,0.998718208189975,1.51320760257211,83,15,"CYP7B1, ABCB11"
"902","Synthesis of glycosylphosphatidylinositol (GPI)",0.317326411421155,0.977870017908165,0.978612872756713,1.4696006313015,1466,16,"PIGB, DPM2"
"903","Synthesis of substrates in N-glycan biosythesis",0.358960573476703,0.977870017908165,-0.909378930764241,-1.15369752608139,2002,61,"ST3GAL5, ST6GALNAC3, ST3GAL3"
"904","Synthesis of very long-chain fatty acyl-CoAs",0.777432901223297,0.977870017908165,-0.546975795614859,-0.711074900459153,4257,20,"TECR, HACD1"
"905","Synthesis, secretion, and deacylation of Ghrelin",0.795149415331312,0.977870017908165,0.215543412264724,0.326580538382728,3671,15,"ACHE, SPCS3, BCHE, CRHR2, GHRL, IGF1, INS, KLF4, MBOAT4, PCSK1, PLA2G7, SEC11A, SEC11C, SPCS1, SPCS2"
"906","T41 mutants of beta-catenin aren't phosphorylated",0.644001732351667,0.977870017908165,0.361465290427039,0.547674029625871,2973,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"907","TAK1 activates NFkB by phosphorylation and activation of IKKs complex",0.698470502549162,0.977870017908165,-0.770916331766352,-0.979465586043256,3835,23,"CHUK"
"908","TBC/RABGAPs",0.821645997745209,0.977870017908165,0.586590688224355,0.753203254839013,3643,40,"TBC1D14, TBC1D24, TBC1D20, ARF6"
"909","TCF dependent signaling in response to WNT",0.792148229682627,0.977870017908165,-0.553236622691239,-0.805850299488825,4317,159,"UBB, CUL3, PSMB2, TLE4, CREBBP, DVL2, SMARCA4, CHD8"
"910","TCR signaling",0.874091569767442,0.977870017908165,-0.545949069721066,-0.740163328211066,4810,99,"UBB, PDPK1, CUL1, PSMB2, CHUK, PAK2"
"911","TGF-beta receptor signaling activates SMADs",0.453105310531053,0.977870017908165,-0.962717817101175,-1.18621734316819,2516,32,"UBB, PMEPA1, SMAD7, ZFYVE9, FURIN"
"912","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)",0.58393753485778,0.977870017908165,-0.94684063341044,-1.29512786729991,3140,16,"UBB, ARHGEF18"
"913","TICAM1, RIP1-mediated IKK complex recruitment",0.642274916635791,0.977870017908165,-0.808628931452146,-1.09127615581976,3466,17,"UBB, CHUK"
"914","TNF signaling",0.469391429600288,0.977870017908165,-0.946324565758105,-1.16357391139088,2606,41,"UBB, MADD, CHUK, SPPL2A"
"915","TNFR1-induced NFkappaB signaling pathway",0.702959444647424,0.977870017908165,-0.770914896486602,-0.972271216792606,3847,24,"CHUK"
"916","TNFR2 non-canonical NF-kB pathway",0.818951540263016,0.977870017908165,-0.582993530892794,-0.769320672370409,4545,82,"UBB, CUL1, PSMB2, CHUK"
"917","TNFs bind their physiological receptors",0.373496610540127,0.977870017908165,0.975438596491228,1.41656365573946,1707,18,"EDA, CD27"
"918","TP53 Regulates Metabolic Genes",0.673392181588903,0.977870017908165,-0.66710378192439,-0.880312907186082,3737,82,"PRKAG2, AGO2, YWHAG, COX8A, SESN1"
"919","TP53 Regulates Transcription of Cell Cycle Genes",0.837911095048789,0.977870017908165,-0.597239658617206,-0.735583288229559,4636,42,"CNOT6L, CNOT4"
"920","TP53 Regulates Transcription of Cell Death Genes",0.12921751615219,0.977870017908165,-0.982367247669234,-1.20539599818998,719,36,"CREBBP"
"921","TP53 Regulates Transcription of DNA Repair Genes",0.0305015815634885,0.608916882116728,0.989985790648894,1.29905006460842,134,59,"CDK13, ATF2"
"922","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release",0.201556131900704,0.977870017908165,-0.982389852236691,-1.32577326851264,1087,17,"CREBBP"
"923","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest",0.871309192200557,0.977870017908165,-0.192052890777845,-0.268339049757996,4691,15,"ZNF385A, TP53, TFDP2, TFDP1, SFN, RBL2, RBL1, PRMT1, PCNA"
"924","TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain",0.728126726837355,0.977870017908165,-0.5972873791413,-0.793147644665707,3952,18,"CNOT6L, CNOT4"
"925","TRAF6 mediated NF-kB activation",0.246850465583349,0.977870017908165,-0.978742070454852,-1.27237608300663,1351,20,"CHUK"
"926","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0.64062217399168,0.977870017908165,-0.699187901467325,-0.913224366838604,3541,78,"UBB, CUL1, CHUK"
"927","TRAF6-mediated induction of TAK1 complex within TLR4 complex",0.571402042711235,0.977870017908165,-0.956745828440209,-1.33677897491553,3076,15,"UBB"
"928","TRIF(TICAM1)-mediated TLR4 signaling",0.744156778137361,0.977870017908165,-0.620022938852429,-0.826942455749087,4138,88,"UBB, CUL1, CHUK"
"929","TRP channels",0.58586980670962,0.977870017908165,0.800967954587113,1.10321778712232,2636,22,"TRPC1, TRPC4"
"930","Tat-mediated HIV elongation arrest and recovery",0.899041071105482,0.977870017908165,-0.267658762961014,-0.331268788481901,4968,29,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"931","Tat-mediated elongation of the HIV-1 transcript",0.313174460431655,0.977870017908165,0.970466986551328,1.24782166211765,1392,41,"NCBP2, CCNH"
"932","Telomere C-strand (Lagging Strand) Synthesis",0.841769847050255,0.977870017908165,-0.462140310202644,-0.587159087328861,4622,23,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLA2, POLA1, PCNA"
"933","Telomere Maintenance",0.936425501432665,0.979935535138707,-0.428183476322367,-0.525552206070738,5228,35,"WRAP53, TINF2, TERT, TERF2IP, TERF2, TERF1, RUVBL2, RUVBL1, RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POT1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLA2, POLA1"
"934","Termination of O-glycan biosynthesis",0.603342618384401,0.977870017908165,-0.848134874913581,-1.1850261950193,3248,15,"ST6GALNAC3, ST3GAL3"
"935","Termination of translesion DNA synthesis",0.0209802857659613,0.605187072507423,-0.997163695299838,-1.22882560755814,115,30,"UBB"
"936","The citric acid (TCA) cycle and respiratory electron transport",0.974185079851236,0.983570292566566,0.480904914755436,0.715573151031077,4452,161,"ATP5MG, NDUFS1, NDUFS4, COX19, FAHD1, SDHA, OGDH, COX7C, VDAC1, HAGH"
"937","The phototransduction cascade",0.745220097821254,0.977870017908165,0.586075564197544,0.788322791850509,3351,25,"NMT1, CALM1"
"938","The role of GTSE1 in G2/M progression after G2 checkpoint",0.766450916936354,0.977870017908165,-0.648754903285903,-0.811194106440517,4262,53,"UBB, HSP90AB1, PSMB2"
"939","The role of Nef in HIV-1 replication and disease pathogenesis",0.555050872093023,0.977870017908165,-0.960035104300277,-1.20440180106464,3054,25,"PACS1, PAK2, AP1M1, ATP6V1H"
"940","Thrombin signalling through proteinase activated receptors (PARs)",0.105063291139241,0.977870017908165,-0.988252768025925,-1.23570575034337,580,26,"GNB1"
"941","Thromboxane signalling through TP receptor",0.126343090033346,0.977870017908165,-0.988259901491127,-1.33369512801543,681,17,"GNB1"
"942","Tie2 Signaling",0.876230045921714,0.977870017908165,0.17476383265857,0.253797721940038,4006,18,"ANGPT1, ANGPT2, ANGPT4, DOK2, GRB14, GRB2, GRB7, HRAS, KRAS, NRAS, PIK3CA, PIK3CB, PIK3R1, PIK3R2, PTPN11, SHC1, SOS1, TEK"
"943","Tight junction interactions",0.503608134703696,0.977870017908165,0.907842494157712,1.31839839738312,2302,18,"MPP5, CLDN1"
"944","Toll Like Receptor 10 (TLR10) Cascade",0.648258437105216,0.977870017908165,-0.699193646783515,-0.90789408714562,3591,74,"UBB, CUL1, CHUK"
"945","Toll Like Receptor 2 (TLR2) Cascade",0.627302275189599,0.977870017908165,-0.699183590436208,-0.920115269215329,3473,81,"UBB, CUL1, CHUK"
"946","Toll Like Receptor 3 (TLR3) Cascade",0.747072599531616,0.977870017908165,-0.620027253975926,-0.822362375353463,4146,85,"UBB, CUL1, CHUK"
"947","Toll Like Receptor 4 (TLR4) Cascade",0.720240262104114,0.977870017908165,-0.619997011205016,-0.848238933689885,3956,106,"UBB, CUL1, CHUK"
"948","Toll Like Receptor 5 (TLR5) Cascade",0.648258437105216,0.977870017908165,-0.699193646783515,-0.90789408714562,3591,74,"UBB, CUL1, CHUK"
"949","Toll Like Receptor 7/8 (TLR7/8) Cascade",0.637382501807665,0.977870017908165,-0.699186464651683,-0.914817535932714,3525,79,"UBB, CUL1, CHUK"
"950","Toll Like Receptor 9 (TLR9) Cascade",0.617255043227666,0.977870017908165,-0.69918071544155,-0.925040759682487,3426,83,"UBB, CUL1, CHUK"
"951","Toll Like Receptor TLR1:TLR2 Cascade",0.627302275189599,0.977870017908165,-0.699183590436208,-0.920115269215329,3473,81,"UBB, CUL1, CHUK"
"952","Toll Like Receptor TLR6:TLR2 Cascade",0.627302275189599,0.977870017908165,-0.699183590436208,-0.920115269215329,3473,81,"UBB, CUL1, CHUK"
"953","Toll-like Receptor Cascades",0.91582615074271,0.977870017908165,-0.515194831288082,-0.721348363293324,4993,123,"UBB, CUL1, CHUK"
"954","Trafficking of AMPA receptors",0.381985892566468,0.977870017908165,-0.967044840626688,-1.19170951511801,2111,30,"MYO6, CAMK2A, EPB41L1, CAMK2G"
"955","Trafficking of GluR2-containing AMPA receptors",0.697437011294527,0.977870017908165,0.295740939922288,0.43586177974295,3210,17,"AP2A1, AP2A2, AP2B1, AP2M1, AP2S1, GRIA1, GRIA2, GRIA3, GRIA4, GRIP1, GRIP2, NSF, PICK1, PRKCA, PRKCB, PRKCG"
"956","Transcription of E2F targets under negative control by DREAM complex",0.39347906632086,0.977870017908165,-0.969570204439646,-1.3084726558054,2123,17,"MAX"
"957","Transcription of the HIV genome",0.132719514933753,0.977870017908165,0.970412999322952,1.29153783450998,590,68,"NCBP2, TAF9"
"958","Transcription-Coupled Nucleotide Excision Repair (TC-NER)",0.00144927536231884,0.605187072507423,-0.997154664318136,-1.29973556863298,7,77,"UBB"
"959","Transcriptional Regulation by E2F6",0.44050405040504,0.977870017908165,-0.963325678778873,-1.18696632282923,2446,32,"YAF2, MAX, RBBP7"
"960","Transcriptional Regulation by MECP2",0.784458004307251,0.977870017908165,-0.630562806484578,-0.794900714528898,4370,57,"AGO2, NCOR2, OPRM1, SST, CAMK2A, GRIN2B, CAMK2G, HDAC2"
"961","Transcriptional Regulation by TP53",0.160616705698673,0.977870017908165,-0.737622155531758,-1.18089922214955,822,333,"PRKAG2, UBB, AGO2, JMY, YWHAG, PDPK1, BRD1, CREBBP, COX8A, CNOT6L, CNOT4, SESN1, HDAC2, RBBP7"
"962","Transcriptional Regulation by VENTX",0.89159891598916,0.977870017908165,0.367197814006325,0.476070567283859,3947,33,"AGO1, AGO3, AGO4, ANAPC1, ANAPC10, ANAPC15, ANAPC16, ANAPC2, ANAPC4, ANAPC5, ANAPC7, CCND1, CDC16, CDC23, CDC26, CDC27, CEBPB, CSF1R, CTNNB1, EHMT1, EHMT2"
"963","Transcriptional activation of mitochondrial biogenesis",0.669723121179432,0.977870017908165,-0.724454821997759,-0.905848231759739,3724,53,"CRTC3, MEF2D, CREBBP"
"964","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer",0.27889809146561,0.977870017908165,-0.968236804757721,-1.19051658049478,1548,41,"UBB, NCOR2, SKIL, SMAD7, RNF111"
"965","Transcriptional regulation by RUNX1",0.478994679875252,0.977870017908165,-0.68484409558542,-0.997551132544365,2610,159,"UBB, AGO2, PSMB2, CCND2, CREBBP, YAF2, SCMH1, SMARCA4, ITCH"
"966","Transcriptional regulation by RUNX2",0.654316481109692,0.977870017908165,-0.650493644550749,-0.892930867866723,3584,109,"UBB, FBXW7, CUL1, PSMB2, WWP1"
"967","Transcriptional regulation by RUNX3",0.694594594594595,0.977870017908165,0.618060794768287,0.855049032008332,3083,90,"MAML2, PSMA1, ITGA4, PSMB3, PSMD14, PSMD9"
"968","Transcriptional regulation by small RNAs",0.906724511930586,0.977870017908165,-0.539100849230835,-0.665443424788451,5015,46,"AGO2, NUP98"
"969","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors",0.728696041154104,0.977870017908165,0.630407436474464,0.834352005710262,3257,28,"APOE, CDKN1A"
"970","Transcriptional regulation of granulopoiesis",0.17262969588551,0.977870017908165,0.985822306238185,1.3173840403748,771,26,"CREB1, CBFB"
"971","Transcriptional regulation of pluripotent stem cells",0.551685809559096,0.977870017908165,-0.960663922812226,-1.29645328276669,2977,17,"FOXP1"
"972","Transcriptional regulation of white adipocyte differentiation",0.875028045770698,0.977870017908165,0.538171436173119,0.725818140071948,3899,75,"CEBPD, NCOA6"
"973","Transferrin endocytosis and recycling",0.608569878864581,0.977870017908165,-0.898563941512537,-1.11221268683616,3365,28,"ATP6V0C, ATP6V0B, TFRC, ATP6V1C1"
"974","Translation",0.465507465507466,0.977870017908165,-0.64606745682239,-0.994234045591134,2462,240,"SRP9, EIF4E, EIF5, MRPS21, MRPL4, MRPL21, MRPS33, SRP14, EIF4A2"
"975","Translation initiation complex formation",0.959754556939181,0.982248804367443,-0.487066377936516,-0.6019205052069,5317,47,"EIF4E, EIF4A2"
"976","Translesion Synthesis by POLH",0.439123227113649,0.977870017908165,-0.967110111722501,-1.28424127820659,2383,18,"UBB"
"977","Translesion synthesis by POLI",0.407187847350871,0.977870017908165,-0.968760542473517,-1.30737998552915,2197,17,"UBB, REV3L"
"978","Translesion synthesis by POLK",0.407187847350871,0.977870017908165,-0.968760542473517,-1.30737998552915,2197,17,"UBB, REV3L"
"979","Translesion synthesis by REV1",0.405651608105596,0.977870017908165,-0.968762650114694,-1.32511371047061,2181,16,"UBB, REV3L"
"980","Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template",0.517049533381192,0.977870017908165,-0.940626775241053,-1.15417910496918,2880,36,"UBB, REV3L"
"981","Translocation of SLC2A4 (GLUT4) to the plasma membrane",0.673326133909287,0.977870017908165,-0.742457369338695,-0.91847390212134,3740,48,"PRKAG2, YWHAG, KIF3A, KIF3B"
"982","Transmission across Chemical Synapses",0.581652155447016,0.977870017908165,0.603527369979947,0.929591278801549,2738,225,"NRG1, SLC1A3, ADCY1, PPM1E, ARHGEF9, RPS6KA2, RIMS1, CREB1, COMT, CASK, KCNJ4, GRIK2"
"983","Transport of Mature Transcript to Cytoplasm",0.267382070198972,0.977870017908165,0.86425949967901,1.1748717739992,1195,78,"SRSF2, SRSF1, SRSF7, SRSF11, NUP93, POLDIP3, RANBP2, U2AF1, RNPS1, FYTTD1, SRSF4, NCBP2"
"984","Transport of Mature mRNA Derived from an Intronless Transcript",0.942338782108856,0.979935535138707,-0.489034908582038,-0.601662923045573,5245,40,"EIF4E, SYMPK, NUP98"
"985","Transport of Mature mRNA derived from an Intron-Containing Transcript",0.150922177237967,0.977870017908165,0.957275011650112,1.27743767901207,670,70,"SRSF2, SRSF1, SRSF7, SRSF11, NUP93, POLDIP3, RANBP2, U2AF1, RNPS1, FYTTD1, SRSF4, NCBP2"
"986","Transport of Mature mRNAs Derived from Intronless Transcripts",0.945984875765214,0.980957939302813,-0.489032949373813,-0.601301078183527,5253,41,"EIF4E, SYMPK, NUP98"
"987","Transport of Ribonucleoproteins into the Host Nucleus",0.538272706985048,0.977870017908165,0.853823482726092,1.11581819523226,2411,31,"NUP93, RANBP2, AAAS"
"988","Transport of bile salts and organic acids, metal ions and amine compounds",0.0847000674005841,0.97544693006387,0.977457351746548,1.29696281878523,376,66,"SLC6A15, BSG"
"989","Transport of inorganic cations/anions and amino acids/oligopeptides",0.176931690929451,0.977870017908165,0.887196954620884,1.2338303199746,789,93,"AHCYL2, SLC1A3, SLC4A3, SLC24A2, SLC8A3, SLC4A4, SLC6A15, SLC4A10"
"990","Transport of the SLBP Dependant Mature mRNA",0.804210049796288,0.977870017908165,0.58626784557355,0.758737134173424,3552,35,"NUP93, RANBP2, NCBP2"
"991","Transport of the SLBP independent Mature mRNA",0.801632282929041,0.977870017908165,0.586268949872223,0.757046240490972,3535,34,"NUP93, RANBP2, NCBP2"
"992","Transport of vitamins, nucleosides, and related molecules",0.183237616654702,0.977870017908165,-0.977570598567761,-1.19951035649604,1020,36,"APOD"
"993","Transport to the Golgi and subsequent modification",0.582398239823982,0.977870017908165,0.628042397906183,0.928264940849781,2646,153,"MGAT5, LMAN2L, TMED9, MIA3, TBC1D20, DYNC1I2, TFG, ACTR10, ST3GAL4, MAN2A2, SEC23IP"
"994","Triglyceride catabolism",0.543223647518126,0.977870017908165,-0.960868978545405,-1.31431641928563,2921,16,"MGLL, LIPE"
"995","Triglyceride metabolism",0.532730560578662,0.977870017908165,-0.960910072913854,-1.20151659684637,2945,26,"MGLL, LPIN2, LIPE"
"996","Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",0.652390222799048,0.977870017908165,0.397255768452301,0.596566164576499,3015,16,"DCP1A, DCP2, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"997","UCH proteinases",0.868312015852999,0.977870017908165,-0.552775232264688,-0.729444480634862,4819,82,"UBB, PSMB2, SMAD7, ASXL1"
"998","Ub-specific processing proteases",0.692688290269379,0.977870017908165,-0.598610168958877,-0.866750691740421,3779,153,"UBB, USP47, PSMB2, SMAD7"
"999","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A",0.924541861300755,0.977870017908165,-0.518825261411334,-0.643003539327135,5145,49,"UBB, PSMB2"
"1000","Ubiquitin-dependent degradation of Cyclin D",0.924541861300755,0.977870017908165,-0.518825261411334,-0.643003539327135,5145,49,"UBB, PSMB2"
"1001","Unblocking of NMDA receptors, glutamate binding and activation",0.438561256162133,0.977870017908165,-0.966999595087056,-1.25711072835979,2401,20,"CAMK2A, GRIN2B, CAMK2G"
"1002","Unfolded Protein Response (UPR)",0.680057647270762,0.977870017908165,-0.658651338814292,-0.873590759186354,3774,85,"PREB"
"1003","Uptake and actions of bacterial toxins",0.650813743218806,0.977870017908165,-0.851189108864111,-1.06432211523584,3598,26,"HSP90AB1, SV2A, FURIN"
"1004","VEGFA-VEGFR2 Pathway",0.874323836999639,0.977870017908165,-0.547362322012358,-0.727770527293268,4848,87,"PDPK1, PAK2"
"1005","VEGFR2 mediated cell proliferation",0.10397946084724,0.977870017908165,-0.990080302314596,-1.2998149797675,566,19,"PDPK1"
"1006","VEGFR2 mediated vascular permeability",0.804347826086957,0.977870017908165,-0.577870500880935,-0.728805290442099,4402,24,"PDPK1, PAK2"
"1007","Vasopressin regulates renal water homeostasis via Aquaporins",0.678984357288597,0.977870017908165,0.714817437835165,0.923040277109071,2994,34,"ADCY1, ADCY2"
"1008","Vif-mediated degradation of APOBEC3G",0.924541861300755,0.977870017908165,-0.518825261411334,-0.643003539327135,5145,49,"UBB, PSMB2"
"1009","Viral Messenger RNA Synthesis",0.470298139430621,0.977870017908165,0.853810226662887,1.10018128417332,2097,43,"NUP93, RANBP2, AAAS"
"1010","Viral mRNA Translation",0.816893830703013,0.977870017908165,-0.60444217115215,-0.764563339215538,4554,59,"RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"1011","Visual phototransduction",0.380439659039928,0.977870017908165,0.817733690745843,1.09531735609631,1695,71,"APOE, NMT1, ABCA4"
"1012","Vitamin B5 (pantothenate) metabolism",0.748375920311823,0.977870017908165,0.237266410308305,0.359494132548374,3455,15,"AASDHPPT, COASY, ENPP1, ENPP2, ENPP3, FASN, PANK1, PANK2, PANK3, PANK4, PDZD11, PPCDC, PPCS, SLC25A16, SLC5A6"
"1013","Voltage gated Potassium channels",0.607674943566591,0.977870017908165,0.761511238769353,0.979729298923307,2691,39,"KCND2, KCNAB2, KCNG2"
"1014","Vpr-mediated nuclear import of PICs",0.533843040251855,0.977870017908165,0.853822378874865,1.11080416465579,2373,32,"NUP93, RANBP2, AAAS"
"1015","Vpu mediated degradation of CD4",0.925305975521958,0.977870017908165,-0.518826340370528,-0.641826013240189,5140,48,"UBB, PSMB2"
"1016","VxPx cargo-targeting to cilium",0.253805244819366,0.977870017908165,-0.978406100276672,-1.28448864446898,1383,19,"ARF4"
"1017","WNT ligand biogenesis and trafficking",0.688880774146431,0.977870017908165,-0.759366986097989,-0.987185920072778,3772,20,"WNT9A, WNT7B, WNT7A, WNT5B, WNT5A, WNT4, WNT3A, WNT3, WNT2B, WNT2, WNT16, WNT10A, WNT1, WLS, VPS35, VPS29, VPS26A"
"1018","WNT5A-dependent internalization of FZD4",0.64828226555246,0.977870017908165,-0.693878639058014,-0.969497172878161,3490,15,"CLTC, DVL2"
"1019","XBP1(S) activates chaperone genes",0.769536184804187,0.977870017908165,-0.658736668824417,-0.814072016584122,4263,47,"PREB"
"1020","ZBP1(DAI) mediated induction of type I IFNs",0.252500926268989,0.977870017908165,-0.97874637338911,-1.32085625226953,1362,17,"CHUK"
"1021","Zinc transporters",0.627483751160631,0.977870017908165,-0.756594481548944,-1.05712464628212,3378,15,"SLC39A8, SLC39A7, SLC39A6, SLC39A3, SLC39A2, SLC39A14, SLC39A10, SLC39A1, SLC30A8, SLC30A7, SLC30A6, SLC30A5, SLC30A3, SLC30A2, SLC30A1"
"1022","activated TAK1 mediates p38 MAPK activation",0.573414422241529,0.977870017908165,0.735724047953586,1.08430707302479,2639,17,"TAB2, IKBKG"
"1023","mRNA 3'-end processing",0.28819287967553,0.977870017908165,0.923101061064102,1.20147980630786,1278,54,"SRSF2, SRSF1, SRSF7, SRSF11, POLDIP3, U2AF1, CPSF7, RNPS1, FYTTD1, SRSF4, NCBP2"
"1024","mRNA Capping",0.415865921787709,0.977870017908165,0.970490917685191,1.27902410121132,1860,29,"NCBP2, CCNH"
"1025","mRNA Splicing",0.375647668393782,0.977870017908165,0.697744463582963,1.0559675790352,1739,184,"SRSF2, SRSF1, SRSF7, SRSF11, LSM7, HNRNPU, U2AF1, CPSF7, SRSF10, RNPS1, ELAVL1, SRSF4, TRA2B, NCBP2"
"1026","mRNA Splicing - Major Pathway",0.384233261339093,0.977870017908165,0.69775958061795,1.05121793771386,1778,176,"SRSF2, SRSF1, SRSF7, SRSF11, LSM7, HNRNPU, U2AF1, CPSF7, SRSF10, RNPS1, ELAVL1, SRSF4, TRA2B, NCBP2"
"1027","mRNA Splicing - Minor Pathway",0.477047704770477,0.977870017908165,0.81913338016304,1.0617975853883,2119,51,"SRSF2, SRSF1, SRSF7, NCBP2"
"1028","mRNA decay by 3' to 5' exoribonuclease",0.639670853183196,0.977870017908165,0.376374553059435,0.570263794565646,2953,15,"DCPS, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"1029","mRNA decay by 5' to 3' exoribonuclease",0.108055435253356,0.977870017908165,0.99190447277879,1.50288377334624,498,15,"LSM7, DCP1A"
"1030","mTOR signalling",0.344580043072505,0.977870017908165,-0.966532134709089,-1.18596580867752,1919,36,"PRKAG2, STRADA, EIF4E"
"1031","mTORC1-mediated signalling",0.121599415738543,0.977870017908165,-0.988392495613443,-1.28492174803248,665,20,"EIF4E"
"1032","p53-Dependent G1 DNA Damage Response",0.929032258064516,0.977870017908165,-0.518813383222726,-0.657381740350347,5183,60,"UBB, PSMB2"
"1033","p53-Dependent G1/S DNA damage checkpoint",0.929032258064516,0.977870017908165,-0.518813383222726,-0.657381740350347,5183,60,"UBB, PSMB2"
"1034","p53-Independent DNA Damage Response",0.924541861300755,0.977870017908165,-0.518825261411334,-0.643003539327135,5145,49,"UBB, PSMB2"
"1035","p53-Independent G1/S DNA damage checkpoint",0.924541861300755,0.977870017908165,-0.518825261411334,-0.643003539327135,5145,49,"UBB, PSMB2"
"1036","p75 NTR receptor-mediated signalling",0.725278676734987,0.977870017908165,-0.628147205939147,-0.840527704047493,4033,90,"UBB, ARHGEF12, ARHGEF11, ARHGEF7, ARHGEF18, FGD4, HDAC2"
"1037","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex",0.644001732351667,0.977870017908165,0.361465290427039,0.547674029625871,2973,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"1038","rRNA modification in the nucleus and cytosol",0.301874012192368,0.977870017908165,0.913429294789049,1.19023769092318,1336,55,"NOL11, FCF1, UTP11, BMS1"
"1039","rRNA processing",0.732478155791039,0.977870017908165,-0.572453609522403,-0.846981035402107,3939,178,"RBM28, XRN2, EBNA1BP2, EXOSC10, TBL3, UTP4"
"1040","rRNA processing in the mitochondrion",0.804089830199014,0.977870017908165,-0.409178026724254,-0.531936197096173,4403,20,"TRMT10C, TFB1M, PRORP, NSUN4, MTERF4, MT-ND5, MT-ND4, MT-ND3, MT-ND2, MT-ND1, MT-CYB, MT-CO3, MT-CO1, MT-ATP8, MT-ATP6, MRM3, MRM2, MRM1"
"1041","rRNA processing in the nucleus and cytosol",0.749448123620309,0.977870017908165,-0.572502771080852,-0.832406081924603,4073,158,"RBM28, XRN2, EBNA1BP2, EXOSC10, TBL3, UTP4"
"1042","snRNP Assembly",0.439810640216411,0.977870017908165,0.850435114250793,1.099031243644,1950,49,"NUP93, RANBP2, NCBP2"
"1043","tRNA Aminoacylation",0.308586762075134,0.977870017908165,0.977585741290845,1.30637727055384,1379,26,"FARSA, AARS2"
"1044","tRNA modification in the nucleus and cytosol",0.857271702367531,0.977870017908165,0.550693545206967,0.707110049640063,3801,40,"TRMT1, ADAT1"
"1045","tRNA processing",0.23370288248337,0.977870017908165,0.82633834435826,1.17864446614029,1053,112,"NUP93, RANBP2, TRMT1, AAAS"
"1046","tRNA processing in the mitochondrion",0.73136270682283,0.977870017908165,-0.392608959654568,-0.53702680964246,3933,16,"TRNT1, TRMT10C, PRORP, MT-ND6, MT-ND5, MT-ND4, MT-ND3, MT-ND2, MT-ND1, MT-CYB, MT-CO3, MT-CO1, MT-ATP8, MT-ATP6"
"1047","tRNA processing in the nucleus",0.400316098442086,0.977870017908165,0.853796949078643,1.11253417750666,1772,55,"NUP93, RANBP2, AAAS"
"1048","trans-Golgi Network Vesicle Budding",0.725567976920303,0.977870017908165,-0.650102603574141,-0.841687025060377,4023,72,"CLTC, TFRC, HSPA8, PUM1, AP1M1"
